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Background: Previous research has demonstrated that plasma carotenoids are a reliable biomarker of
usual fruit and vegetable intake. The review aims were to synthesize (i) the mean dietary intake and (ii)
plasma concentrations of carotenoids reported from validation studies (iii) compare the strength of the
relationship between the two, measured using different dietary assessment methods.
Methods: Six databases were used to locate studies that included: adult populations, assessment of di-
etary intake, measurement of plasma carotenoids and reported the comparison between the two
measures.
Results: One hundred and forty-two studies were included with 95,480 participants, the majority of
studies were cross-sectional (n ¼ 86), with randomized controlled trials (RCTs) (n ¼ 18), 14 caseecontrol
studies and 13 cohorts. The most common reported dietary carotenoid and plasma carotenoid was
lycopene: weighted dietary mean intake (4555.4 ug/day), and plasma concentration 0.62 umol/L (95% CI:
0.61, 0.63, n ¼ 56studies. The strongest weighted correlation between the two measures was found for
cryptoxanthin (r ¼ 0.38, 95% CI 0.34, 0.42) followed by a-carotene (r ¼ 0.34, 95% CI 0.31, 0.37).
Conclusion: This review summarizes typical dietary intakes and plasma concentrations and their ex-
pected associations based on validation studies conducted to date which provides a benchmark for future
validation studies.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epidemiological studies have reported that regular consump-
tion of fruits and vegetables, in accordance with World Cancer
Research Fund guidelines [1], is associated with reduced risk of
some cancers including breast, oesophageal and lung [2e6]. In
addition having an adequate fruit and vegetable intake substan-
tially lowers risks of coronary heart disease [7,8], stroke [9,10] and
type 2 diabetes mellitus [11,12] speciﬁcally showing decreased risk
with higher consumption of green leafy vegetables [13,14]. In
addition fruit and vegetable intake has been associated with
decreased risk of asthma in adults and children [15].
A variety of plant components such as ﬁber, carotenoids andniversity Dr, Callaghan, NSW
T.L. Burrows).
Ltd. This is an open access article uother phytochemicals are thought to contribute to these protective
effects [16]. Carotenoids are obtained from the diet as brightly
coloured pigments which originate in plant foods. Variations in
digestion and absorption exist between individuals, with plasma
concentrations of carotenoids having a half-life between 26 and 76
days [17]. However some carotenoid supplement studies report
peak concentrations in plasma up to two weeks following con-
sumption [18].
The main carotenoids of interest are lycopene and b-carotene
and this is because of the documented associations with decreased
risk of disease. These carotenoids are highly prevalent in fruits and
vegetables. Speciﬁcally lycopene is found in tomatoes and tomato
based products while b-carotene is found in high concentrations in
carrots and cantaloupe. Other carotenoids including cryptoxanthin
are found in fruits such as oranges, while lutein is found in lettuce,
kale and spinach [19]. Lutein is often combined with zeaxanthtin in
reports due to chromatographic overlap.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mental to a range of research domains, including epidemiological
studies examining the relationship between dietary intake and
disease outcomes, evaluating whether populations are consuming
adequate intakes of fruit and vegetables and hence obtaining the
protective advantage from disease and monitoring of changes in
population intakes over time. Measuring the dietary intake of ca-
rotenoids and examining the relationship with plasma carotenoid
concentrations is one way in which intake can be scrutinized using
an independent biomarker and the validity of intake assessment
method evaluated.
Validity is deﬁned as the accuracy of a measure, assessed by
comparing results from an assumed “gold standard” measure of
known validity such as doubly labelled water, to values obtained by
another instrument. In free living individuals, there is no gold
standard measure of total or individual nutrient intakes when
comparing actual intake with that measured using a dietary
assessment method or tool [20]. However, comparison of one di-
etary intake assessment method to another method is a common
approach, but does carry the risk of correlated errors [21,22].
Plasma biomarkers offer an objective and independent variable
that can act as a proxy for intake of speciﬁc foods and therefore is
suitable for use when validating dietary assessment tools [23].
Regardless of individual variability in absorption, availability, and
metabolism [24,25], plasma concentrations of carotenoids reﬂect
intake of fruits and vegetables due to their abundance in these
foods [24]. Due to the diverse phytochemical composition across a
range of vegetables and fruits, selecting a single carotenoid as sole
biomarker is not likely to be meaningful [26]. Instead, a range of
carotenoids is recommended when using them as biomarkers of
fruit and vegetable intake. Previous research has shown a dos-
eeresponse relationship between intake and appearance of carot-
enoids in plasma [27], making carotenoids a fairly reliable
biomarker of total carotenoid intake However, the strength of the
relationship between intake of individual dietary carotenoids and
plasma concentrations across a range of studies has not been
ascertained. Establishing reference ranges for diet and plasma ca-
rotenoids, could allow comparison of speciﬁc dietary tools in terms
of validity statistics in measuring dietary intakes of carotenoids
and/or fruits and vegetables.
Therefore the aims of this review were to synthesize from the
best available dietary validation studies to date (i) the mean dietary
intake of carotenoids in adults; (ii) the mean plasma carotenoid
concentrations reported in dietary validation studies (iii) the
strength of the relationship between dietary intakes of carotenoids,
measured using different dietary intake assessment methods, and
plasma carotenoid concentrations.
2. Methods
A three-step strategy was undertaken to identify studies pub-
lished in the English language up to May 2014. The review meth-
odology was registered with PROSPERO (ID number
CRD42013004777).
In stage one, six online databases were searched, CINAHL,
Cochrane, MEDLINE, ProQuest, PubMed and Excerpta Medica. Key
words used individually and in combination were: dietary assess-
ment OR food frequency questionnaire OR diet/dietary recall, diet
record, weighed food record, validity/validation AND carotene OR
carotenoids OR fruit OR vegetable. Electronic searches were sup-
plemented by manual cross checking of the reference lists of rele-
vant publications. All study designs were included.
After the removal of duplicates, stage 2 involved the assessment
of titles and abstracts of identiﬁed studies by two independent
reviewers with discrepancies decided by consensus using a thirdreviewer. A'priori inclusion/exclusion criteria were applied to
determine the eligibility of each publication for inclusion in the
review, as per the following inclusion criteria: adult populations
(18 or 19  yrs or ‘adults’ depending on the database searched), a
measure of dietary intake, a measure of plasma carotenoids as a
biomarker of intake, reported the comparison/correlation/agree-
ment between diet and biomarker assessments. Carotenoids,
individually or in combination, included a- and b-carotene, cryp-
toxanthin, lycopene, zeaxanthin, and lutein. Papers that met the
inclusion criteria, or where eligibility was unclear, were retrieved.
These were then evaluated for inclusion by two independent re-
viewers with discrepancies discussed with a third person.
Risk of bias was assessed using a standardized tool from the
American Academy of Nutrition and Dietetics [28]. Ten quality
criteriawere rated as being absent, present or unclear in each study.
This included the assessment of population bias, study blinding, a
description of the intervention and assessment tool, statistical
methods, and study funding. An overall quality rating was assigned
to each study as being plus/positive, neutral or minus/negative.
Data were extracted using standardized tables developed for
this review. In cases of uncertainty regarding quality assessment, or
data extraction, a third independent reviewer was consulted until
consensus was reached.
The dietary intakes of carotenoids and plasma carotenoid con-
centrations, and the relationship between them, were grouped by
dietary assessment method where possible. These dietary intake
assessment methods were 24 h recall, food frequency question-
naire (FFQ), diet history, food records, and other non-standard di-
etary questionnaires which included dietary methods not covered
by the other categories.
2.1. Data synthesis
Results were pooled using meta-analysis if the following data
were available in addition to the reported number of participants:
correlation coefﬁcients (or equivalent) between dietary carotenoid
intake and plasma carotenoid concentrations (a carotene, b caro-
tene, cryptoxanthin, lutein/zeaxanthin and lycopene); dietary in-
takes (reported as mg/day) and plasma concentrations. For plasma
concentrations the data were entered as mmol/L and if reported in
other units they were converted to mmol/L using the relevant
conversion factors. If there was signiﬁcant heterogeneity, the
random effects model was used for statistical analysis. If studies
reported more than one correlation statistic between diet and
plasma due to use of multiple dietary assessment methods, the
strongest correlation was used (n ¼ 3 studies).
Analysis were undertaken by each individual carotenoid and
also separately for each diet assessment method (24 h recall, FFQ,
diet history, food record and questionnaire) and where possible,
overall regardless of diet assessment method. Sub-analysis by sex
was also undertaken if there were enough studies to conduct
separate meta-analyses. The reporting of the associations between
diet and plasma carotenoid concentrations was rarely separated
out by supplement use versus no use, supplements weremost often
added into dietary intake estimates thus the impact of supplements
could not be compared in this review.
There were not enough studies for comparison by ethnicity.
Meta-analyses were conducted using Comprehensive Meta-
Analysis Professional version 2 (Englewood, New Jersey, USA).
3. Results
The search strategy identiﬁed 4176 articles, as outlined in Fig. 1.
For the full search strategy see Supp Table 1. Following elimination
of duplicates, initial assessment of titles and abstracts, and
Fig. 1. Flow diagram of article identiﬁcation retrieval and inclusion for the systematic review.
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articles from 142 studies were identiﬁed for critical appraisal and
included in the review.
The results of the quality assessment appraisal are summarized
in Supplementary Table 2. The majority of included studies were
classiﬁed as being of positive quality (n ¼ 111, 77%), with ten (7%)
classiﬁed as being of negative quality and 23 (16%) of neutral
quality. Ten percent of studies (n ¼ 13) did not describe the
handling of withdrawals or non-completers and the majority of
studies only conducted correlation analysis and not other valida-
tion statistics such as Bland Altman and Kappa statistics. As the
inclusion criteria for the current review included all study types, a
large proportion of the studies were cross-sectional and appropri-
ately deemed as “not applicable” against the criteria of “assessing
the comparability of study groups” (n¼ 92, 65%) and “description of
intervention” (46%).
As shown in Table 1, over half of the studies (n ¼ 69) were
conducted in the USA with the next most common regions being
the UK (n ¼ 9), France (n ¼ 7), Italy (n ¼ 6) and the Netherlands
(n ¼ 5). The majority of included studies were cross-sectional
(n ¼ 86), followed by randomized controlled trials (RCTs)
(n ¼ 18) with 14 studies for caseecontrol and 13 for cohort. The
total number of participants was 95 480 across the included
studies. The majority of studies included healthy individuals free of
disease and not takingmedications and assessed both sexeswith 31
assessing females only and six studies conducted in males only
[19,24,29e37].3.1. Diet
In descending order the most common dietary assessment
methods used were: food frequency questionnaires (n ¼ 103
studies), 24 h recalls (n ¼ 35), food diary/estimated food records
(n ¼ 30) with reporting period between one and seven days,
generic food questionnaire or fruit and vegetable screeners
(n ¼ 11), weighed food records (n ¼ 10) with reporting periods
varying between two and seven days, diet history method (n ¼ 6)
and diet quality score (n ¼ 2). Of those studies which utilised an
FFQ, a total of 36 studies provided extra details regarding the
reporting period. The most common reporting periods were the:
previous 12 months (n ¼ 23), previous three months (n ¼ 7) and
previous month (n¼ 7). A total of 58 studies reported details on the
number of items within an FFQ, with a mean number of 128 food
items (range 27e255). There were 43 studies which assessed di-
etary intake using two of the above methods simultaneously, while
ﬁve studies [20,38e41] used three or more methods within the
same study. As shown in Table 2, the most common dietary carot-
enoids assessed were: b-carotene (n ¼ 88 studies), followed by
lycopene (n ¼ 47) and a-carotene (n ¼ 46). Thirty eight studies
assessed lutein and zeaxanthin as a combined variable, while only
18 assessed lutein and seven zeaxanthin individually. Sixteen
studies assessed dietary intake as intake of fruits and vegetables
only, rather than individual carotenoid intakes. The nutrient data-
bases used to evaluate dietary carotenoids varied with over 21
different databases used. The most common however was the
Table 1
Description of included studies.
Source Country Study design n Gender Age Dietary method þ
reporting period
Dietary carotenoids
assessed
Nutritional database
used
Biochemical
carotenoids assessed
Biochemical
method
Fasting
time length
AAA Epic group,
(1997) [61]
Spain Cohort 64 47% M 35e60 yrs Diet history (baseline &
12 months)
12  24-hr recalls during
the 12 months
b-carotene EPIC nutrient database
for nutritional
epidemiology
b-carotene, a-carotene,
cryptoxanthin,
lycopene,
luteinzeoxanthin,
HPLC 12 h fast
Alberti-Fidanza et al.
(1998) [62]
Italy Cross sectional 79 44% M >30 yrs Diet history þ
2-day WFR,
2-day duplicate portion
chemical analysis
b-carotene, retinol European food
composition tables
b-carotene, a- HPLC 12 h fast
Al-Delaimy et al.
(2005) [44]
France, Italy,
Sweden,
Netherlands,
Denmark, Spain,
Germany, UK,
Greece
Prospective
cohort
2969 NR 45 yrs Food questionnaires (FQ)
Dietary method differed
for each country. FQ were
either extensive, semi-
quantitative, diet history,
food record or 24hr
recall.
Fruits and vegetables EPIC nutrient database
for nutritional
epidemiology
Lutein, zeaxanthin, b-
cryptoxanthin,
lycopene, a-carotene,
b-carotene
HPLC NR
Allen et al. (2003)
[63]
USA RCT 40 (36
completed)
50% M 18e65 yrs Daily checklist of
lycopene containing
foods to assess
compliance with
allocated diets. 3-day FR
(3 time points over 6
weeks)
Lycopene (3 groups
-tomato sauce, tomato
soup and tomato juice)
USDA food composition
database
Lycopene, a-carotene,
b-carotene, lutein, b-
cryptoxanthin,
zeaxanthin,
HPLC Fasting
Anderson et al.
(2005) [64]
Norway Cross sectional 100 with 3
measures; 86
with 4
measures.
100% M 20e55 yrs 14 day 3 d WFR (5
periods/1 week apart
180-item FFQ (8 veg
questions, 8 fruit
questions, dietary
supplements),
27-item FFQ.
Fruits and vegetables. Database developed by
Department of
Nutrition, University of
Oslo.
Lutein, zeaxantin,
lycopene, a-carotene,
b-carotene
HPLC 12hr fast
Arab et al. (2011)
[65]
USA Prospective cohort 262 33% M 21e69 yrs 24 h recalls using web-
based DietDay - 9349
foods, >7000 food
images þ 124 item diet
history FFQ.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, and the
combined intakes of
lutein and zeaxanthin.
USDA food composition
database and National
Cancer Institute
database.
Lycopene, a-carotene,
b-carotene, b-
cryptoxanthin and
combined
lutein þ zeaxanthin
HPLC 10hr fast
Arnaud et al. (2001)
[31]
Cuba Prospective cohort 106 100% M 27e59 yrs Semi-quantitative FFQ (7
consecutive days at 4
time points over a 1yr
period)
Total carotenoids Cuban NUTRISIS food
composition database
Lycopene, a-carotene,
b-carotene, b-
cryptoxanthin, lutein-
zeaxanthin,
HPLC 12hr fast
Bermudez et al.
(2005) [66]
USA Cross sectional 584 41% M 60 yrs 118-item semi-
quantitative FFQ. 13 fruit,
23 vegetable items plus
dietary supplement use.
a-carotene, b-carotene,
b-cryptoxanthin,
lutein, zeaxanthin, and
lycopene þ b-carotene
from supplements.
MN (Minnesota?) Food
and Nutrient Database
a-carotene, b-carotene,
lycopene lutein,
zeaxanthin, b-
cryptoxanthin,
HPLC 12hr fast
Bernstien et al.
(2002) [67]
USA RCT 70 20% M 70 yrs Modiﬁcation of Gladys
Block FFQ. Food list
collapsed into 32 food
groups.
a-carotene, b-carotene,
cryptoxanthin, lutein,
lycopene,
NR a-carotene, b-carotene,
cryptoxanthin, lutein,
lycopene,
NR 12hr fast
Bingham et al.
(1995; 1997) [68
e71]
UK Prospective cohort 160 160 50e65 yrs 4-day weighed food
records at 4 timepoints
over 12 months - 2 FFQs
(each with 130 food
items) were completed -
27% of question related to
vegetables in Cambridge
FFQ and 18% in Oxford., 2
variants of the 24hr recall
(structured/
unstructured) and 3
types of food diary (7-day
record þ 2 checklists).
b-carotene equivalents Food tables a-carotene, b-carotene,
cis-carotnen, b-
cryptoxanthin, lutein,
lycopene,
Absorptiometric
detection
Overnight fast
Block et al. (2001)
[24]
USA Cross sectional 116 100% M 35e72 yrs
(Mean 52 yrs)
60-item FFQ (National
Cancer Institute)
Fruits and vegetables National Cancer
Institute software.
b-carotene,
cryptoxanthin,
HPLC NR
including 10 vegetable
and 6 fruit items.
Bodner et al. (1998,
1999) [72,73]
UK Cross sectional 273 NR 39e45 yrs Self-administered FFQ b-carotene UK National Nutrient
Databank
b-carotene HPLC Avoid fruit and fruit
juice 6 h prior
Boeing at al (1997)
[74]
Germany Longitudinal Cross
sectional
92 47% M 35e64 yrs Self-administered 158-
item FFQ (baseline and
12-months) þ
24hr recalls monthly/12
months
a-carotene þ b-
carotene (combined)
Federal Coding System
(V 2.1)
a-carotene þ b-
carotene (combined)
Unclear NR
Bogers et al. (2003;
2004) [45,75]
Netherlands RCT (2003 only
reports Cross
sectional data;
2004 report
additional follow-
up data)
161 100% F 41± 4 yrs 106-item semi-
quantitative FFQ
assessing food intake
over the previous month.
17 fruit items, 21
cooked vegetable items,
14 raw vegetable items
and 5 fruit juice items.
Completed at baseline,
1 þ 12 months.
total vegetables,
cooked vegetables, raw
vegetables, fruit, fruit
juice
Unclear a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein,
HPLC Overnight fast
Bolton-Smith et al.
(1991) [76]
UK Cross sectional 196 100% M 45.8 ± 2.9 yrs FFQ b-carotene McCance and
Widdowson's The
Composition of Foods
Carotenes Unclear NR
Bone et al. (2000)
[77]
USA Cross sectional 19 16% M 18e59 yrs Health Habits and
History questionnaire
frequency of
consumption weekly,
monthly, yearly.
Lutein þ zeaxanthin Nutritionist V (First
Data Bank, CA, USA).
Lutein þ zeaxanthin HPLC Not fasting
Bowman et al.
(2011) [78]
USA Case control 38 50% M Mean: 74 yrs 124-item FFQ (National
Cancer Institute)
assessing intake over the
previous 12 months.
Completed at baseline
and 1 month.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
National Cancer
Institute Diet*Calc
version 1.4.3
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC Overnight fasting
Brantsaeter et al.
(2007) [79]
Norway Cross sectional 119 100% F Range 23e44 yrs,
Mean 31 yrs
Semi-quantitative 255-
item FFQ with additional
items on dietary
supplements. þ 4-day
weighed food record
b-carotene, total
carotenoids
FoodCalc and
Norwegian food
composition table.
b-carotene HPLC Non-fasting
Brunner et al. (2001)
[80]
UK Cross sectional 860 53% M 39e61 yrs 127-item FFQ including
questions of supplement
intake. þ
7-day diet diary
including photos of
portion sizes.
Carotenes (b-carotene
activity)
4th and 5th versions of
McCance and
Widdowson's The
Composition of Foods
b-carotene HPLC 4e8 h
Burri et al. (2010)
[81]
USA Cross sectional 49 51% M Mean ± SD 39.7
± 12.3 yrs
FFQ developed from US
national dietary intake þ
3-day diet record was
completed with photos
provided to estimate
portion size.
lycopene Block dietary data
systems to analyse FFQ
and USDA for 3-day
diet record.
Lycopene HPLC Overnight fast
Campbell et al.
(1994) [82]
USA Cross sectional 99 51% M 18e37 yrs FFQ Foods high or low in
carotenoids
Food carotenoid
composition data
Lutein; cryptoxanthin;
Lycopene; a-carotene;
b-carotene
HPLC Fasted overnight
Canﬁled et al. (1997)
[83]
USA RCT 12 100% F 23e36 yrs 3 24-h dietary-intake
records completed incl.
weekdays and I weekend
day.
a-carotene, b-carotene,
lutein, lycopene
US Department of
Agriculture (USDA)
Continuing Survey of
Food Intake II-86
database.
a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC Fasted
Canﬁeld et al.,)2001)
[84]
Honduras RCT 97 100% F 15e43 yrs 24-h dietary recall Not determined UC a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC Non-fasted
(continued on next page)
Table 1 (continued )
Source Country Study design n Gender Age Dietary method þ
reporting period
Dietary carotenoids
assessed
Nutritional database
used
Biochemical
carotenoids assessed
Biochemical
method
Fasting
time length
Cappuccio et al.
(2003) [85]
UK Cross sectional 271 39% M 18e70 yrs 24-h dietary recall Not determined NR b-carotene only HPLC Non-fasted
Carlsen et al. (2011)
[86]
Norway Cross sectional 147 UC 18e80 yrs 7-d weighed food records Not determined Food database AE-07
and KBS software
system (KBS, version
4.9, 2008)
a-carotene, b-carotene,
lutein, zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC Fasted
Carroll et al. (1999)
[87]
Ireland Cross sectional 118 50% M for 24
e45yrs 46%
M > 64 yrs group
n ¼ 64 for
24e45 y
and n ¼ 54
for >65 y groups
7-d estimated food
records and FFQ
a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
Reference to dietary
analysis programme,
Comp-Eat (Nutrition
Systems, London, UK).
a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC NR
Cartmel et al. (2005)
[88]
USA RCT 57 72% M
28% F
>21 yrs FFQ to determine F & V
intakes
Not determined serves of F & V a -carotene, b -
carotene, lutein,
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC NR
Cena et al. (2008)
[89]
Italy Cross sectional 87 100% F 20.25 yrs FFQ validation by 7-
d food records
lutein and zeaxantin USDA-NCI carotenoid
database
lutein and zeaxanthin HPLC fasted
Cena et al. (2009)
[90]
Italy Cross sectional 21 100% F 24e42 yrs FFQ lutein USDA-NCI carotenoid
database
lutein HPLC fasted
Chung et al. (2009)
[91]
USA Cross sectional 25 52% M 31.9 ± 2.0 yrs FFQ a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
DietSys (version 3.7)
nutrient analysis
software
a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC fasted
Ciulla et al. (2001)
[92]
USA Cross sectional 280 49% M 18e50 yrs FFQ Dietary b - carotene
and lutein plus
zeaxanthin
University of
Minnesota Nutrition
Coding Centre
Database
b - carotene and lutein
plus zeaxanthin
HPLC NR
Coates et al. (1991)
[93]
USA Cross sectional 91 100% F 30e69 yrs FFQ a-carotene, b-carotene,
lutein, b-
cryptoxanthin,
lycopene
USDA a-carotene, b-carotene,
lutein plus zeaxanthin,
b-cryptoxanthin,
lycopene
HPLC Non-fasting
Cooney et al. (1995)
[94]
USA Cross sectional 21 48% M 31e63 yrs FFQ NR USDA a-carotene, b-carotene,
lutein plus zeaxanthin,
b-cryptoxanthin,
lycopene
HPLC Fasted
Curran-Celentano
et al. (2001) [95]
USA Cross sectional 280 NR 36 ± 7.9 yrs
(Mean ± SD)
FFQ b-carotene;
lutein þ zeaxanthin;
lycopene
USDA b-carotene; lutein;
zeaxanthin; lycopene
HPLC NR
Dauchet et al. (2008)
[96]
France Randomised,
double-blind,
placebo-
controlled,
primary-
prevention trial
3521 42% M 35e60 yrs 6  24 h dietary records F & V UC b-carotene HPLC Fasted
Daures et al. (2000)
[97]
France Cross sectional 87 29% M 41.9 ± 11.8 yrs FFQ b-carotene UNIDAP Plasma b-carotene HPLC Fasted
Dixon et al. (1996)
[98]
USA Cross sectional 10 70% M 24e65 yrs 4 FFQ and 10 3-
d food records
Dietary total
carotenoids
ESHA nutrient
database, version 3.0
Serum a-carotene, b-
carotene, lutein plus
zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC Fasted
Dixon et al. (2006)
[99]
USA Cross sectional 130 34% M >20 yrs 1 FFQ and 4 24hr
food recalls
a carotene, b carotene,
lutein þ zeaxanthin,
cryptoxanthin
University of
Minnesota Nutrition
Data System for
Research (NDSR)
Serum a-carotene, b-
carotene, lutein plus
zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC Fasted
Eliassen et al. (2006)
[100]
USA Cross sectional 214 51% M 49% F Mean e 47.7 yrs FFQ F & V and supplements NCI Serum a-carotene, b-
carotene, lutein plus
zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC NR
El-Sohemy et al.,
2002 [101]
Costa Rica Case control study 459 75% M Men 56 ±
11 Women
59 ± 10 yrs
FFQ and 7 d food record a-carotene, b-carotene,
lutein plus zeaxanthin,
b-cryptoxanthin,
lycopene
USDA Serum a-carotene, b-
carotene, lutein plus
zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC Fasted
Enger et al. (1995)
[102]
USA Case control study 215 63% M 50e74 yrs FFQ a-carotene, b-carotene,
lutein plus zeaxanthin,
b-cryptoxanthin,
lycopene
Nutrient data base
Mangels et al. (1993).
Serum a-carotene, b-
carotene, lutein plus
zeaxanthin, b-
cryptoxanthin,
lycopene
HPLC Fasted
Faure et al. (2006)
[103]
France Cross sectional 12,741 39% M 35e60 yrs 6 d food records b-carotene SU.VI.MAX computer b-carotene HPLC Fasted
Fawzi et al. (2004)
[104]
USA Cross sectional 204 100% F AA 30.0 (6.1)
Caucasian
32.5 (4.0)
FFQ a-carotene, lutein plus
zeaxanthin, lycopene
USDA Serum a-carotene,
lutein plus zeaxanthin,
lycopene
HPLC NR
Ferrari et al. (2005)
[105]
9 European
countries
Cross sectional 2910 48% M NR FFQ & 24 h food record a-carotene, b-
cryptoxanthin, and
lycopene
EPIC a-carotene, b-
cryptoxanthin, and
lycopene
NR NR
Floreani et al. (2000)
[106]
Italy Case control study 210 16% M 51.5 ± 10 yrs FFQ F&V UC lutein, zeaxanthin,
lycopene, b-carotene,
a-carotene, b-
cryptoxanthin
HPLC NR
Forman et al. (1993)
[46]
USA Cross sectional 57 100% M 20e40 yrs Health Habits and
History Questionnaire
(FFQ)100 items with 16
items fruit, 19
vegetables þ 7 d food
diary checked by
dietitian at end of study
for completeness
a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
USDA carotenoids a -carotene, b -
carotene, lutein plus
zeaxanthin, b -
cryptoxanthin,
lycopene
HPLC Fasted
Freedman et al.
(2010) [107]
USA cohort 1811 100% F 50e79 yrs FFQ lutein plus zeaxanthin Nutrient and food
group estimates were
computed at the Fred
Hutchinson Cancer
Research Center,
Seattle, Washington
Lutein and zeaxanthin NR Fasted
Freisling et al. (2009)
[108]
Austria Cross sectional 226 27% M 55e98 yrs FFQ & 1-day estimated
food record
lutein, zeaxanthin, b-
carotene, a-carotene, b-
cryptoxanthin
Department of
Nutritional Sciences of
the University of
Vienna
Lutein, zeaxanthin, b-
carotene, a-carotene, b-
cryptoxanthin
HPLC Fasted
Galan et al. (2005)
[109]
France RCT 3128 42% M F ¼ 35e60;
M ¼ 45-60
6 24-hr recalls over 18
months (4 week days and
2 weekend days
b - carotene French CIQUAL
table þ Mc Cance and
Widdowson's
b-carotene HPLC 12 h
George et al. (2012)
[38]
USA Cross sectional 470 54% M F ¼ 53± 8 yrs;
M ¼ 54± 8 yrs
1 diet history
questionnaire -FFQ (prev
12 m) þ 2(min)  24R
(103e105 days
apart) þF&V
screener(past 1 m)
a-carotene, cis- and
trans-b-carotene,cis-
and trans-b-
cryptoxanthin, lutein,
zeaxanthin, and cis-
and trans-lycopene
FFQ -1994e96 (CSFII)
Nutrition Data Systems
for Research (NDS-R)
from the University of
Minnesota þ24R (Food
intake Analysis System
a-carotene, cis- and
trans-b-carotene,cis-
and trans-b-
cryptoxanthin, lutein,
zeaxanthin, and cis-
and trans-lycopene
HPLC Fasted
Gerber et al. (2000)
[110]
France Cross sectional 146 47% M 49 ± 14 1X FFQ (PAST 12M) Total carotenoids UNIDAP a-carotene, b-
carotene,b-
cryptoxanthin, lutein,
lycopene
HPLC NR
Gomez-Aracena
et al. (2003)
[111]
Spain Cross sectional 51 100% F 62 ± 5 48 h recall (2 successive
days) þ FFQ
a-carotene, b-carotene,
lycopene
Spanish Food Comp
Tables
a-carotene, b-carotene,
lycopene
HPLC NR
Goodman et al.
(1996) [112]
USA Cross sectional 1182 M & F Median (IQR):
A-EM ¼ 56(51e63);
H-SM ¼ 58(53e62);
H-SF ¼ 58(53e62)
FFQ þ data on vitamin
supp use
b-carotene USDA b-carotene HPLC Not fasted
Greene et al. (2008)
[113]
USA 295 (3 sites:
URI ¼ 176, IIT/
Rush ¼ 57,
Emory ¼ 276)
M&F Adults with 40% >
60 yrs
Multiple pass 24R þ FV
screener
NR speciﬁcally NR a-carotene, b-
carotene,b-
cryptoxanthin, lutein/
zeaxanthin, lycopene
HPLC Fasted
Grievink et al. (1999)
[114]
Netherlands Cross sectional 227 49% M 59.8 ± 6.3 yrs FFQ (past 12m) b-carotene NR b-carotene HPLC NR
(continued on next page)
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Source Country Study design n Gender Age Dietary method þ
reporting period
Dietary carotenoids
assessed
Nutritional database
used
Biochemical
carotenoids assessed
Biochemical
method
Fasting
time length
Hallfrisch et al.
(1994) [115]
USA Cross sectional - 431 54% M 20e95 yr 7-day diet record þ vit
supp
Carotenes USDA, McCance &
Widdowson,
Pennington & Church,
Dicks,Physician's Desk
Reference ﬁr Non-
prescription Drugs
b-carotene HPLC Fasted
Hammond et al.,
1995 [116]
Finland Cross sectional 20 (ten pairs) F ¼ 6 pairs; M ¼ 4
pairs
19e22 yrs FFQ (100 items; time
frame not speciﬁed)
b-carotene, lutein/
zeaxanthin, lycopene,
cryptoxanthin
Health Habits&History
Questionnaire Diet
System Analysis
Software (v3)
Lutein, zeaxanthin, b-
carotene
HPLC NR
Hann et al., 2001
[117]
USA Cross sectional
case control
340 100% F All ¼ 21e80 yr;
mean ± SEM ¼
49.9 ± 0.6 yr
3-day food record,
Healthy Eating Index
score calculated
b-carotene USDA þ food
manufacturers (in
program
NUTRITIONIST IV)
a-carotene, b-
carotene,b-
cryptoxanthin, lutein,
lycopene (n ¼ 333)
HPLC Fasted
Hebert et al., 1994
[118]
USA Cross sectional 167 56%M mean ± SD:
39.0 ± 11.6
FFQ (timeframe NR) b-carotene University of
Minnesota's Nutrition
Data System
b-carotene NR Fasted
Hercberg et al., 1994
[119]
France Cross sectional 834 M&F 18e97 yr; Dietary survey interview
by dietitian (101 food/
beverage items
collected) þ previous 6 m
b-carotene French self database b-carotene HPLC Fasted
Hendrickson et al.
(2013) [19]
USA Case control? 2787 100% F 30e35 yrs FFQ with supplements
assessed also
(supplement users later
excluded from analysis)
a-carotene b-carotene,
b- cryptoxanthin
lycopene, lutein/
zeaxanthin
USDA a-carotene b-carotene,
b- cryptoxanthin
lycopene, lutein/
zeaxanthin
HPLC Fasted (approx. 7 h)
Hiraoka et al. (2001)
[120]
Japan Cross sectional 150 100% F 21e22 yr 3-day WFR b-carotene Standard Tables of Food
Composition in Japan
b-carotene HPLC Fasted
Hodge et al. (2009)
[121]
Australia Cohort 3100 35% M Mean ± SD:
M ¼ 55.3 ± 8.5;
F ¼ 54.5 ± 8.5
FFQ (including supps) -
prev 12 months
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein/
zeaxanthin
USDA a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein/
zeaxanthin
HPLC NR
Holmes et al. (2007)
[32]
USA Cross sectional 104 100% M Mean ± SD ¼
63.3 ± 7.5
FFQ lycopene, b-carotene USDA (þMcCance &
Widdowson's, journals
and manufactures
Lycopene, a-carotene,
b-carotene
HPLC Not fasted
Iribarren et al.
(1997) [122]
USA Case Control 323 60%M Mean ± SD ¼
59 ± 5
FFQ (66 item), past 12 m pro-vitamin A
carotenoids
NR b-carotene HPLC Fasted
Jacques et al. (1995)
[123]
USA Cross sectional 471 31% M 65 yrs 3-d food record total carotenoids GRAND þ USDA for
carotenoids
Total carotenoids HPLC NR
Jansen et al. (2004)
[124]
Netherlands Cross sectional 591 48% M 20e59 yrs;
mean ± SD:
M ¼ 39.5 ± 11.5;
F ¼ 39.6 ± 11.6
FFQ (178 item); past 12
months
Fruit and veg only
reported
n/a a-carotene; b-carotene,
b-cryptoxanthin,
luetin, lycopene,
zeaxanthin,
canthaxanthin
HPLC Not fasted
Jarvinen et al. (1993)
[125]
Sweden Cross sectional 341 male and female Mean 56.8 ± 12.1 Diet history interviews
for previous 1 yr period
a -carotene, b -
carotene, gamma
carotene, lutein,
lycopene
Finnish foods database b - carotene HPLC Yes 8 h
Jilcott et al. (2007)
[33]
USA RCT 236 1005 M 40e64 yrs; ave
53 yrs
Dietary Risk Assessment
(54Q) þ FFQ (136 item)
(n ¼ 104 completed)
Fruit and veg only
reported
NR a-carotene; b-carotene,
b-cryptoxanthin,
luetin, lycopene,
zeaxanthin
HPLC Fasted
Kabagambe et al.
(2001) [126]
Costa Rica caseecontrol
study
120 65% M Mean ± SD ¼
59 ± 10
FFQ (past
12 m) þ 7  24R (7/12m)
(ref) þ FFQ (1 yr later)
a-carotene, b-caroten,
b-cyrptoxanthin,
lycopene, and
zeaxanthin þ lutein
USDA a-carotene, b-caroten,
b-cyrptoxanthin,
lycopene, and
zeaxanthin þ lutein
HPLC Fasted
Kanetsky et al.
(1998) [127]
USA caseecontrol 145 (total): 32
with cervial
dysplasia, 113
controls
100% F 18 yrs FFQ (60 items, past 12m) a-carotene, b-carotene,
lycopene,
cryptoxanthin, luetin
HHHQ-DIETSYS V 3.0 a-carotene, b-carotene,
lycopene,
cryptoxanthin, luetin
Radioimmunoassay
techniques
Yes
Kant et al. (2002)
[128]
USA Cross sectional 13,400 F ¼ 6948;
M ¼ 6452
20 yrs 24hr recall NR speciﬁcally; F&V
intake (in addition to
various quantitative
ax)
USDA a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein/
zeaxanthin
See ref paper#29 & 30
Kant et al. (2005)
[129]
USA Cross sectional 8719 49% M 20 yrs <
50 yr ¼ 5896;
50 yrs ¼ 2764
24hr recall þ3 diet
quality scores: Healthy
Eating Index (HEI);
Recommended Food
Score (RFS); Dietary
Diversity Score (DDS-R)
NR NR a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein/
zeaxanthin
NR Fasted
Kardinaal et al.
(1995) [130]
Netherlands Cross sectional 85 45% M 50e70 yrs;
mean ± SD,
M ¼ 59.5 ± 6.3,
F ¼ 58.3 ± 5.9
FFQ (95 item; prev 12
mths)
b-carotene Dutch Food
Composition Table
b-carotene HPLC Not fasted
Katsouyanni et al.
(1997) [131]
Greece longitudinal 80 53% M 25e67 yrs 2 FFQ (190-items,
previous 12
mths) þ 12 24hr recalls
1 per mth in between
FFQs
b-carotene Composition of Greek
Foods and Dishes
a-carotene b-carotene HPLC Fasted
Kiely et al. (1999)
[132]
Ireland Case control 66 100% F 16e40 yrs FFQ b-carotene Compeat 4 þ EU AAIR
for carotene
b-carotene HPLC Not fasted
Knutsen et al. (2001)
[133]
USA longitudinal 193 M&F Mean ± SD B:
total ¼ 47.2 ±
14.8; F ¼ 46.0 ±
13.7; M ¼ 49.3
± 16.5.
4 24hr recall þ FFQ
(200 item, time not
speciﬁed) þ 4x 24hr
recall e 8 24 h recall
collected over ~6mths
Carotene Nutritional Data
Systems
Carotene spectrophotometry
method (Deluca - ref#26)
Fasted
Kobayashi et al.
(2011) [134]
Japan Cross sectional 215 47% M M: 55.6 ± 5.2,
F: 53.3 ± 5.3
7-d DR e measuring
equipment provided.
a -carotene, b -
carotene, lycopene,
created 2 databases
[1]: raw food only [2];
compensated database
to consider cooking
losses Standard tables
of food composition in
Japan (FCT5) and USDA
Serum a -carotene, b -
carotene, lycopene
NR NR
Le Marchand et al.
(1994) [135]
Hawaii Cohort 15 80% M 63.6(54e77) 3-d DR measuring
equipment provided
a -carotene, b -
carotene, lutein, b -
cryptoxanthin,
lycopene,
For carotenoids:
Mangels et al. The
carotenoid content of
fruits and vegetables:
an evaluation of
analytical data
a -carotene, b -
carotene, lutein, b -
cryptoxanthin,
lycopene,
HPLC 12 h
Lin et al. (2010)
[136]
Taiwan Case-control 34 case (COPD);
43 controls
COPD: 21M, 13F;
HC: 13M, 30F
COPD: 70.4 ±
9.6; HC: 63.9 ±
5.9
Personal interview; 24 h
food recall; semi-
quantitative FFQ (68 F&V
items e 'cooling',
'neutral' and 'heating'
foods)
a -carotene, b -
carotene
USDA National
Nutrient Database for
Standard Reference,
release 20
a -carotene, b -
carotene, lutein,
lycopene
HPLC Yes, time not given
Liu et al. (1992)
[137]
USA longitudinal n ¼ 224 100% F 24 h recall group:
23.8 ± 4.8;
biochemical ax:
23.6 ± 4.7
FFQ at baseline using
visual cues, þ24 h dietary
recall at baseline, 2mths,
4mths, 6mths
b - carotene National Cancer
Institute
b - carotene UC No
Ma et al. (2009)
[138]
China RCT 37 51% M 22e30 yrs FFQ at baseline and ﬁnal
visit (12wks).
Lutein, B-carotene,
retinol equivalents
analysis not described lutein, B-carotene HPLC Yes, overnight
Machefer et al.
(2007) [34]
France Cross sectional 19 100% M 41.4 ± 1.8 7-d DR, Retinol, b - carotene analysed using
computer dietary
analysis Ciqual
B-carotene, retinol HPLC NR
Maleksha et al.
(2006) [139]
Iran longitudinal,
reproducibility
study
131 51M, 80F in text.
However, Table 2
shows 49M, 82F
M: 51.2(13.2);
F: 49.9(9.8)
12 mths study: 150-item
semi-quantitative FFQ
x4; 24hr food recalls x12;
B-carotene nutritionist software
V.IV, USDA FCT for most
items, Iran FCT for
some items
Lutein, zeaxanthin,
canthaxanthin, B-
cryptoxanthin,
lycopene, a-carotene,
B-carotene No
HPLC NR
Mandel et al. (1997)
[140]
USA Cross sectional 42 86% M 61.6 ± 1.2 7-d DR e 3
representative days
selected. Analysed with
Nutritionist IV interface
software
B-carotene USDA and National
Cancer Institute
B-carotene HPLC NR
Margetts et al.
(1993) [141]
ENGLAND Cross sectional 1844 42% M 16e64 Short questionnaire
included questions on
general dietary habits; 7-
d WFR
Carotene (not
speciﬁed)
NR a-carotene, B-carotene NR NR
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Source Country Study design n Gender Age Dietary method þ
reporting period
Dietary carotenoids
assessed
Nutritional database
used
Biochemical
carotenoids assessed
Biochemical
method
Fasting
time length
McNaughton et al.
(2005) [142]
Australia RCT 28 39% M 48 ± 10.5 129-item semi-
quantitative FFQ at
baseline (for previous 6
months); WFR for 2
nonconsecutive days
every 2months  6
a -carotene, b -
carotene, lutein, b -
cryptoxanthin,
lycopene, total
carotenoids
US Dep Agriculture
supplemented by
Nutrition Program,
University Queensland
a -carotene, b -
carotene, lutein
(includes zaexanthin),
b - cryptoxanthin,
lycopene, total
carotenoids
HPLC Non fasting
Meyerhardt et al.
(2005) [143]
USA Cross sectional 192 NR Median 55 [29e85] 1 131-item semi-
quantitative FFQ,
(previous 3 months).
a -carotene, b -
carotene,
lutein þ zeaxanthin,
lycopene, b -
cryptoxanthin
USDA supplemented
information for some
supplements and BF
cereals
a -carotene, b -
carotene,
lutein þ zeaxanthin,
lycopene, b -
cryptoxanthin
HPLC Y. 39%fasted only
Michaud et al.
(1998) [144]
USA cohort 307 39% M Mean ± SD M:
55.4 ± 10.5; F:
52.7 ± 7.2
FFQ at baseline and at 12
mths (131-item FFQ
completed by men, 126-
item FFQ completed by
women), period
evaluated 12 mths; 1-
week diet record x2 over
12 mths,
a -carotene, b -
carotene,
lutein(þzeaxanthin),
lycopene, b -
cryptoxanthin
USDA a -carotene, b -
carotene, lutein,
lycopene, b -
cryptoxanthin
HPLC UC
Mohammadifard
et al. (2011) [39]
Iran cohort T1: 123; T2: 101 T2: 64M, 59F; T2:
53M, 48F
Mean SD T1:
40.7 ± 8.4; T2:
41.1 ± 8.2
110 item FFQ designed to
assess fruit and veg
intake in adults of
Isfahan. 1 24hr recall. 2
 food records, 3 non-
consecutive days (inc 1
weekend day).
None. Just whole fruits
and vegetables
National Nutrition &
Food Technology
Research Institute
B-carotene HPLC Fasting overnight
Natarajan et al.
(2006) [145,146]
USA RCT 1013 100% F NR 153-item, semi-
quantitative FFQ,
reporting period 3mths,
completed at baseline
and 12 mths; 4 24-hr
diet recalls, (including
2wkd days and 2 week
days) over a 3-wk period
at baseline and 12 mths,
Total carotenoids
(diet þ supplements)
FFQ: USDA CSFII a -carotene, b -
carotene, lutein
(þzeaxanthin),
lycopene, b -
cryptoxanthin
HPLC Y. NR
Newby et al. (2003)
[30]
USA cross sectional 187 men 53.3 ± 0.4 24 h diet recall þ FFQ 40
items and reporting
period 1 year
Total carotene index Multiple risk factor
intervention trial lipid
research based on
USDA
Total carotene HPLC 12 h fast
Nolan et al. (2007)
[147]
Ireland Cross sectional 828 35% M 20e60 166-item semi-
quantitative FFQ
reporting period
previous 2e3 months
Lutein, zeaxanthin Food composition data
from UK, US and
European sources plus
recipes/manufacturer
information where
needed
Lutein, zeaxanthin HPLC NR
Neuhouser et al.
(2007) [148]
USA Cross-sectional 413 100% F Mean. Non-
hispanic white
31.6 yr, Hispanic
38.8 yr, Native
American 38.7 yr
Interview: section 1 e
household pantry
inventory with Y/N
responses to the
presence of speciﬁc
foods. 5 A DAY for Better
Health Questionnaire FFQ
5A DAY fruit and
veg serves
NA a -carotene, b -
carotene,
lutein þ zeaxanthin,
lycopene, b -
cryptoxanthin
HPLC Yes. Time NR
Ocke et al. (1997)
[149]
The
Netherlands
cohort 121 52% M M:20e60 yrs;
F: 20e70 yrs
Dutch EPIC 178-item FFQ,
reporting period 1yr,
administered baseline, 6
mths, 12 mths (focused
on relative validity of
baseline FFQ); 24-hr
recall interview/
month  12; quarterly
blood collections  4
b - carotene Adapted version of
1993 computerised
Dutch FCT; weighted
mean nutrient
composition derived
from database of the
Dutch National Food
Consumption Survey
1987/88.
b - carotene HPLC No
Olafsdottir et al.
(2006) [150]
Iceland Cross sectional 53 100% F 36± 5 yrs 2  24-hr recalls over 1
month; 130-item semi
quantitative FFQ, period
for 3 months; assisted by
portion pictures of 3
portion sizes
b - carotene National Nutrition
Database ISGEM
b - carotene HPLC Yes. Time NR
Palli et al. (1999)
[151]
Italy caseecontrol 945 59% M M: 59.5; F: 57.8 FFQ 181 items asked with
aid of an atlas containing
pictures of foods and
portion sizes, period for
12 months prior
Carotene (not
speciﬁed)
Italian FCT carotene (represents
alpha, beta and
gamma)
HPLC Yes, Time NR
Pierce et al. (2006)
[152]
USA Randomised trial 2922
(participants
were from the
WHEL study
100% F 18e70 yrs Self-reported dietary
intake using a set of four
24hr dietary recalls over
a 3 week period.
None, whole foods
only. Food, juice and
supplements
Minnesota Nutritional
Data System software
(Nutritional Data
System version 4.01,
2001 University of
Minnesota,
Minneapolis, MN
a -carotene, b -
carotene, b-
cryptoxanthin,
lutein þ zeaxanthin,
lycopene
HPLC Fasting (unsure of
time length)
Pollard et al. (2003)
[153]
England Cross sectional 54 100% F 54.2 yr (range:
51.8e56.7 yrs)
4 day food diary
previously completed for
the Non-Starch
Polysaccharide substudy
from the UK Women's
Cohort Study. 24 hr recall
performed at second
time point
b-carotene, carotene
equivalents
Dietary assessment
package COMP-EAT
(Carlson Bengston
Consultants Ltd,2001)
b-carotene, lutein,
cryptoxanthin and
lycopene
HPLC Overnight fast.
Polsinelli et al.
(1998) [154]
USA Cross sectional 20 100% F Mean 52.7 yrs
(range 45e65 yrs)
7 day food records Fruit and vegetable
intake
Nutritionist IV for
Windows software
(version 4.0, 1995, First
DataBank, The Hearst
Corporation,
a -carotene, b -
carotene, b-
cryptoxanthin, lutein,
lycopene
HPLC Fasted (unsure of
time length)
Porrini et al. (1995)
[155]
Italy Cross sectional 38 11 M 33 F Mean age 27.1
(SD 6.3) yrs
Semi-quantitative FFQ
(Fidanza et al., 1994). List
of 93 foods most
commonly consumed
foods in Italy. Followed
by 7 day weighed food
record.
b-carotene Nutrient database
compiled from food
composition tables plus
partly published data
on cooked foods
b-carotene HPLC Overnight fast.
Rao et al. (2007)
[156]
Canada Cross sectional 33 100% F 56.33 ± 0.45 yrs Seven day FR lycopene NutriBase 5 Clinical
Edition software
(Cybersoft, In., AZ).
lycopene, b-
cryptoxanthin, a- & b-
carotene, lutein
HPLC 12 h fast
Re et al. (2003) [157] Britain Cross sectional 1687 Free living:
632 M, 643 F.
Institution:
204 M, 208 F.
(yrs) [64e84] Four day dietary record
(weekdays and weekend
days).
Weight/type of tomato
products consumed on
summed: Raw/
processed Tomato
containing products
NR lycopene (n ¼ 1055) HPLC Overnight fast
from 22:00 h.
Resnicow et al.
(2000) [158]
USA Cross sectional 1114 28% M 18e87 yrs Three FFQ's. 1. Seven
item F þ V FFQ for past
month 2. two item
measure of no of F þ V
serves consumed/day. 3.
36-item measure of F þ V
intake. A subsample
(n ¼ 414) also completed
a 24hr recall
a -carotene, b -
carotene, lutein,
cryptoxanthin,
lycopene
USDA Nutrition
Coordinating Center
database
a -carotene, b -
carotene, lutein,
cryptoxanthin,
lycopene
HPLC UC
Rifas-Shiman et al.
(2001) [159]
USA Longitudinal 160 43%M 16e65 yrs PrimeScreen (18 items on
foods and 7 items on
vitamin supplements)
and a 131 item semi-
quantitative FFQ
b-carotene, lutein/
zeaxanthin
Harvard Nutrient
composition database
b-carotene, lutein/
zeaxanthin
UC UC
Ritenbaugh et al.
(1996) [160]
USA Cross sectional 162 57% M Females 57.3 ±
11.7 Males 57.5 ±
11.0yrs.
Arizona FFQ, modiﬁed
from Block's HHHQ.
a -carotene, b -
carotene, lutein,
lycopene
Block's carotenoid ﬁle
output. Mangel's data
base.
a -carotene, b -
carotene, lutein,
lycopene
HPLC UC
Rock et al. (1997)
[161]
USA Cross sectional 109 60% M 21e84 yrs Fred Hutchinson Cancer
Research Centre FFQ
based on previous 3
month intake
b - carotene Minnesota Nutrition
Data System nutrient
database.
a - carotene, b -
carotene, b -
cryptoxanthin,
lycopene, lutein
HPLC No. Sample
taken 3hr
postprandial
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Rock et al. (1999)
[162]
USA Cross sectional 1042 39% M 37.8% (18e34 yrs),
44.5% (35e54 yrs),
17.7% (55 þ yrs)
Health Habits and
History Questionnaire
(FFQ)100 items with 16
items fruit, 19
vegetables þ 7 d food
diary
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
University of
Minnesota's Nutrient
Data System.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein,
zeaxanthin
HPLC 6 h fast
Rock et al. (2001)
[163]
USA RCT 53 (27 in
intervention
group and 26 in
control group
100% 27.8 ± 0.6 yrs
(mean ± SD).
Range 19e45 yrs.
Self-administered FFQ
with a reference period of
'over the past yr',
consisted of 122 food
items, 19 adjustment
questions on food
purchasing and
preparation and
summary questions on
usual intake of F þ V.
a-carotene, b-carotene,
b-cryptoxanthin,
lutein/zeaxanthin,
lycopene, total
University of
Minnesota (Version
2.92, 1996,.
a-carotene, b-carotene,
b-cryptoxanthin,
lutein/zeaxanthin,
lycopene
HPLC NR
Rock et al. (2002)
[164]
USA Cross sectional 2786 (1368 in
cohort)
39% M Cross-section:
44 ± 16 yrs (range
18e92 yrs), Cohort:
45 ± 16 yrs (range
18e91 yrs)
Self-administered FFQ
with reference period of
'over the past month'
Lutein þ zeaxanthin Minnesota Nutrition
Coordinating Centre
(NCC) nutrient
database (Minneapolis)
a-carotene, b-carotene,
b-cryptoxanthin,
lutein, zeaxanthin,
lycopene
HPLC Fasted, unsure
of time
Romieu et al. (1990)
[165]
USA Cross-section 370 NR e semi-quantitative FFQ
(116 food items)
Frequency of
consumption over the
past yr.
Food high in
carotenoids
Computed using
empirical weights?
b-carotene HPLC Non-fasted
Romieu et al. (1999)
[166]
Mexico Cohort 110 All female Mean(SD) 35.7(9.6)
years, range
15e54 years
FFQ developed using the
methodology described
by Willett et al. and
included a matrix listing
of 116 food items
(relevant to Mexican
people) & 10 frequencies
of consumption. The FFQ
was administered at
baseline and at 1 year.
four 24 h recalls every 3
months for a total of 16
24 h recalls per
participant over the 1
year study.
a-carotene, b-carotene,
lycopene,
lutein þ zeaxanthin,
total carotene
USDA complemented
by the National
Institute of Nutrition in
Mexico database.
No Plasma a- carotene,
b-carotene, lycopene,
lutein, zeaxanthin
NR Non fasting
Russel-Briefel et al.
(1985) [29]
USA Baseline of
intervention
187 only 35 had
bloods
male Age 53.3 ± 0.4 weight
(lb) 191 2.1
24 h recall þ FFQ of 40
items reporting period
1 yr info on supplements
collected in addition
Total carotene Multiple risk factor
intervention Trial lipid
research clinics food
analysis tape based on
USDA
Total plasma
carotenoids
12 h
Ryden et al. (2012)
[167]
Sweden Cross sectional 284 49% M Male: 57 [52e62]
yrs, female: 57
[51e63] yrs
FFQ with 92 country
speciﬁc food items. Also
included questions about
regular vitamin
supplementation (±3
times/week) and alcohol
intake also assessed.
Intake of high
carotenoid F þ V
Not speciﬁed. b-cryptoxanthine, a-
carotene, b-carotene,
lutein (þzeaxanthin),
lycopene
HPLC Fasted, unsure
of time
Stallone et al. (1997)
[168]
England Cross sectional 865 53% M Male: 50.0 ± 6.0 yrs
(range 39e61),
Female: 50.0 ±
6.0yrs (range
39e61 yrs)
Open-ended estimated
seven-day diet diary with
7 time periods: before
breakfast, breakfast, mid-
morning, lunch, tea,
evening meal, later
evening.
Carotene (as total b-
carotene activity)
Computerised system
developed for the
Whitehall II dietary
data. based on the 4th
and 5th editions of
McCance and
Widdowson and
supplementary tables
Plasma b-carotene HPLC 4- 8 h
Sasaki et al. (2000)
[169]
Japan Cross sectional 86 49% M Male: 41.9 ± 8.3
(range 31e58),
a-carotene, b-carotene
and total carotene
Intakes calculated
using an ad-hoc
HPLC Non-fasted
Female: 43.2 ±
10.6 (range 24e67)
Diet history
questionnaire (prev
month).
computer algorithm
developed to analyse
the questionnaire
Serum a-carotene, b-
carotene and total
tene
Satia et al. (2009)
[170]
USA Cross sectional 164 (81 White,
83 African
American (AA)
47% M Mean (SD): White:
32.5 (7.9) yrs.
African-American:
30.9 (7.9) yrs.
Antioxidant Nutrient
Questionnaire: 92 item
self administered
questionnaire. Included
80 foods. Dietary recalls:
4 unannounced
telephone administered
24-hr recalls. Dietary
supp inventory:
a- carotene, b-
carotene, b-
cryptoxanthin,
lutein þ zeaxanthin,
lycopene
Nutrition Data System
software (version
5.0.35, 2006, University
of Minnesota,
Minneapolis)
arotene, b-
tene, b-
toxanthin,
in þ zeaxanthin,
pene
UC Semi-fasted (6 h)
Schroder et al.
(2001) [40]
Spain Cross sectional 44 30% M Mean ± SD:
30.7 ± 10.4 yrs
1) 3d EFR
weekdays þ weekends.
2) 72 h recall
questionnaire with food
list of 90 foods A subset
(n ¼ 19) completed a 2nd
72 h recall. 3) FFQ
administered twice at 6
week interval. 157 food
items A subset (n ¼ 29)
repeated the FFQ
b-carotene Diet Analysis
Nutritionist IV (N
squared computing,
San Bruno, SA, USA)
rotene (Blood
ples obtained once
9 subjects and
ce, onemonth apart,
nother 24
ticipants.
HPLC Fasted (unsure of
time length)
Shai et al. (2005)
[171]
Israel Cohort 161 78% M Mean ± SE: 50.0
± 0.5 yrs
1) Three semi-
quantitative FFQ at 1
month, 6 months and 13
months. 2) Six 24hr recall
interviews on random
workdays using a
modiﬁed USDA 24hr
recall. At 1,3,6,8,11 and
13 months
b-carotene NR rotene at 1 and 6
nths
Spectrophotometrically Fasted
overnight
Signorello et al.
(2010) [172]
USA Cross sectional 255 (125 African
American (AA),
130 non-
Hispanic
whites)
AA: 63 F, 62 M.
Whites: 64 F,
66 M.
40þ 59 yrs: AA:
25 F, 32 M. White:
18 F, 23 M.
50e59 yrs: AA:
20 F, 17 M. Whites:
22 F, 20 M. 60 þ
yrs AA: 18 F, 13 M.
Whites: 24 F, 23 M.
89-item FFQ
administered through a
computer-assisted in-
person interview. Nine
items are speciﬁc to fruits
or fruit juices, 13 are
speciﬁc to vegetables.
a- carotene, b-
carotene, b-
cryptoxanthin,
lutein þ zeaxanthin,
lycopene
nutrient databases
developed for the SCCS
that were based on
dietary patterns in the
southern US.
arotene, b-
tene, b-
toxanthin,
in þ zeaxanthin,
pene
HPLC Non-fasted
Roidt et al. (1988)
[173]
USA Cross sectional 302 57% M Mean (SD): 58.5
(4.6) yrs. (Range
48e68 yrs)
FFQ with 71 food items
assessing frequency of
intake over the past yr.
b-carotene, UC arotene and b-
tene
Reverse phase HPLC NR
Sauvageot et al.
(2013) [174]
Luxembourg Cross Sectional 922 51%M M/F
18e29yrs e 78/82
30e49yrs e 207/193
50e69yrs e 185/177
Semi quantitative FFQ, 73
items over the past 3
months, photos to guide
portion size, in of on
supplement use also
collected
b-carotene þ
Fruit and vegetable
SU.VI.MAX rotene UC 8 h fast
Shiraishi et al.
(2013) [35]
Japan Cross sectional 95 100% F Mean ± SD 35.3 ± 4.9 Diet History
Questionnaire 22 page
reporting period prev
month, in of on
supplements also
obtained
b-carotene Japanese food
composition tables
rotene HPLC UC
Stryker et al. (1990)
[175]
USA Cross sectional 330 42% M Mean ± SD: 35.4 ±
13.5 F; 35.8 ± 12.3 M
Self-administered FFQ -
116 food categories
including major food
sources of preformed Vit
A and carotene.
Additional frequency and
type of vitamin
supplementation
Carotene (carotenoid
precursors of Vit A
USDA rotene, b-carotene,
pene
HPLC Non-fasting
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Table 1 (continued )
Source Country Study design n Gender Age Dietary method þ
reporting period
Dietary carotenoids
assessed
Nutritional database
used
Biochemical
carotenoids assessed
Biochemical
method
Fasting
time length
Su et al. (2006) [176] USA Cross sectional 17,688 47% M 18e45 yrs Mean ± SD:
Females 31.0 ± 7.9;
Males 30.8 ± 7.9;
55 þ yrs Mean ± SD:
Females 71.1 ± 9.7;
Males 70.4 ± 9.4
24 h recall collected
through automated
dietary data collection
system. Additional
questions asked about
use of vitamin and
mineral supplements.
Salad, Vegetable UC a-carotene, b-carotene,
lycopene
HPLC Unclear
Svendsen et al.
(2007) [177]
Norway RCT 138 75% M 21e72 yrs; Mean
± SD 48.2 ± 9.0
Dietary interview based
on 174-item FFQ
conducted at baseline
and 3 months (previous 3
months). 28 vegetable
items, 29 fruits and
berries.
b-carotene, vegetable,
fruits/juices/berries
Norwegian food
composition tables
a-carotene, b-carotene,
lycopene, lutein,
zeaxanthin, b-
cryptoxanthin
HPLC Overnight
fasting e 10 h
Talegawkar et al.
(2008) [178]
USA Cross sectional 402 39% M 34 yrs; Mean ± SE
F 61.5 ± 0.6;
M 60.2 ± 0.8
24 h recalls conducted
over phone in order to
design a representative
FFQ for use in this study.
Short 158-item FFQ used
at baseline, 4 24 h
recalls, one month apart
and long 283-item FFQ
administered one week
after ﬁnal recall. Included
use of supplements.
a-carotene, total b-
carotene, dietary b-
carotene, lycopene, b-
cryptoxanthin,
combined lutein/
zeaxanthin.
NR a-carotene, b-carotene,
lycopene, b-
cryptoxanthin,
combined lutein/
zeaxanthin.
HPLC Fasting e 10 h
Tangney et al. (2004)
[179]
USA Cross sectional 59 42% M Mean ± SD: 73.8 ± 5.8 156-item FFQ completed
at baseline and 12e14
months after. Home-
based 24 h recalls
administered every 2
months over the 12e14
month period.
total b-carotene,
dietary b-carotene, a-
carotene, b-
cryptoxanthin,
lutein þ zeaxanthin,
lycopene
Harvard nutrient
database - updated
continually using USDA
nutrient database.
b-carotene, a-carotene,
b-cryptoxanthin,
lutein þ zeaxanthin,
lycopene
HPLC Fasting
Tan-Un et al. (2004)
[180]
China Case-control 72 NR Mean ± SD
asthmatics: 39 ± 15.9;
non-asthmatics:
35 ± 10.0
Telephone administered
semiquantitative 30-item
FFQ to assess intake over
previous 12 months.
dietary carotene Published food tables
from Hong Kong and
China.
b-carotene Macro- and
micro-method
modiﬁed from
Emmerie-Engel
method.
Non-fasting
Tarwadi et al. (2008)
[181]
India Case-control 240 49% M 50e75 yrs Structured 94-item FFQ
including seasonal fruit
and vegetable intake.
b-carotene Indian food
composition tables
(Nutritive value of
Indian foods - National
Institute of Nutrition,
Indian Council of
Medical Research)
plasma b-carotene Spectrophotometric
and ﬂuorescence-based
estimations
Fasting
Thomson et al.
(2007) [182]
USA Cross sectional 207 100% F 18-70 yrs; Mean ±
SD 53.5 ± 9.1
153-item FFQ
administered at baseline.
Supplement intake was
also recorded.
a-carotene, b-carotene,
lutein þ zeaxanthin,
lycopene and b-
cryptoxanthin,
supplemental b-
carotene
CSFII
USDA
a-carotene, b-carotene,
lutein þ zeaxanthin,
lycopene and b-
cryptoxanthin
HPLC Fasting
Toft et al. (2008)
[183]
Denmark Cross sectional 264 47% M Mean(Range):
48.4(38e63)
28-day diet history with
a checklist to conclude
and a 198-item semi-
quantitative FFQ
assessing food intake
over the past month.
b-carotene, fruits and
vegetables
Danish Food
Composition Databank
(version 6)
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene, lutein,
zeaxanthin
HPLC Fasting - 8hr
Torronen et al.
(1996) [184]
Finland RCT 38 100% F Range: 20e53 yrs;
Mean: 30 yrs
Intakes of b-carotene
were assessed by a 1-
month FFQ. Energy and
other nutrients assessed
by 4-day food record.
b-carotene Finnish foods database b-carotene HPLC Overnight fast
Tucker et al. (1999)
[185,186]
USA Cross sectional [1] 638 [2]; 547 [1] 408 F 230 M
[2]; 346 F 201 M
>65 yrs Semi quantitative 126-
item food-frequency
questionnaire including
vitamin supplements.
a-carotene, total b-
carotene, dietary b-
carotene, b-
cryptoxanthin,
lycopene,
USDA a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC Non-fasting
lutein þ zeaxanthin &
fruit and veg intake
VandenLangenberg
et al. (1996) [50]
USA Cross sectional 400 45% M >43 yrs 100-item FFQ
(Block-NCI
Health Habits
and History
Questionnaire
HHHQ) intake
over the
previous
12 months.
[1] a-carotene, b-
carotene, b-
cryptoxanthin, a-
cryptoxanthin,
lycopene,
lutein þ zeaxanthin
[2]; all but a-
cryptoxanthin
National Cancer
Institute (NCI) and
combined USDA-NCI.
[1] a-carotene, b-
carotene, b-
cryptoxanthin, a-
cryptoxanthin,
lycopene,
lutein þ zeaxanthin;
total carotenes [2] all
but a-cryptoxanthin
HPLC Non-fasting
Vioque et al. (2007)
[187]
Spain Cross sectional 545 46% M Mean: 73.5 yrs Semi-quantitative 135-
item FFQ (modiﬁed from
Harvard questionnaire)
including vitamin
supplements.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
USDA-NCI carotenoid
database.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC 85% were non-fasted
Vioque et al. (2013)
[36]
Spain Cross sectional 740 100% F <29yrs 336, 30e24
285, >35,119
Semi-quantitative 135-
item FFQ (modiﬁed from
Harvard questionnaire)
including vitamin
supplements.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
USDA complimented
with Spanish sources
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC Nonfasting
Walqvist et al.
(1999) [188]
Australia RCT 224 62% M 30e75 yrs;
Mean 56 yrs
FFQ administered at
baseline and 12 months
assessing intake over the
previous 12 months.
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
Carotenoid food
composition database
USDA-NCI
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC Fasting
Wallstrom et al.
(2001) [189]
Sweden Cross sectional 529 48% M 46e67 yrs Modiﬁed diet history
combining quantitative
and semiquantitative
measures. Part 1
recorded cooked meals,
beverages supplements
during 7 consecutive
days; part 2 was a 168-
item questionnaire on
foods consumed
regularly (other than
cooked foods) during the
past yr.
b-carotene Swedish national food
administration food
database.
b-carotene (food
derived, total including
supplements)
HPLC Non-fasting
Wawrzyniak et al.
(2013) [37]
Sweden Cross sectional 159 100% F 56e75 yrs FFQ 96 item reporting
period prev yr
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
þ Fruits and vegetables
Various Swedish
sources
a-carotene, b-carotene,
b-cryptoxanthin,
lycopene,
lutein þ zeaxanthin
HPLC Fasting
Willett et al. (1983)
[190]
USA RCT 58 Male and female 20e60 yrs FFQ e 99 items with
speciﬁed portion size.
Supplementary questions
about margarine, cooking
oil, breakfast cereal and
vitamin supplements.
Reporting period NR
Carotene, vitamin E and
Vitamin A
USDA carotenoids 1975 Plasma carotene HPLC Fasting
Wolters et al. (2006)
[191]
Germany Cross sectional 178 100% F 60e70 yrs
(mean 63.2 ± 2.73)
3 day diet record b carotene German food code b carotene HPLC Overnight
Yong et al. (1994)
[51]
USA Cross sectional 98 Mean age 28.6 ± 5.1 7 consecutive days of
Diet records and FFQ
-Health Habits and
History Questionnaire
100 items reporting
period 1 yr, with portions
rated as S,M or L(12 fruits
and juices, 17 vegetables
a carotene, b carotene,
b cryptoxanthin lutein
and zeaxanthin and
lycopene
USDA a carotene, b carotene,
b cryptoxanthin lutein
and zeaxanthin and
lycopene
HPLC Fasting
Ylonen et al. (2003)
[192]
Finland Cross sectional 182 Men 101 Women
81
Mean age 53 ± 1 3 day estimated food
record (2 weekdays þ 1
weekend day). Estimated
food portion by picture
booklet
a carotene, b carotene
and lycopene
NUTNET developed by
the National Public
Health Institute,
Helsinki
a carotene, b carotene
and lycopene
HPLC Fasting no other
details reported
Unless otherwise speciﬁed, reported as mean ± SD, F ¼ female, M ¼ Male, BMI reported as kg/m2, HPLC ¼ High Performance Liquid Chromatography, FFQ ¼ food frequency questionnaire, FR ¼ food record, NR ¼ not reported, UC
Unclear.
Table 2
Outcomes of included studies.
Source Dietary carotenoid intake Plasma carotenoid concentrations Associations between diet and plasma
correlations
Limitations
AAA Epic group, (1997) [43] Diet history:
b - carotene Mean(SD) (mg/dl)
total 4418 (3329); M 4210 (2995)F 4584
24 h recall:
b - carotene Mean(SD) (mg/dl)
total - 2976 (1719);
M 4210 (2995);
F 3120 (1710);
Mean(SD) (mg/dl)
a-carotene total 5.2 (4.2); M 3.7 (2.3); F 6.3 (4.9);
b-carotene total 24.2 (15.7); M 15.2 (7.7); F 31.2
(16.7);
cryptoxanthin total 17.9 (9.6); M 14.3 (6.8); F20.7
(10.5);
lutein-zeaxanthin total 17.0 (7.0); M 15.8 (6.7); F
17.9 (7.3);
lycopene 30.9 (16.6); M 27.1 (9.8); F 33.9 (19.9);
Total carotenoids total 95.1 (42.2); M 75.6 (26.8); F
110.1 (46.0);
Diet history: b-carotene (M&F) 0.33; M
0.27; F 0.40; smokers 0.04; non-smokers
0.39; total carotenoids (M&F) 0.27; M 0.15;
F 0.35; smokers 0.03; non-smokers 0.32;
24 h recall: b-carotene (M&F) 0.42; M 0.42;
F 0.44; smokers 0.37; non-smokers 0.44;
total carotenoids (M&F) 0.28; M 0.19; F
0.32; smokers 0.22; non-smokers 0.31.
Dietary fat not assessed.
Unclear which are signiﬁcant andwhich
are not.
Alberti-Fidanza et al. (1998) [62] Weighed record: b-carotene (mg)
2059.2 ± 1176.3; diet history: b-
carotene (mg) 3325.0 ± 2004.2;
Chemical analysis:
b-carotene (mg) 961.5 ± 814.7;
b-carotene (mmol/L) 0.60 ± 0.33; No signiﬁcant correlations between dietary
intake and plasma concentrations.
Al-Delaimy et al. (2005) [44] NR Mean(SE) mmol/L:
M
a-carotene 0.12 (0.01); b-carotene 0.36 (0.01); b-
cryptoxanthin 0.23 (0.01); lutein 0.38 (0.005);
zeaxanthin 0.09 (0.001); lycopene 0.74 (0.01); total
carotenoids 1.94 (0.023);
F
a-carotene 0.20 (0.005); b -carotene 0.54 (0.012); b-
cryptoxanthin 0.34 (0.007); lutein 0.44 (0.006);
zeaxanthin 0.09 (0.001); lycopene 0.71 (0.01); total
carotenoids 2.35 (0.03)
Fruits and vegetables from FQ: a -carotene
0.09; b-carotene 0.17; cryptoxanthin 0.46;
lutein 0.38; zeaxanthin 0.36; lycopene 0.24;
total carotenoids 0.38; fruits and veg from
24HDR: a -carotene 0.10; b -carotene 0.15;
cryptoxanthin 0.39; lutein 0.31; zeaxanthin
0.32; lycopene 0.14; total carotenoids 0.30;
fruits from FQ: a -carotene NS; b -carotene
0.11; cryptoxanthin 0.52; lutein 0.37;
zeaxanthin 0.37; lycopene 0.22; total
carotenoids 0.36; fruits from 24HDR: a
-carotene 0.06; b -carotene 0.11;
cryptoxanthin 0.39; lutein 0.25; zeaxanthin
0.26; lycopene 0.10; total carotenoids 0.25;
veg from FQ: a -carotene 0.16; b -carotene
0.21; cryptoxanthin 0.26; lutein 0.30;
zeaxanthin 0.26; lycopene 0.19; total
carotenoids 0.31; veg from 24HDR: a
-carotene 0.13; b -carotene 0.16;
cryptoxanthin 0.19; lutein 0.23; zeaxanthin
0.22; lycopene 0.12; total carotenoids 0.21.
Country speciﬁc questionnaires only
validated within country, not between.
Allen et al. (2003) [63] Mean intake of lycopene at baseline was
6.4 mg/day and after 2 weeks 0.31 mg/
day.
Plasma concentrations (mmol/L; Mean ± SE) at
baseline (total group and week 6 in the three
intervention groups (sauce/soup/juice).
Baseline: a-carotene 0.12 ± 0.01; b carotene
0.45 ± 0.06; cryptoxanthin 0.37 ± 0.04; lutein
0.22 ± 0.02; zeaxanthin 0.06 ± 0.004; lycopene
1.06 ± 0.04;
6 weeks:
a -carotene 0.12 ± 0.03/0.11 ± 0.01/0.22 ± 0.03; b
-carotene 0.53 ± 0.09/0.43 ± 0.06/0.85 ± 0.24;
cryptoxanthin 0.47 ± 0.13/0.35 ± 0.06/0.30 ± 0.08;
lutein 0.20 ± 0.02/0.25 ± 0.02/0.25 ± 0.03;
zeaxanthin 0.12 ± 0.01/0.11 ± 0.01/0.11 ± 0.01.
lycopene 1.68 ± 0.07/1.04 ± 0.05/0.98 ± 0.05;
Correlation of dietary lycopene and plasma
lycopene: Baseline r ¼ 0.578; p < 0.0005;
After 3 week
(Week 6) diet intervention r ¼ 0.499;
p < 0.005
Poor reporting of dietary outcomes.
Anderson et al. (2005) [64] Mean(SD), weighed record (WR) and
180-item FFQ ¼ g/day. 27-item
FFQ ¼ times/day.
Mean(SD) (mmol/L):
a-carotene 0.09(0.07);
b-carotene 0.5(0.23)
WR: veg and a -carotene (0.52); Veg and
lutein (0.21)
180-item FFQ: Veg and a-carotene (0.39);
Combined correlations reported for
supplement and non-supplement users.
Small sample size, men only.
Fruit: WR 109(107); 180-item FFQ
128(107); 27-item FFQ 0.9(0.6);
Vegetable: WR 108(59); 180-item FFQ
115(70); 27-item FFQ 0.8(0.4)
Lutein 0.17(0.06);
Zeaxanthin 0.04(0.02);
Lycopene 0.75(0.38);
27-item FFQ: Veg and a-carotene (0.35).
No signiﬁcant correlations for fruit and
plasma concentrations.
Arab et al. (2011) [65] Mean intake (mg/day) in african
americans (AA) and whites (W)
24HDR: a -carotene (AA) 310; (W) 71; b
-carotene (AA) 1420; (W) 2027.
cryptoxanthin: (AA) 110; (W) 120;
Lutein þ zeaxanthin: (AA) 3420; (W)
4500; lycopene: (AA) 3170; (W) 6320;
DHQ: a carotene (AA) 406; (W) 557;
b -carotene (AA) 2620; (W) 3152.
cryptoxanthin (AA) 152; (W) 132;
lutein þ zeaxanthin (AA) 2316 (W)
2606;
lycopene (AA) 4924; (W) 5659;
African Americans: Mean mmol/L e
a -carotene 0.06; b -carotene 0.28; cryptoxanthin
0.18;
lutein þ zeaxanthin 0.25; lycopene 0.60;
Whites: Mean mmol/L e
a carotene 0.07; b -carotene 0.31; cryptoxanthin
0.16;
lutein þ zeaxanthin 0.27; lycopene 0.57;
Whites: a-carotene 0.27; b -carotene 0.38.
b-cryptoxanthin 0.51; lutein þ zeaxanthin
0.48; lycopene 0.13; Incomplete reporting
of signiﬁcant correlations within groups,
only other signiﬁcances reported is
between groups (whites and african
americans). In 24HDR, there was a
signiﬁcant difference between AA andW for
all carotenoids except lycopene and for
DHQ, only lutein þ zeaxanthin and b-
carotene showed a signiﬁcant difference
between AA and W.
Analysis contains data from subjects
who consumed supplements.
Arnaud et al. (2001) [31] Mean total carotenoids (mg)
Period 1: 1028;
Period 2: 779;
Period 3: 586;
Period 4: 1395
Mean ± SD or Median(range) carotenoids (nmol/L)
Period 1: a-carotene 51(2e466); b-carotene 95(13
e1088); cryptoxanthin 93 ± 67; lutein-zeaxanthin
563(163e3503);
lycopene 348(41e2130); total carotenoids
1427 ± 702;
Period 2: a -carotene 24(2e192); b -carotene 106(6
e1011);
cryptoxanthin 117 ± 91; lutein-zeaxanthin 494(128
e7766);
lycopene 74(4e492); total carotenoids 1206 ± 978;
Period 3: a -carotene 32(6e155); b carotene 60(6
e415);
cryptoxanthin 132 ± 85; lutein-zeaxanthin 486(156
e2228);
lycopene 120(2e1713); total carotenoids
1037 ± 554;
Period 4:; a -carotene 43(6e685); b carotene 90(13
e909);
cryptoxanthin 112 ± 85; lutein-zeaxanthin 492(163
e3459);
lycopene 310(19e2533); total carotenoids
1243 ± 868
Carotenoids expressed as mmol/L
Period 1 (March-April): r ¼ 0.148
(p ¼ 0.048);
Period 3 (October): r ¼ 0.200 (p ¼ 0.017).
Plasma total carotenoids expressed as
mmol/mmol cholesterol Period 3: r ¼ 0.216
(p ¼ 0.010).
Sample not representative of healthy
population and included men only. FFQ
not referenced or validated.
Bermudez et al. (2005) [66] Mean ± SE mg/day:
a-carotene Hispanic men (HM)
685 ± 60;
hispanic women (HW) 786 ± 51; Non-
Hispanic men (NHM) 981 ± 109;
Non-hispanic women (NHW) 908 ± 87;
b-carotene HM 3281 ± 189; HW
635 ± 214;
NHM 4091 ± 338; NHW 3815 ± 368;
cryptoxanthin HM 152 ± 10; HW
170 ± 8;
NHM 164 ± 24; NHW 126 ± 19;
lutein þ zeaxanthin HM 1470 ± 96;
HW 1556 ± 80; NHM 2882 ± 341; NHW
2251 ± 273; lycopene HM 6067 ± 297;
HW 5352 ± 249; NHM 5793 ± 578;
NHW 4638 ± 463
Mean ± SE nmol/L:
a -carotene HM 101 ± 0.05; HW 129 ± 0.04; NHM
72 ± 0.09;
NHW 78 ± 0.07; b -carotene HM 227 ± 0.05; HW
301 ± 0.04;
NHM 261 ± 0.09; NHW 291 ± 0.07; cryptoxanthin
HM 89 ± 0.05; HW 114 ± 0.04; NHM 93 ± 0.10;
NHW 106 ± 0.08;
lutein HM 212 ± 0.04; HW 210 ± 0.03; NHM
185 ± 0.09; NHW 189 ± 0.07; zeaxanthin HM
68 ± 0.04; HW 67 ± 0.03;
NHM 58 ± 0.10; NHW 65 ± 0.08; lycopene HM
448 ± 0.03;
HW 461 ± 0.03; NHM 345 ± 0.09; NHW 346 ± 0.07
Total carotenoid intake with a -carotene
0.23 ± 0.03; b -carotene 0.24 ± 0.04;
cryptoxanthin 0.29 ± 0.03;
lutein þ zeaxanthin 0.16 ± 0.04; lycopene
0.09 ± 0.03 (p < 0.001 for all except
lycopene p < 0.01).
Results reported combined for
supplement and non-supplement users.
Non-validated FFQ.
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Bernstien et al. (2002) [67] Mean ± SE (mg/day) Baseline/Follow-
up/Change: Nutrition group: a
carotene 454 ± 331/1003 ± 803/
549 ± 126; b-carotene 4046 ± 2072/
6454 ± 3012/2408 ± 495;
cryptoxanthin 91.3 ± 76.1/148.5 ± 89.5/
57.2 ± 15.1; lutein 2720 ± 2529/
4240 ± 4739/1521 ± 741; lycopene
1347 ± 753.4/2291 ± 1290/944 ± 199;
Exercise group a -carotene 795 ± 718/
790 ± 680/-5.7 ± 130; b ecarotene
4586 ± 2691/4689 ± 2485/103 ± 490;
cryptoxanthin 132.5 ± 93.1/
139.1 ± 70.1/6.6 ± 14.8; lutein
2330 ± 2178/2247 ± 2458/-84 ± 454;
lycopene 1551 ± 1031/
1828 ± 1031 277 ± 156
Mean ± SE (mg/L) Baseline/Follow-up/Change:
Nutrition group: a -carotene 0.33 ± 2.50/
0.42 ± 3.03/0.09 ± 0.39; b -carotene (umol/L)
0.8 ± 0.6/1.0 ± 0.7/0.2 ± 0.10; cryptoxanthin
1.01 ± 3.05/1.09 ± 3.82/0.08 ± 0.28; lutein
1.94 ± 11.2/2.27 ± 10.5/0.33 ± 1.80; lycopene
0.72 ± 5.35/0.76 ± 4.45/0.04 ± 0.58; total
carotenoids 11.8 ± 37.6/12.9 ± 47.9/
1.2 ± 4.35;Exercise group a -carotene 0.38 ± 2.57/
0.33 ± 2.52/0.01 ± 0.34; b -carotene (umol/L)
0.8 ± 0.6/0.9 ± 0.6/0.1 ± 0.07 cryptoxanthin
0.96 ± 1.75/0.99 ± 1.88/0.03 ± 0.24; lutein
2.15 ± 13.0/2.42 ± 16.8/0.27 ± 2.00; lycopene
0.73 ± 4.72/0.77 ± 5.52/0.04 ± 0.60; total
carotenoids 12.7 ± 54.6/13.1 ± 55.8/0.36 ± 5.04;
Baseline correlations between intake and a
-carotene (r ¼ 0.29; p ¼ 0.08) and b
-carotene (r ¼ 0.33; p ¼ 0.08). Changes in
intake of a-carotene and b-carotene
signiﬁcantly correlated with plasma a-
carotene (r¼ 0.33; p¼ 0.09) and b-carotene
(r ¼ 0.33; p ¼ 0.020).
Although method of plasma carotenoid
analysis was not reported.
Bingham et al. (1995) [68e71] 5 quintiles: Mean ± SE carotene g/day e
1st (lowest) quintile 3.5 ± 0.3;
2nd 3.7 ± 0.4;
3rd 3.1 ± 0.3;
4th 3.7 ± 0.4; 5th (highest) 3.5 ± 0.4
Reported in Bingham 1995: Mean ± SE mmol/L:
a-carotene 1st: 0.12 ± 0.02; 2nd: 0.13 ± 0.02; 3rd:
0.11 ± 0.01; 4th: 0.11 ± 0.02; 5th: 0.07 ± 0.01, b-
carotene 1st: 0.57 ± 0.06; 2nd: 0.62 ± 0.07; 3rd:
0.50 ± 0.07; 4th: 0.49 ± 0.07; 5th 0.35 ± 0.04; cis-
carotene 1st: 0.05 ± 0.005; 2nd: 0.05 ± 0.004; 3rd:
0.05 ± 0.006; 4th: 0.04 ± 0.005; 5th: 0.04 ± 0.003;
cryptoxanthin 1st: 0.26 ± 0.02; 2nd: 0.28 ± 0.04;
3rd: 0.29 ± 0.03; 4th: 0.30 ± 0.06; 5th: 0.24 ± 0.04;
lutein 1st: 0.45 ± 0.03; 2nd: 0.47 ± 0.04; 3rd:
0.39 ± 0.03; 4th: 0.44 ± 0.05; 5th 0.32 ± 0.03;
lycopene 1st: 0.33 ± 0.02; 2nd: 0.36 ± 0.04; 3rd:
0.28 ± 0.03; 4th: 0.30 ± 0.06; 5th: 0.24 ± 0.04;
Reported in Bingham 1997(26 suppl 1): Mean ± SD
carotene (mg): 16-day weighed records 3.4 ± 1.9;
FFQ 5.1 ± 3.2; 24-h recall 3.5 ± 3.7; 7-day estimated
food record (food diary) 3.2 ± 1.8
1995 results: dietary b-carotene
equivalents and plasma b carotene
(r ¼ 0.48); dietary b carotene equivalents
and plasma a-carotene (r ¼ 0.62). P-values
NR. 1997(6) results: correlations between
dietary carotene and plasma b-carotene:
weighed records r ¼ 0.46; checklist
r ¼ 0.30; checklist with portions r ¼ 0.27;
oxford FFQ r ¼ 0.15; cambridge FFQ
r ¼ 0.04; unstructured 24hr recall r ¼ 0.09;
structured 24hr recall r ¼ 0.00.
Few dietary carotenoids reported.
Female only sample.
Block et al. (2001) [24] Fruit and vegetable frequency (times/
day) - Mean ± SD: 2.9 ± 1.9
Mean ± SD, (mg/dl):
b-carotene:13.5 ± 11.4; cryptoxanthin: 11.2 ± 9.1;
total carotenoids: 80.6 ± 34.0
b -carotene (0.35; p¼ 0.001); cryptoxanthin
(0.43; p ¼ 0.0001); total carotenoids (0.34;
p ¼ 0.001).
Men only
Bodner et al. (1998) [72] Mean ± SD (mg/day):
b-carotene F: 2051.3 ± 1146.4; M:
2014.0 ± 1272.8; total b -carotene F:
2065.9 ± 1165.1; M: 2024.4 ± 1272.4
Mean b -carotene (mmol/L):
Females 0.5 ± 0.4;
Males: 0.4 ± 0.4
b -carotene (including supplement users)
(r¼ 0.24; p < 0.001); excluding supplement
users (r ¼ 0.22; p < 0.001).
Poorly described dietary assessment
methods
Boeing at al (1997) [74] Mean dietary carotenoid intake
across quintiles of 24 h recall (mg/
day):
Quintile [1]: 1.6 ± 0.3 [2]: 2.2 ± 0.1 [3]:
2.7 ± 0.2 [4]: 3.6 ± 0.3;
[5]: 5.8 ± 1.7. Mean intake from 24 h
recalls across quintiles of FFQ (mg/
day):
[1]: 2.8 ± 1.8 [2]: 2.9 ± 1.9 [3]: 2.9 ± 0.9
[4]: 3.2 ± 1.5 [5]: 4.2 ± 1.8.
Mean plasma concentrations across quintiles of
24 h recall (mg/ml) [1]: 344 ± 146 [2]: 386 ± 339
[3]: 363 ± 197 [4]: 610 ± 349 [5]: 753 ± 478;
Mean intake from 24 h recalls across quintiles of
FFQ
[1]: 394 ± 229 [2]: 358 ± 239 [3]: 491 ± 362 [4]:
595 ± 500;
[5]: 631 ± 349
Plasma carotenoids/FFQ (0.35) - no p-value
reported
Unclear if blood collection was fasting,
few carotenoids measured, dietary fat
not accounted for.
Bogers et al. (2003; 2004) [45,75] Results from 2003: Mean intake by
either summing [1] all items in a
category i.e. fruit [2] question for that
Results from 2003: Plasma concentrations at 10th,
25th, 50th, 75th and 90th %iles (mmol/L):
a-carotene: 10th 0.06; 25th 0.09; 50th 0.13; 75th
Results from 2003: Total vegetables [1]: a
-carotene; 0.20 (0.01); b-carotene 0.14
(0.08); lutein 0.25 (0.00); total carotenoids
No adjustment for demographics,
lipids/fat intake. 1-month reporting
period dietary assessment
category (g/day) [1]: total veg
264 ± 123; cooked veg 204 ± 94; raw
veg 60 ± 66; fruit 195 ± 128; fruit juice
79 ± 95;
[2]: total veg 151 ± 69; cooked veg
110 ± 51; raw veg 41 ± 38; fruit
156 ± 116; fruit juice 67 ± 84.
Results from 2004: Mean ± SD
(servings per day) Baseline/1month e
intervention group: Total veg 3.4 ± 1.7/
4.6 ± 1.4; Total fruits 1.9 ± 1.1/2.9 ± 1.2;
Citrus fruits 0.4 ± 0.5/0.7 ± 0.6; Total
fruits and vegetables 5.3 ± 2.3/7.5 ± 2.0
0.19; 90th 0.24; b-carotene 10th 0.21; 25th 0.29;
50th 0.45; 75th 0.65; 90th 1.02; b-cryptoxanthin
10th 0.30; 25th 0.39; 50th 0.51; 75th 0.71; 90th
1.04; lutein 10th 0.24; 25th 0.29; 50th 0.38; 75th
0.48; 90th 0.61; lycopene 10th 0.14; 25th 0.22; 50th
0.26; 75th 0.36; 90th 0.43; total carotenoids 10th
1.24; 25th 1.49; 50th 1.90; 75th 2.20; 90th 2.94.
Results from 2004: Mean ± SD (mmol/L) Baseline/
1month e intervention group: a -carotene
0.18 ± 0.20/0.19 ± 0.19; b -carotene 0.58 ± 0.48/
0.64 ± 0.44; cryptoxanthin 0.62 ± 0.33/0.70 ± 0.31;
lutein 0.39 ± 0.14/0.48 ± 0.18; lycopene 0.28 ± 0.11/
0.26 ± 0.11
0.22 (0.01) [2];: a -carotene 0.37 (0.00); b-
carotene 0.26 (0.00); b-cryptoxanthin 0.19
(0.02); Lutein 0.30 (0.00); total carotenoids;
0.32 (0.00); Cooked vegetables [1]: a-
carotene; 0.14 (0.08); lutein 0.21 (0.01);
total carotenoids 0.19 (0.02) [2];: a
-carotene 0.24 (0.00); b -carotene 0.15
(0.05); b-cryptoxanthin 0.14 (0.07); lutein
0.24 (0.00); total carotenoids 0.23 (0.00);
Raw veg [1]: a -carotene 0.20 (0.01); b
carotene 0.17 (0.03); lutein 0.20 (0.01);
total carotenoids 0.21 (0.01) [2];: a
-carotene 0.31 (0.00); b carotene 0.25
(0.00); -cryptoxanthin 0.23 (0.00); lutein
0.22 (0.01); total carotenoids 0.31 (0.00);
fruit [1]: a -carotene 0.17 (0.04); b
-carotene 0.22 (0.01); cryptoxanthin 0.42
(0.00); lutein 0.15 (0.06); total carotenoids
0.34 (0.00) [2];: a-carotene 0.15 (0.07); b
-carotene 0.18 (0.02); cryptoxanthin 0.43
(0.00); total carotenoids 0.30 (0.00); fruit
juice [1] or [2] - nil signiﬁcant. Results
from 2004 (p<0.01 unless otherwise
speciﬁed): total veg: a-carotene 0.37; b-
carotene 0.17(p < 0.05); Lutein 0.26; total
carotenoids 0.24; total fruits: a-carotene
0.23; b-carotene 0.23; cryptoxanthin 0.42;
total carotenoids 0.39; citrus fruits: b-
cryptoxanthin 0.57; total carotenoids 0.27;
total fruits and veg: a-carotene 0.36; b-
carotene 0.23; b-cryptoxanthin 0.31; Lutein
0.23; total carotenoids 0.37.
Bolton-Smith et al. (1991) [193] Mean ± SD (mg/day):b-carotene
smokers 2924 ± 1695; non-smokers
3526 ± 2248
Mean ± SD (mg/l/day): carotenes smokers
166 ± 103;
Non-smokers 238 ± 143.
Correlations smokers 0.03; non-smokers
0.26. Only signiﬁcant in non-smokers
(p < 0.01).
Few carotenoids reported.
Bone et al. (2000) [77] Range of concentrations of
lutein þ zeaxanthin (mg/ml1): 0.08
e0.35.
UC Correlation value lutein þ zeazanthin
r ¼ 0.74; p < 0.001.
Methods poorly reported, small sample
size
Bowman et al. (2011) [78] UC UC a-carotene 0.49; b-carotene 0.43;
cryptoxanthin 0.41; lutein þ zeaxanthin
0.48;
p < 0.01 for all. Not signiﬁcant for lycopene.
Small sample size.
Brantsaeter et al. (2007) [79] Mean þ SD (mg/day) b -carotene: FFQ:
nonsupplement users 2660 ± 1880;
supplement users 4140 ± 2230; 4-day
FR: nonsupplement users 2130 ± 1770;
supplement users 4410 ± 3190
Mean ± SD (mmol/L):Non-supplement users
b-carotene 0.42 ± 0.20; total carotenoids
1.69 ± 0.51;
supplement users FFQ b-carotene 0.58 ± 0.27;
total carotenoids 2.03 ± 0.34; supplement users
food record
b -carotene 0.58 ± 0.23; total carotenoids
2.16 ± 0.65
Correlation between plasma b-carotene and
FFQ b-carotene 0.16 (NS); plasma b-
carotene and food record b-carotene
0.32(p < 0.01).
Non-fasting blood collection, females
only.
Brunner et al. (2001) [80] Mean ± SD (mg/day) carotenes:
FFQ: F 3100 ± 1741; M 2713 ± 1530;
7-day diary: F 2221 ± 1230; M
2181 ± 1197
NR Correlation between dietary carotenes and
plasma b-carotene FFQ F 0.20(p < 0.001); M
0.22 (p < 0.0001); 7-day diary F 0.16
(p < 0.01); M 0.23 (p < 0.0001); Correlation
between dietary carotenes and plasma b-
carotene/cholesterol FFQ F 0.21 (p < 0.001);
M 0.28 (p < 0.0001); 7-day diary F 0.20
(p < 0.001); M 0.29 (p < 0.0001).
Plasma carotenoid data UC/NR.
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Burri et al. (2010) [81] Mean ± SD lycopene (mg/day):
3-day diet record 5054 ± 5875;
FFQ 6656 ± 7671
Mean ± SD (mmol/L): 0.51 ± 0.26 Regression of association of dietary
lycopene (FFQ) and serum lycopene,
adjusted for bioaccessibility, energy and fat
(parameter estimate 0.0089, P ¼ 0.043, for
energy; 0.0027, P ¼ 0.0001, for
bioaccessibility). Model of association of
dietary lycopene (3-FR) and serum
lycopene, (0.0072 for energy and 0.0098 for
bioaccessibility, P ¼ 0.0001 for both). 3D-
DR, lycopene adjusted for bioaccessibility,
and FFQ lycopene adjusted for
bioaccessibility were signiﬁcantly
associated with serum lycopene
concentrations (P ¼ 0.001), whereas the
relation between FFQ corrected for energy
and serum lycopene approached
signiﬁcance (P ¼ 0.053). Correlation
between serum lycopene and dietary
lycopene estimated by the FFQ (0.35).
Method of triads: FFQ and 3D-DR estimates
of lycopene adjusted for bioaccessibility
were correlated with serum lycopene (0.33;
0.48 respectively).
Exclusion of smokers - not
representative of wider population.
Small sample size.
Campbell et al. (1994) [26] Servings/day, Mean (SD) e
F þ V 52.9 (32.4) F 22.2 (15.8) V 30.7
(20.7) High lutein foods 5.5 (5.9);
High lycopene foods 7.0 (4.2);
High b-carotene foods 6.0 (6.5)
(mg/dl); a-carotene e 5.6 ± 4.3; b-carotene e
15.7 ± 11.7;
cryptoxanthin - 8.3 ± 4.7; Lutein - 18.0 ± 6.2;
Lycopene e 37.3 ± 14.7;
High b-carotene foods (r ¼ 0.41); high
lutein foods (r ¼ 0.46); and high lycopene
foods (r ¼ 0.1 1)
Dietary carotenoids UC
Canﬁeld et al. (1997) [83] 3-d FR (ug/day):
a-carotene; 1303 ± 762;
b - carotene 5078 ± 2473;
lutein 2754 ± 2600;
lycopene 4551 ± 3447
Group 1, n ¼ 6; mmol/L, mean ± SEM
a-carotene 0.25 ± 0.01; b-carotene 0.75 ± 0.2; b-
cryptoxanthin 0.18 ± 0.04; lutein plus zeaxanthin
0.29 ± 0.01;
lycopene 0.58 ± 0.03 & (Group 2, n ¼ 6; mmol/L,
mean ± SEM)
a-carotene 0.23 ± 0.08; b-carotene 0.64 ± 0.2;
b-cryptoxanthin 0.20 ± 0.01; lutein plus zeaxanthin
0.28 ± 0.01; lycopene 0.76 ± 0.01
Correlation between diet and serum levels
not reported.
Females only and correlation between
diet and blood levels UC.
Canﬁeld et al. (2001) [84] No. of mothers reporting servings of
fruits and vegetables:
0 serves: n ¼ 24 1: 30 2: 17 3: 14 4: 4
5: 4 > 6: 1
No. of mothers reporting servings of
fruits and vegetables high in B-
carotene: 0 serves: n ¼ 76 1: 17
2: 1 3: 0 4: 0 5: 0 > 6: 0
(Placebo, n ¼ 18; mmol/L, mean ± SEM)
a-carotene 0.076 ± 0.03; b-carotene 0.267 ± 0.12;
cryptoxanthin 0.047 ± 0.03; lutein plus zeaxanthin
0.13 ± 0.03; lycopene 0.225 ± 0.08 & (Palm Oil
Carotene, n¼ 31; mmol/L, mean± SEM) a-carotene
0.086 ± 0.03;
b-carotene 0.322 ± 0.39; b-cryptoxanthin
0.04 ± 0.01;
lutein plus zeaxanthin 0.117 ± 0.04; lycopene
0.175 ± 0.08 &
(Carotene Supplement, n ¼ 36; mmol/L,
mean ± SEM)
a-carotene 0.067 ± 0.03; b-carotene 0.207 ± 0.01;
b-cryptoxanthin 0.039 ± 0.02; lutein plus
zeaxanthin 0.131 ± 0.04; lycopene 0.195 ± 0.08
Correlation between diet and serum levels
not reported.
Females only and correlation between
diet and blood levels UC.
Cappuccio et al. (2003) [85] Fruit intake (portions/day): Mean (SE)
F: 1.8 (0.1) M: 1.8 (0.1) Vegetable: F: 1.8
b-carotene (mmol/L) e
1.18 (0.6) for males and
1.01 (0.8) for females
Correlation between diet and plasma levels
not reported.
Dietary carotenoids
(0.1) M: 1.9 (0.1) F&V: F: 3.6 (0.1)
M: 3.7 (0.2)
Carlsen et al. (2011) [86] FFQ intakes (g/d) Median (IQ range)
Fruit and juice: 220 (147e368)
Vegetables: 243 (166e332)
Fruit, juice & veg: 513 (354e644)
WR intakes Fruit and juice: 248 (117
e363) Vegetables: 161 (118e222)
Fruit, juice & veg: 418 (269e591)
nmol/L e Median (IQ Range):
a-carotene 98 [57e168]; b-carotene 414 (274
e616);
b-cryptoxanthin 141 (83e211); lutein 156 (122
e209);
zeaxanthin 39 [28e53]; lycopene 567 (403e758);
TOTAL 1529 (1156e2031)
Correlation between diet and plasma levels
not reported.
Dietary carotenoids UC
Carroll et al. (1999) [87] Estimated records (mg/d) Mean (SD)
YM ¼ younger male/OM ¼ older male/
YF ¼ younger female/OF ¼ older
female.
a-carotene: YM 775 (656)/OM 812
(651)/YF 771 (598)/OF 973 (530)
b-carotene: YM 2921 (1797)/OM 3099
(2060)/YF 2850 (1539)/OF 3358 (1447)
Cryptoxanthin: YM 189 (288)/OM 116
[153]/YF 165 [157]/OF 108 [160]
Lutein þ Zeaxanthin: YM 1005 (675)/
OM 778 (320)/YF 943 (385)/OF 1015
(463)
Lycopene: YM 3198 (4129)/OM 2092
(1809)/YF 2877 (2066)/OF 2285 (2367)
Total: YM 8089 (5002)/OM 6899
(4624)/YF 7605 (3007)/OF 7739 (3245)
FFQ
a-carotene: YM 2285(1470)/OM 1217
(1375)/YF 2426 (1872)/OF 1223 (797)
b-carotene YM 8077 (4463)/OM 5277
(4607)/YF 8795 (6022)/OF 5496 (3035)
cryptoxanthin: YM 471 (466)/OM 295
(346)/YF 727 (803)/OF 317 (338)
Lutein þ Zeaxanthin: YM 2323 (1436)/
OM 1877 (1462)/YF 2615 (2120)/OF
2120 (1277) Lycopene: YM 7642
(6262)/OM 2026 (2211)/YF 8045
(9393)/OF 4615 (5368) Total: YM 20800
(9563)/OM 10693 (8475)/YF 22608
(16368)/OF 13773 (8823)
Plasma (nmol/L) Mean (SD)
a-carotene: YM 92 [43]/OM 122 [81]/YF 107 [53]/
OF 166 [94] b-carotene: YM 393 [194]/OM 472
(222)/YF 462 [186]/OF 553 (254)
cryptoxanthin:YM191 [113]/OM 117 [96]/YF 296
(226)/OF 123 [62] Lutein: YM 207 [70]/OM 140
[62]/YF 237 [73]/OF 170 [56]Zeaxanthin: YM 97
[40]/OM 49 [25]/YF 83 [25]/OF 57 [19]
Lutein þ Zeaxanthin: YM 304 [99]/OM 187 [73]/YF
320 [94]/
OF 223 [73]Lycopene: YM 297 [125]/OM 91 [69]/YF
253 [110]/OF 111 [61] Total: YM 1693 (473)/OM
992 (395)/
YF 1813 (567)/OF 1177 (436)
Plasma carotenoid concentrations may be a
useful biomarker of several carotenoids,
excluding b-carotene, in groups aged
24 ± 45 y.
Cartmel et al. (2005) [88] Reported F & V serves Placebo; nmol/L, median (25e75th percentile
range)
a-carotene 52 [28e98]; b-carotene 208 (123e336);
b-cryptoxanthin 55 [43e158]; lutein 164 (107
e222);
zeaxanthin 47 [31e62]; lycopene 302 (158e447) &
Intervention a-carotene 46 [30e90]; b-carotene
249 (113e482); b-cryptoxanthin 79 [54e145];
lutein 161 (128e215);
zeaxanthin 49 [37e70]; lycopene 304 (191e477)
Plasma carotenoid conc increased with
increase in fruit & vegetable intervention
Dietary carotenoids UC
Cena et al. (2008) [89] Lutein and Zeaxanthin;
1107 ± 113 mg/day by FFQ and
1083 ± 116 mg/day by 7-d food record
analysis
Lutein and Zeaxanthin; 0.33 ± 0.09 mmol/L Dietary intake of lutein and zeaxanthin
measured with the FFQ and plasma
concentration were signiﬁcantly correlated
(r ¼ 0.76, P < 0.0001).
Major carotenoids not determined
Cena et al. (2009) [90] Mean (SD) e Dietary Lutein 1242 [113]
mg/d
Mean (SD) e Plasma Lutein 0.69 (0.49) mmol/L Both breast milk and plasma lutein
concentrations were signiﬁcantly
correlated with dietary lutein intake
(r ¼ 0.86, P ¼ 0001 and r ¼ 0.94, P ¼ 0001,
respectively).
Major carotenoids not determined
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Chung et al. (2009) [91] m/day e (Mean ± SEM): a-carotene
(367.2 ± 48.3); b-carotene
(2960.7 ± 393.9); b-cryptoxanthin
(135.5 ± 22.3); lutein plus zeaxanthin
(2534.6 ± 439.3); lycopene
2105.4 ± 341.2)
nmol/L e (Mean ± SEM):
a-carotene (98.6 ± 18.2);
b-carotene (568.8 ± 71.7);
b-cryptoxanthin (422.4 ± 68.6);
lutein plus zeaxanthin (231.9 ± 23.9); lycopene
(405.8 ± 32.4)
Dietary intake was signiﬁcantly correlated
with serum concentrations of a-carotene, b-
carotene, and cryptoxanthin.
Ciulla et al. (2001) [92] mg/day e (Mean ± SD):
b-carotene (2772 ± 2134);
lutein plus zeaxanthin (1102 ± 839)
mmol/L e (Mean ± SD):
b-carotene (0.281 ± 0.287);
lutein plus zeaxanthin (0.372 ± 0.169)
Statistically signiﬁcant (P < 0.05)
relationships were found between macular
pigment density and serum lutein plus
zeaxanthin& dietary lutein plus zeaxanthin
Other carotenoids not determined
Coates et al. (1991) [194] mg/day e (Mean ± SEM):
a-carotene (185.2 ± 19.6);
b-carotene (2657 ± 224);
b-cryptoxanthin (174 ± 16.7);
Lutein (3407 ± 357);
Lycopene (257 ± 32.0)
mg/dL e (Mean ± SEM):
a-carotene (3.40 ± 0.44);
b-carotene (20.4 ± 1.74);
b-cryptoxanthin (8.43 ± 0.56);
lutein plus zeaxanthin (24.2 ± 1.8);
lycopene (21.5 ± 1.25)
Little correlation between dietary and
serum carotenoid levels.
Cooney et al. (1995) [94] Not reported mmol/L e (Mean ± SD):
a-carotene (0.17 ± 0.11);
b-carotene (0.64 ± 0.64);
b-cryptoxanthin (0.29 ± 0.18);
lutein plus zeaxanthin (0.41 ± 0.14);
lycopene (0.52 ± 0.22)
Diet history showed good agreement with
plasma levels for most carotenoids.
Dietary carotenoids UC
Curran-Celentano et al. (2001) [95] mg/day e (Mean ± SD):
b-carotene (2935 ± 2698);
Lutein þ zeaxanthin (1101 ± 838);
Lycopene (8366 ± 6106)
mmol/L e (Mean ± SD):
b-carotene (0.28 ± 0.29);
Lutein (0.28 ± 0.13);
Zeaxanthin (0.091 ± 0.044);
Lycopene (0.601 ± 0.288)
Serum lutein þ zeaxanthin and dietary
intake of lutein þ zeaxanthin were
signiﬁcantly correlated
Dauchet et al. (2008) [96] Mean (SD)
Vegetables þ Fruits þ Juices M: 416
[182]F: 465 [156] Vegetables M: 198
[87] F: 213 [80] Fruitsþ Fruit JuicesM:
218 144) F: 242 [118] Fruits M: 180
[128] F: 199 [104]Fruit Juices M: 37
[66] F: 43 [57]
mmol/L e Median (Range):
b-carotene 0.33 (0.18e0.54)
Root vegetables and citrus fruits were
particularly associated with serum b-
carotene
Dietary carotenoids UC
Daures et al. (2000) [97] b-carotene (mean ± SD) ¼ 4.2 ± 8.4 mg/
day
blood levels not reported For b-carotene intake assessment, the triad
model was the best with estimates of
validity coefﬁcient of 0.39 (CI 0.18e0.60) for
the FFQ and 0.85 (CI 0.43e1.0) for plasma
level.
Other carotenoids not reported
Dixon et al. (1996) [98] Dietary total carotenoids (Mean ± SD):
FFQ - 3167 ± 1815 and
3 d FR e 3563 ± 2545
Mean (SD):
a-carotene 0.12 (0.08) mmol/L; b-carotene 0.41
(0.28);
b-cryptoxanthin 0.28 (0.43); lutein plus zeaxanthin
211 [75] ug/Lycopene 0.29 (0.11) mmol/L;
TOTAL 835 (343) ug/L
Total Carotenoids (P < 0.005) Serum total and lutein plus zeaxanthin
units as ug/L while all other carotenoids
as umol/L.
Dixon et al. (2006) [99] mg/d Mean (95% CI)
DHQ a-carotene W: 526 (429, 646)
M: 425 (308, 587) b-carotene
W: 2683 (2277, 3160) M: 2452 (1916,
3138) b-cryptoxanthin W: 130
[109,154] M: 129 [103,163] lutein plus
zeaxanthin W: 2119 (1827, 2459)M:
2068 (1682, 2543) lycopene W: 5612
(4815, 6540) M: 6762 (5486, 8335)
4  24-HR a-carotene W: 332 (237,
mmol/L e Mean (95%CI):
F a-carotene 0.11 (0.09e0.13);
b-carotene 0.31 (0.25e0.38);
b-cryptoxanthin 0.09 (0.08e0.11);
Lutein plus zeaxanthin 0.28 (0.25e0.31);
Lycopene 0.61 (0.54e0.69)
M a-carotene 0.07 (0.05e0.09);
b-carotene 0.21 (0.16e0.27);
b-cryptoxanthin 0.08 (0.07e0.10);
Using the method of triads, validity
coefﬁcients for the DHQ were comparable
to the 4 24-HR and were especially strong
for a-carotene, cryptoxanthin,
lutein þ zeaxanthin
Dietary carotenoids not listed
465) M: 209 (128, 339) b-carotene W:
1956 (1609, 2377) M: 2049 (1565,
2684) cryptoxanthinW: 58 (44, 76) M:
95 [63,142] lutein plus zeaxanthin
W: 1410 (1214, 1638) M: 1616 (1340,
1949) lycopene W: 3505 (2495, 4922)
M: 7658 (5860, 10,007)
lutein plus zeaxanthin 0.26 (0.23e0.30);
lycopene 0.66 (0.58e0.74)
Eliassen et al. (2006) [100] Fruits and vegetable consumption
Serves/day (Mean SD) e
Health Centre Participants
Usual Care - 3.0 (1.3) Intervention - 3.8
(1.7) Small Business Participants
Usual Care e 3.2 (1.7) Intervention - 3.8
(1.9) TogetherUsual Care - 3.1 (1.6) and
Intervention - 3.8 (1.8)
USUAL CARE mg/L e Mean (SD):
a-carotene 47 (27.7); b-carotene 194.4 (107.1);
b-cryptoxanthin 80.3 (38.6); lutein plus zeaxanthin
201 (67.8); lycopene 463.5 (162.2)
AND INTERVENTION: a-carotene 64 (48.7); b-
carotene 241 (143.9); b-cryptoxanthin 80 (37.2);
lutein plus zeaxanthin 194.7 (64.5); lycopene 489.3
(138.8)
F&V intake was signiﬁcantly correlated
with a-carotene when both groups were
combined, (P ¼ 0.02), b-carotene
(P ¼ 0.006) in the usual care group but not
in the intervention group. In the usual care
group, the correlations of lutein plus
zeaxanthin (P ¼ 0.03) and b-cryptoxanthin
P ¼ 0.01) with fruit and vegetable intake
were higher than in the intervention group
(P ¼ 0.08, 0.09).
Dietary carotenoids UC
El-Sohemy et al. (2002) [101] M mg/d - Mean (SD):
a-carotene 447 (449); b-carotene 3407
(2407); b-cryptoxanthin 383 (446);
lutein plus zeaxanthin 2412 (2857);
lycopene 5451 (5274) F:
a-carotene 727 (849); b-carotene 4668
(3564); b-cryptoxanthin 552 (523);
lutein plus zeaxanthin 2893 (2487);
lycopene 5772 (4789)
M nmol/L - Mean (SD):
a-carotene 135 [92]; b-carotene 484 (407); b-
cryptoxanthin 181 (202); lutein plus zeaxanthin
316 [143];
lycopene 501 (338) F: a-carotene 180 [151]; b-
carotene 821 (725); cryptoxanthin 275 (295); lutein
plus zeaxanthin 328 [165]; lycopene 585 (338)
a-carotene; b-carotene; lutein plus
zeaxanthin; cryptoxanthin; lycopene
Enger et al. (1995) [102] mg/d e Mean (SD): Modiﬁed FFQ:
a-carotene 940 (790); b-carotene 4800
(3230); b-cryptoxanthin 70.1 (66.3);
lutein plus zeaxanthin 3230 (2290);
lycopene 5180 (3860) Willet FFQ: a-
carotene 940 (790); b-carotene 4770.0
(3220.0); b-cryptoxanthin 69.5 (68.2);
lutein plus zeaxanthin 3270.0 (2500.0);
lycopene 4280 (3520.0)
mmol/L e Mean (SD):
a-carotene 0.138 (0.123);
b-carotene 0.571 (0.423);
b-cryptoxanthin 0.367 (0.231);
lutein plus zeaxanthin 0.324 (0.136);
lycopene 0.742 (0.380)
The crude and partial correlation
coefﬁcients of dietary and plasma levels of
b-carotene are slightly lower than those
found in other studies
Faure et al. (2006) [103] M: b-Carotene (mg/day) Means±
3140 ± 1540 (35e45yrs);
4090 ± 2290 (45e50yrs);
4110 ± 2310 (50e60yrs);
4470 ± 2240 (60e63yrs)
F: 3790 ± 2152 (35e45yrs);
3810 ± 2164 (45e50yrs); 4120 ± 2216
(50e60yrs);
4100 ± 1931 (60e63yrs)
Not reported In male volunteers, serum b-carotene was
signiﬁcantly related to tobacco smoking,
alcohol consumption estimated dietary
intake, serum cholesterol, and serum
triglycerides while in female volunteers it
was dependant on tobacco smoking,
cholesterol, serum triglycerides, and serum
cholesterol.
Estimated dietary intake of b-carotene was
higher in the 50- to 63-year-old volunteers,
it was signiﬁcantly higher in nonsmokers,
and higher in the summer.
Other carotenoids not reported
Fawzi et al. (2004) [104] mg/d (mean ± SD): AFRICAN
AMERICANS
a-carotene 586 ± 740, lutein plus
zeaxanthin 3207 ± 2915, lycopene
5017 ± 4557: CAUCASIANS a-carotene
656 ± 577, lutein plus zeaxanthin
2928 ± 2089, lycopene 8717 ± 6511
mg/L (mean ± SD): AFRICAN AMERICANS
a-carotene 64 ± 32, lutein plus zeaxanthin
212 ± 38.7,
lycopene 446 ± 57: CAUCASIANS
a-carotene 81 ± 22, utein plus zeaxanthin 219 ± 46,
lycopene 444 ± 79
Plasma a-carotene levels were:
1.9 (p ¼ 0.10) and 2.9 (p ¼ 0.0007) mg/L
higher for every 100 mg increase in dietary
intake amongst African American and
Caucasian respectively. Extreme dietary
deciles saw an increase in a-carotene of
275% for African Americans and 152% for
Caucasian women
Increases were also seen for lycopene,
lutein, and g-tocopherol, ranging from 12%
to 64%.
Other carotenoids not reported
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Ferrari et al. (2005) [105] Region Speciﬁc means (SE) of carrot,
fruit and tomato intake (all g/day) for
DQ and 24-HDR
FranceCarrot: 20.0 (1.7) and 11.2 (2.9)
Fruit: 249.9 (13.6) and 232.5 (17.6)
Tomato: 22.0 (1.8) and 44.7 (8.6)
Florence, Italy Carrot: 12.4 (1.2) and 4.6
(1.2) Fruit: 336.0 (12.6) and 349.7 (22.8)
Tomato: 85.4 (3.9) and 79.6 (7.2) Vares/
Turin Italy Carrot: 16.4 (1.4) and 7.2
(2.0)Fruit: 354.0 (14.6) and 379.7 (19.0)
Tomato: 83.9 (3.6) and 77.2 (8.1)
Ragusa/Naples Italy Carrot: 9.7 (1.4)
and 2.9 (1.0)Fruit: 514.5 (23.0) and
382.7 (21.4)Tomato: 48.9 (2.4) and 77.1
(8.3)
Northern Spain Carrot: 9.0 (1.8) and
5.8 (1.1) Fruit: 344.9 (17.4) and 337.8
(18.3)
Tomato: 69.2 (4.8) and 49.6 (5.9)
Granada Spain Carrot: 7.9 (0.9) and 7.7
(1.1) Fruit: 339.4 (14.8) and 359.7 (19.2)
Tomato: 100.7 (5.0) and 99.2 (8.6)
Murcia Spain Carrot: 5.7 (0.7) and 6.5
(1.3) Fruit: 409.2 (15.2) and 408.6 (21.3)
Tomato: 94.5 (4.7) and 105.2 (7.2)
Cambridge UK Carrot: 28.8 (1.4) and
21.2 (2.4) Fruit: 218.9 (10.6) and 163.8
(13.3) Tomato: 42.4 (2.0) and 42.5 (4.1)
Oxford UK Carrot: 39.4 (2.5) and 21.8
(3.9) Fruit:425.7 (32.5) and 298.8 (19.5)
Tomato: 54.1 (3.2) and 81.1 (7.2) The
Netherlands Carrot: 13.0 (0.8) and 8.8
(2.6) Fruit: 218.2 (9.5) and 204.6 14.2)
Tomato: 15.7 (0.9) and 22.3 (4.8)
Athens, Greece Carrot: 32.9 (3.1) and
8.7 (0.2) Fruit: 654.7 (30.5) and 259.1
(17.3)
Tomato: 163.6(6.4) and 101.2 (8.9)
Heidelberg Germany Carrot: 8.2 (0.6)
and 11.2 (2.5) Fruit: 148.4 (7.2) and
157.3 (14.2) Tomato: 34.5 (1.5) and 47.4
(6.4) Potsdam Germany Carrot: 8.0
(0.7) and 11.4 (3.7) Fruit: 163.4 (7.0)
and 261.8 (16.7) Tomato: 26.2 (1.4) and
52.2 (6.2) Malmo Sweden Carrot: 22.4
(2.3) and 13.4 (2.4)Fruit: 186.5 (8.8) and
131.0 (10.1) Tomato: 45.8 (2.6) and 47.1
(4.7)
Umea Sweden Carrot: 37.8 (3.8) and
16.6 (2.8) Fruit: 161.8 (9.3) and 153.0
(11.0)Tomato: 18.4 (1.5) and 39.9 (3.8)
Denmark Carrot: 34.3 (3.4) and 21.7
(3.9) Fruit: 193.8 (11.8) and 196.5 (16.0)
Tomato: 42.9 (1.9) and 38.6 (5.0)
Region speciﬁc means (SE) of a-carotene/B-
cryptoxanthin/Lycopene (all mmol) France 0.32
(0.02)/0.29 (0.02)/0.69 (0.04) Florence, Italy 0.14
(0.01)/0.30 (0.02)/0.96 (0.03)
Vares/Turin Italy 0.19 (0.01)/0.40 (0.02)/0.97 (0.03)
Ragusa/Naples Italy 0.13 (0.01)/0.43 (0.02)/1.31
(0.03)
Northern Spain 0.09 (0.01)/0.39 (0.02)/0.48 (0.02)
Granada Spain 0.09 (0.01)/0.44 (0.02)/0.70 (0.03)
Murcia Spain 0.08 (0.01)/0.44 (0.02)/0.70 (0.02)
Cambridge UK 0.21 (0.01)/0.17 (0.01)/0.75 (0.02)
Oxford UK 0.29 (0.02)/0.22 (0.01)/0.93 (0.03)
The Netherlands 0.10 (0.01)/0.22 (0.01)/0.50 (0.02)
Athens, Greece 0.11 (0.01)/0.40 (0.02)/0.86 (0.03)
Heidelberg Germany 0.20 (0.01)/0.20 (0.01)/0.58
(0.02)
Potsdam Germany 0.17 (0.01)/0.22 (0.01)/0.64
(0.02)
Malmo Sweden 0.15 (0.01)/0.16 (0.01)/0.49 (0.02)
Umea Sweden 0.22 (0.01)/0.19 (0.01)/0.50 (0.02)
Denmark 0.19 (0.01)/0.17 (0.01)/0.56 (0.02)
Intraclass correlation coefﬁcients were
0.178 for a-carotene, 0.216 for
cryptoxanthin and 0.299 for lycopene
Values for plasma carotenoids not
presented
Floreani et al. (2000) [106] Fruits (g/day, mean ± SD) e
193 ± 132 for cholestasis patients &
201 ± 14 for controls;
Vegetables e 171 ± 97 for cholestasis
patients & 166 ± 10 for controls
Total carotenoids e 5.73 ± 5.5 for
cholestasis & 5.1 ± 1.9 for controls
Primary biliary cirrhosis (mmol/L);
a-carotene e 0.14 ± 0.10; b-carotene e
0.738 ± 0.47;
cryptoxanthin e 0.384 ± 0.31; Lutein e
0.444 ± 0.24;
zeaxanthin e 0.128 ± 0.08 Lycopene - 0.480 ± 0.32;
Primary sclerosing cholangitis a-carotene e
0.18 ± 0.13;
b-carotene e 0.574 ± 0.28; cryptoxanthin e
0.401 ± 0.24;
Lutein e 0.420 ± 0.19; zeaxanthin e 0.119 ± 0.06
Lycopene e 0.519 ± 0.23; AND CONTROLS a-
carotene e 0.26 ± 0.22; b-carotene e 1.449 ± 0.98;
cryptoxanthin e 0.31 ± 0.25; Lutein e 0.744 ± 0.43;
zeaxanthin e 0.297 ± 0.18 Lycopene e
0.803 ± 0.44;
No validation examined Cholestasis patients have
malabsorption of fat soluble nutrients
Forman et al. (1993) [46] FFQ (mg/day) a -carotene 840 ± 621,
b - carotene 3882 ± 2452,
cryptoxanthin 62 ± 59, lutein plus
zeaxanthin 2516 ± 1528,
lycopene3879 ± 3025 Total
11179 ± 7685 Food diary a -carotene
650 ± 567, b - carotene 3150 ± 2156, b -
cryptoxanthin 38 ± 63, lutein plus
zeaxanthin 2056 ± 2311, lycopene
3652 ± 3123 Total 9546 ± 6034
(mmol/L)
a -carotene 0.09 ± 0.07, b e carotene
0.58 ± 0.3,cryptoxanthin 0.24 ± 0.16, lutein plus
zeaxanthin 0.49 ± 0.19, lycopene 1.06 ± 0.41 Total
2.46 ± 0.65
b e carotene 0.36, cryptoxanthin 0.33 Males only
Freedman et al. (2010) [107] lutein plus zeaxanthin (mg/day, mean
and SD) e 1848 (1284) for controls and
1788 (1226) for cases
lutein plus zeaxanthin (mmol/L, mean and SD)e0.33
(0.16) for controls and 0.30 (0.14) for cases
Association of nuclear cataract risk with
combined- reported dietary lutein/
zeaxanthin and serum lutein/zeaxanthin.
Other carotenoids not reported
Freisling et al. (2009) [108] a-carotene (mg) Geometric mean (95%
CI) Poor (n¼81) 1.8 (1.4e2.2) Fair
(n¼ 67)
1.6 (1.3e2.0) Good (n¼ 86) 2.1 (1.7
e2.5)
Very Good (n¼ 62) 2.5 (2.0e3.2)
Means (95%CI) by FFI categories (mg/L). Poor a-
carotene e 50 [32e67] b-carotene - 181 (135e226)
cryptoxanthin e 52 [41e63] Lutein e 175 (150
e200)Zeaxanthin e 28 [24e32] Fair a-carotene e
38 [28e47] b-carotene - 224 (169e278)
cryptoxanthin e 58 [46e69] Lutein e 180 (154
e205) Zeaxanthin e 26 [22e30] Good a-carotene
e 40 [28e53] b-carotene - 221 (169e273)
cryptoxanthin e 68 [56e80] Lutein e 191 (168
e214)Zeaxanthin e 32 [25e38]Very Good a-
carotene e 45 [34e56]b-carotene - 292 (237e348)
cryptoxanthin e 78 [66e90] Lutein e 204 (180
e228) Zeaxanthin e 32 [28e37]
FFI scores were positively correlated with
plasma concentrations of b-carotene
(r ¼ 0.26), cryptoxanthin (r ¼ 0.31), lutein
(r ¼ 0.21)
zeaxanthin (r ¼ 0.19),
Lycopene not reported and plasma
values not reported as such
Galan et al. (2005) [109] b - carotene (mean ± sd):
M 4.1 ± 2.5
F 4.0 ± 2.6(mg/day)
(mmol/L)
M ¼ 0.47 ± 0.35;
F ¼ 0.67 ± 0.43
b-carotene r ¼ 0.21, P < 0.001)
George et al. (2012) [38] Fruit & vegetable (no potato), intakes
reported; no. of serves, mean(SD) F
F&V¼DHQ ¼ 6.6(3.6);
recalls ¼ 5.1(2.7); F&V
screener ¼ 2.1(1.3) jM F&V:
HQ ¼ 6.8(4.1); Recalls ¼ 5.9(3.0); F&V
screener ¼ 4.6(1.7). F
Fruit¼DHQ ¼ 2.9(2.2);
Recalls ¼ 2.2(1.7); F&V
screener ¼ 2.1(1.3)jMale Fruit intake:
DHQ ¼ 2.8(2.4); Recalls ¼ 2.5(2.0); F&V
screener ¼ 2.2(1.5). Female Vegetable
intake¼DHQ ¼ 3.8(2.1);
Recalls ¼ 2.9(19); F&V
F and M; (mean) mg/dl):
a-carotene - 7.0 and 5.5, trans-b-carotene - 24.7;
18.3,
cryptoxanthin 11.0; 9.7, lutein - 12.5; 10.9,
zeaxanthin - 3.1; 2.9, and cis-lycopene 20.3; 22.0 -
and trans-lycopene - 20.6; 21.9
Unadjusted reported (F and M for
FFQj24Rjscreener): a-carotene: 0.44 and
0.39j0.36 nd 0.29j0.33 and 0.36;
(continued on next page)
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screener ¼ 2.1(0.7) Male Vegetable
intake: DHQ ¼ 4.0(2.7);
Recalls ¼ 3.4(1.9); F&V
screener ¼ 2.4(0.6).
Gerber et al., 92000) [195] Not reported - F &V classiﬁed by DQI
score, median (g): Scores 1 to 4
(n ¼ 10) ¼ 760.2; 5 to 6
(n ¼ 26) ¼ 649.0; 7 (n ¼ 21) ¼ 577.8;
Score 8 (n ¼ 32) ¼ 495.2;
Score 9 (n ¼ 20) ¼ 451.3; Scores 11e14
(n ¼ 18) ¼ 283.1.
Reported by DQI score (mmol/L):
Scores 1 to 4 ¼ 1.04; Scores 5 to 6 ¼ 1.01; Score
7 ¼ 1.00;
Score 8 ¼ 1.06; Score 9 ¼ 0.72; Score 10 ¼ 0.80;
Scores 11 to 14 ¼ 0.170.
Plasma carotene: DQI (non-smokers)
r ¼ 0.12 (p ¼ 0.157); DQI
(smokers) ¼ 0.17 (p ¼ 0.045).
Gomez-Aracena et al. (2003) [111] mg/day(mean ± s.d.): a-
carotene ¼ 383 ± 297; b-
carotene ¼ 1595 ± 860;
lycopene ¼ 1359 ± 816
mg/100 mL:
b-carotene ¼ 30.9 ± 26.4;
lycopene ¼ 14.1 ± 6.9
a-carotene ¼ 0.25; b-carotene ¼ 0.27;
lycopene ¼ 0.25(all p < 0.01)
FFQ - 28 items for carotenes þ addition
of 2 for lycopene
Goodman et al. (1996) [112] All b-carotene (n-1182) mg/d (mean;
95%CI): 2.0 (1.9e2.1)
ng/mL (mean; 95%CI): 143 [136e150] b-carotene (diet vs serum) ¼ 0.24(p < 0.05)
Greene et al. (2008) [113] Not reported - F &V only.
24R e Mean (95%CI)URI:M ¼ 5.26(4.58
e6.00); F ¼ 5.29(4.91e5.69); iT/
Rush:M ¼ 5.09(4.38e5.85);
Emory:M ¼ 4.04(3.30e4.85);
F¼ 3.99(3.65e4.35) FVS - Mean(95%CI):
M ¼ 8.32(7.12e9.61); F ¼ 8.09(7.40
e8.82)jIIT/Rush: M ¼ 5.24(4.350.22)j
Emory: M ¼ 5.00(3.52e6.74);
F ¼ 4.66(4.03e5.33)
Not reported URI:M ¼ n/s; F ¼ 0.43 (p < 0.0001)j IIT/
Rush: M ¼ n/sj Emory: F ¼ n/s;
UC report carotenoids values for plasma
carotenoids Final sample for serum
carotenids differ to those for intake
results, small sample of males
Grievink et al. (1999) [114] Median (range):2.0(0.5e6.1) 0.30(0.00e2.07) 0.31 (sig not reported)
Hallfrisch et al. (1994) [115] Quintile(IU): F: 1 ¼ 1306; 2 ¼ 2608;
3 ¼ 4411; 4 ¼ 6698;
5 ¼ 13910 M:1 ¼ 1273;
2 ¼ 2771; 3 ¼ 4089; 4 ¼ 6122;
5 ¼ 11709
Quintile; mmol/L(mean ± SEM):
F: 1 ¼ 0.53 ± 0.10; 2 ¼ 0.66 ± 0.10; 3 ¼ 0.68 ± 0.10;
4 ¼ 1.07 ± 0.10;
5 ¼ 1.21 ± 0.10M: 1 ¼ 0.45 ± 0.06; 2 ¼ 0.48 ± 0.06;
3 ¼ 0.58 ± 0.06; 4 ¼ 0.56 ± 0.06; 5 ¼ 0.83 ± 0.06
(Age¼<45; 45e59; 60e74; 75þ) with
carotene intake p < 0.0001
Hammond et al. (1995) [116] Not reported for group, instead
reported for 1) twins with signiﬁcantly
different macular pigment and 2) twins
with similar macular density
UC Dietary lutein and zeaxanthin vs serum
lutein, r ¼ 0.48; vs serum zeaxanthin,
r ¼ 0.57. b-carotene, r ¼ 0.67. Lycopene,
r ¼ 0.47. all p < 0.05.
Hann et al. (2001) [117] b-carotene (ug/d) presented by HEI
score category: <65
(n ¼ 58) ¼ 217 ± 42;
65e74(n ¼ 65) ¼ 548 ± 149; 75
e84 ¼ 871 ± 346;
85 ¼ 806 ± 81
HEI score (mmol/L). a-carotene(n ¼ 332):
<65 ¼ 0.08; 65e74 ¼ 0.14; 75e84 ¼ 0.17;
≥85 ¼ 0.22 b-carotene: <65 ¼ 0.49; 65e74 ¼ 0.52;
75e84 ¼ 0.68; ≥85 ¼ 0.85 cryptoxanthin:
<65 ¼ 0.11; 65e74 ¼ 0.19; 75e84 ¼ 0.23;
85 ¼ 0.25 lutein: <65 ¼ 0.36; 65e74 ¼ 0.36; 75
e84 ¼ 0.48; ≥85 ¼ 0.52 lycopene: <65 ¼ 0.71; 75
e84 ¼ 0.73; 75e84 ¼ 0.73; ≥85 ¼ 0.74
a-carotene ¼ 0.41; b-carotene ¼ 0.30;
cryptoxanthin ¼ 0.40; lutein ¼ 0.24 (all
p < 0.05)
Hebert et al. (1994) [118] b-carotene, mean(SD)¼ 2126.2(1276.5)
mg/day; total b-carotene (including
supps) ¼ 2186.2(1331.3)
0.35(0.27) mmol/L 0.32; p < 0.0001
Hercberg et al. (1994) [119] b-carotene (mg/d); median (5th, 95th
percentiles): Categorised by age:
18-30yrs: M ¼ 1057 (108, 2905);
F ¼ 1134 (228, 3091); 30e40yrs:
M ¼ 1228 (195, 3910); F ¼ 1222 (306,
2978); 40e50yrs: M ¼ 1434 (294,
3293); F ¼ 1163 (174, 3170); 50e65yrs:
M ¼ 1433 (322, 3341); F ¼ 1513 (238,
bcarotene (mg/d); median (5th, 95th percentiles):
Categorised by age: 18e30yrs: M¼ 0.48(0.24, 1.38);
F ¼ 0.72(0.26, 1.80)); 30e40yrs: M ¼ 0.65 (0.16,
1.92); F ¼ 0.62 (0.26, 2.36); 40e50yrs: M ¼ 0.48
(0.14, 1.83); F ¼ 0.86 (0.29, 1.93); 50e65yrs:
M ¼ 0.63 (0.24, 1.61); F ¼ 0.89 (0.36, 2.23);
>65: M ¼ 0.90 (0.10, 1.29); F ¼ 0.90 (0.27, 2.23)
>18 yrs: M ¼ 0.002(p < 0.005); F ¼ 0.001
(p < 0.005)
2921); >65: M ¼ 1562 (363, 3710);
F ¼ 1359 (592, 3974)
Hendrickson et al. (2013) [19] Mean ± SD mg/day Training/testing
a carotene 776 ± 496/799 ± 509 b
carotene 4397 ± 2193/4442 ± 2208
Cryptoxanthin 183 ± 92/184 ± 94
Lutein/zeaxanthin 2955 ± 1635/
2950 ± 1630 Lycopene 6336 ± 3219
Total carotenoids 14696 ± 5452/
14,697 ± 5560
Mean ± SD mg/dl a carotene 74 ± 50/74 ± 52 b
carotene 291 ± 207/289 ± 212 Cryptoxanthin
84 ± 46/83 ± 43 Lutein/zeaxanthin 187 ± 74/
181 ± 68 Lycopene 425 ± 176/419 ± 177 Total
carotenoids 1080 ± 403/1062 ± 394
Training/Testing
a carotene 0.34/0.31 (P < 0.001) b carotene
0.26/0.29 (P < 0.001) Cryptoxanthin 0.34/
0.36 (P < 0.001) Lutein/zeaxanthin 0.26/
0.28 (P < 0.001) Lycopene 0.22/0.22 Total
carotenoids 0.20/0.22 (P < 0.001)
Hiroaka et al. (2001) [120] Sum of carotene and retinol only
presented as Vitamin A (mgRE); mean
(SD): 727(861)
b-carotene (mmol/L): 1.33(1.20) r ¼ 0.319; p < 0.001)
Hodge et al. (2009) [121] Unadjusted: Median (IQR):
a-carotene: M ¼ 1245(558e1618);
F ¼ 1130 (654e1799)jb-carotene:
M¼ 5142 (3315e7028); F¼ 5266 (3866
e7125) j cryptoxanthin: M ¼ 324 (160
e588); F ¼ 349 (180e592) j Lutein/
zeaxanthin: M ¼ 1615 (1064e2282);
F ¼ 1697 (1193e2304)
Lycopene: M ¼ 7108 (4067e10513);
F ¼ 6264 (3995e9446)j
Unadjusted: Median (IQR):
a-carotene: M ¼ 0.08 (0.04e0.13); F ¼ 0.11 (0.07
e0.17)j
b-carotene: M ¼ 0.48 (0.28e0.77); F ¼ 0.78 1 (0.47
e1.06)j
cryptoxanthin: M¼ 0.16 (0.09e0.31); F¼ 0.27 (0.15
e0.45)j
Lutein/zeaxanthin: M ¼ 0.30 (0.21e0.43); F ¼ 0.33
(0.23e0.43)
Lycopene: M ¼ 0.50 ((0.32e0.75); F ¼ 0.51 (0.35
e0.72)j
r (% 95 CI):
a-carotene (n ¼ 2744) ¼ 0.35 (0.31, 0.38)j
b-carotene (n ¼ 2876) ¼ 0.23 (0.19, 0.26)j
cryptoxanthin (n ¼ 2975) ¼ 0.40 (0.36,
0.43)jLycopene (n ¼ 2679) ¼ 0.21 (0.18,
0.25)jlutein/zeaxanthin (n ¼ 2990) ¼ 0.21
(0.18, 0.25)
Holmes et al. (2007) [32] b-carotene (mg/d); mean(SD):
4330(3712) lycopene: 6239(4447).
median per decile (n ¼ 10, with
decile#3 þ 4, 5 þ 6, 7 þ 8 combined):
b-carotene: 1 ¼ 1256; 2 ¼ 1773;
3 þ 4 ¼ 2321; 5 þ 6 ¼ 3084;
7 þ 8 ¼ 4239; 9 ¼ 7204; 10 ¼ 11,777
lycopene: 1 ¼ 1145; 2 ¼ 2237;
3 þ 4 ¼ 3410; 5 þ 6 ¼ 5546;
7 þ 8¼8074; 9 ¼ 10,225; 10¼16,054.
Median per decile (n ¼ 10, with decile#3 þ 4, 5 þ 6,
7 þ 8 combined):b -carotene 1 ¼ 129; 2 ¼ 129;
3 þ 4 ¼ 231; 5 þ 6 ¼ 316; 7 þ 8 ¼ 294; 9 ¼ 290;
10 ¼ 500 Lycopene: 1 ¼ 418; 2 ¼ 411; 3 þ 4 ¼ 365;
5 þ 6 ¼ 404; 7 þ 8 ¼ 369;
9 ¼ 449; 10 ¼ 551.
Generalised estimating equations: %
increase in blood levels from decile 1 to 10:
b-carotene ¼ 288% lycopene ¼ 32%;
Iribarren et al. (1997) [122] Quartiles by serum b-carotene (energy-
adjusted residual method). pro-Vitamin
A carotenoids (IU/day): 1 ¼ 6067;
2 ¼ 5905; 3 ¼ 6878; 4 ¼ 8258
Absolute range (mmol/L:
1 ¼ 0.03e0.20; 2 ¼ 0.21e0.31; 3 ¼ 0.32e0.46;
4 ¼ 0.47e1.62
r ¼ 0.11; p-0.04 Single assessment of serum carotenoids
Jacques et al. (1995) [123] Total carotenoids, median (IQR), mg/
d (n ¼ 746): M ¼ 3.1 (5.6); F ¼ 3.5 (5.9)
Reported (mean, 95%CI) per intake category and
combined (mmol/L): <2 mg ¼ 2.2 (2.1, 2.3); 2.0
e5.4 mg ¼ 2.5 (2.3,2.6);
5.5 mg ¼ 2.8 (2.6, 2.9)
Plasma cartoenoids 27% (0.6 mmol/L)
greater in the highest compared to lowest
category (p for trend <0.001)
Jansen et al. (2004) [124] Mean (SD) intake e
Vegetables (g/d):
M ¼ 113(49); F ¼ 127(50)
Fruit)g/d): M ¼ 153(125);
F ¼ 186(145) fruit juices (g/d):
M ¼ 79(92; F ¼ 86(89)veg juices (g/
d):M ¼ 5(8); F ¼ 7(12)
Mean (SD); mmol/L e
a-carotene: M ¼ 0.081(0.060); F ¼ 0.120(0.090) b-
carotene:
M ¼ 0.240(0.152); F ¼ 0.302(0.184) cryptoxanthin:
M ¼ 0.167 (0.132); F ¼ 0.225 (0.167) lutein:
M ¼ 0.251 (0.098); F ¼ 0.304(0.111) zeaxanthin:
M ¼ 0.066 (0.028); F ¼ 0.085 (0.034) lycopene:
M¼ 0.62 (0.308); F¼ 0.658 (0.341) canthaxanthin:
M ¼ 0.010 (0.013); F ¼ 0.009 (0.015)total:
M ¼ 1.435 (0.514); F ¼ 1.704 (0.606)
All ¼ r and p < 0.05. a-carotene vs
Fr þ V þ J: M ¼ 0.29; F ¼ 0.0.28j vs V:
M ¼ 0.21; F ¼ 0.17 j vs Fr: M ¼ 0.28;
F ¼ 0.28jJ ¼ M ¼ 0.12. b-carotene
vsFr þ V þ J: M ¼ 0.24; F ¼ 0.17 jV:
M¼ 0.19; F¼ 0.15 j Fr:M¼ 0.25; F¼ 0.18 jJ:
N/S. b-cryptoxanthin vs V þ Fr þ J:
M ¼ 0.41; F ¼ 0.35jv: M ¼ 0.13; F]N/S. Fr:
M ¼ 0.37; F ¼ 0.37jJ: m ¼ 0.29; F ¼ 0.21.
Lutein vs V þ Fr þ J:M ¼ 0.19; F ¼ 0.20 jV:
M ¼ 0.27; F ¼ 0.19jFr:M ¼ 0.16; F ¼ 0.18 jJ:
N/S. Zeaxanthin vs. V þ Fr þ J: m ¼ 0.18;
M ¼ 0.23 jV:m ¼ 0.16; F]N/S jJ¼M ¼ 0.21;
F ¼ 0.23. Lycopene¼ n/s. Total vs
Vþ Frþ J:M ¼ 0.21; F ¼ 0.18 jV:M ¼ 0.19;
F¼ 0.15 j Fr:M¼ 0.15; F¼ 0.18 jJ:M¼ 0.16;
F]N/S.
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Jarvinen et al. (1993) [125] А carotene (mg) M 67 ± 123, F
105 ± 146,
b - carotene 1589 ± 1862 2060 ± 2184,
gamma carotene 34 ± 38, 48 ± 53
lycopene 602 ± 684 867 ± 964 lutein
1031 ± 457, 895 ± 349
b - carotene (mg/L) men mean 86 ± 78 women
125 ± 94
Linear covariance analysis
Jilcott et al. (2007) [33] UC UC Signiﬁcance not stated (n ¼ 200, those with
values consistent with supp use excluded).
DRA. F&V vs: carotenoid index, r ¼ 0.30,
p < 0.0001; a-cartoene, r ¼ 0.23,
p ¼ 0.0009; b-carotene, r ¼ 0.31, <0.0001;
zeaxanthin plus lutein, r ¼ 0.15, p ¼ 0.03;
Fruit vs cryptoxanthin, r ¼ 0.27,
p < 0.0001; veg vs: a-carotene, r ¼ 0.33,
p¼< 0.0001; b-carotene, r ¼ 0.35,
p < 0.0001. FFQ, 5-A-Day method: F&V vs.
b-carotene, r ¼ 0.26, p ¼ 0.02; Fruit vs.
cryptoxanthin, r ¼ 0.25, p ¼ 0.02; Veg vs b-
carotene, r ¼ 0.24, p ¼ 0.03; others all
p  0.05. FFQ, Summation method: all
p  0.05
Information on supplement use not
collected, therefore those with serum
levels typical of supp use were
excluded.
Kabagambe et al. (2001) [126] Mean(SD), mg.
a-carotene: 24R ¼ 118(70);
FFQ1 ¼ 640(792); FFQ2 ¼ 459(442);
AVE FFQ ¼ 550(547) b-carotene:
24R ¼ 596(351); FFQ1 ¼ 4239(3344);
FFQ2 ¼ 3604(2283); AVE
FFQ ¼ 3921(2442)
cryptoxanthin: 24R ¼ 262(172);
FFQ1 ¼ 610(603); FFQ2 ¼ 457(498);
AVE FFQ ¼ 533(482)
zeaxanthin þ lutein:
24R ¼ 599(292); FFQ1 ¼ 2922 (2892);
FFQ2 ¼ 2423 (2265); AVE FFQ ¼ 2672
(2308)
lycopene: 4R ¼ 916(798);
FFQ1 ¼ 5180(3709);
FFQ2 ¼ 5249(3637);
AVE FFQ ¼ 5215(3108)
not reported - ONLY retinol in plasma All r (þcorrected for day-to-day variation Cr
for 24R only).a-carotene: 24R: r ¼ 0.25;
Cr ¼ 0.33; FFQ1 ¼ 0.32; FFQ2 ¼ 0.28; ave
FFQ ¼ 0.36jb-carotene: 24R: r ¼ 0.26;
Cr ¼ 0.35; FFQ1 ¼ 0.33; FFQ2 ¼ 0.36; ave
FFQ ¼ 0.38j, cryptoxanthin: 24R: r ¼ 0.25;
Cr ¼ 0.43; FFQ1 ¼ 0.53; FFQ2 ¼ 0.55; ave
FFQ ¼ 0.58 j, zeaxanthin þ lutein: 24R:
r ¼ 0.32; Cr ¼ 0.43; FFQ1 ¼ 0.28;
FFQ2¼ 0.26; ave FFQ¼ 0.27 lycopene: 24R:
r ¼ 0.30; Cr ¼ 0.45; FFQ1 ¼ 24; FFQ2 ¼ n/s;
ave FFQ ¼ 0.26
Kanetsky et al. (1998) [127] Median (IQR), mg: cases (n ¼ 32);
controls (n ¼ 113). a-
carotene¼ 204(24.5e400); 199(54.7
e390) b-carotene ¼ 2308 (1270
e4502); 2474 (1424e4368)
Cryptoxanthin ¼ 79 (28.4e145); 90.7
(36.4e141) lycopene¼ 396 (172e816);
618 (341e1250) Lutein ¼ 2209 (1149
e3718); 2657 (1281e5661).
Median (IQR), mg: cases (n¼ 32); controls (n¼ 113).
a-carotene ¼ 1.1(0.30e3.5); 1.1(0.60e2.8)
b-carotene ¼ 7.7 (3.1e19.5); 9.3 (5.1e15.6)
cryptoxanthin ¼ 9.1 (6.3e14.1); 9.7 (7.2e13.7)
Lutein ¼ 76.1 (64.0e118); 77.2 (62.5e104).
lycopene ¼ 32.7 (24.7e54.7); 34.8 (26.5e48.2)
No sig correlations, only when restricted to
control women not taking supp (n ¼ 19) r
(95%CI), Cases; controls. b-carotene ¼ 0.52
(0.09 to 0.79)jLycopene ¼ 0.55 (0.13
e0.81)
Kant & Graubard et al. (2005) [129] Not reported in absolute values, only
association with 3 dietary scores
(Table 3). Pearson's r with Carotene
(RE): HEI ¼ 0.20; RFS ¼ 0.31; DDS-
R ¼ 0.19; all p < 0.0001
n ¼ 7997. Dietary scores (HEI, RFS, DSS-R) split into
quartiles and mean ± SEM reported for each (mmol/
L)
serum a-carotene C1: 0.072 ± 0.002,0.072 ± 0.003,
0.073 ± 0.002C2: 0.083 ± 0.002, 0.077 ± 0.002,
0.085 ± 0.002
C3: 0.093 ± 0.003, 0.084 0.002, 0.092 ± 0.002
C4: 0.118 ± 0.004, 0.114 ± 0.003, 0.119 ± 0.004
All 3 dietary scores were strong ve
predictors of all serum carotenoids, except
lycopene (sig for RFS & DDS-R only @
p < 0.05)
b±SE2: 0.001 ± 0.000, 0.009 ± 0.000, 0.012 ± 0.001
b-carotene C1: 0.322 ± 0.009, 0.326 ± 0.010,
0.330 ± 0.008
C2: 0.359 ± 0.013, 0.340 ± 0.009, 0.357 ± 0.008
C3: 0.373 ± 0.010, 0.354 ± 0.010, 0.374 ± 0.011
C4: 0.441 ± 0.014, 0.438 ± 0.008, 0.454 ± 0.013
b±SE2: 0.003 ± 0.000, 0.022 ± 0.002, 0.035 ± 0.004
cryptoxanthin C1: 0.143 ± 0.003, 0.139 ± 0.004,
0.142 ± 0.003
C2: 0.158 ± 0.004, 0.148 ± 0.004, 0.158 ± 0.004
C3: 0.165 ± 0.003, 0.162 ± 0.004, 0.172 ± 0.004
C4: 0.196 ± 0.005, 0.190 ± 0.004, 0.193 ± 0.006
b±SE2: 0.001 ± 0.000, 0.009 ± 0.000,0.014 ± 0.001
Lutein/zeaxanthin C1: 0.351 ± 0.006,
0.335 ± 0.005, 0.345 ± 0.003C2: 0.367 ± 0.007,
0.343 ± 0.009, 0.372 ± 0.006
C3: 0.386 ± 0.008, 0.370 ± 0.006, 0.389 ± 0.008
C4: 0.411 ± 0.008, 0.424 ± 0.008, 0.413 ± 0.011
b±SE2: 0.002 ± 0.000, 0.016 ± 0.001, 0.019 ± 0.004
Lycopene C1: 0.440 ± 0.005, 0.443 ± 0.007,
0.443 ± 0.006
C2: 0.456 ± 0.006, 0.433 ± 0.007, 0.439 ± 0.007
C3: 0.443 ± 0.007, 0.446 ± 0.007, 0.442 ± 0.006
C4: 0.449 ± 0.007, 0.456 ± 0.006, 0.466 ± 0.007
b±SE2: 0.000 ± 0.000, 0.002 ± 0.001, 0.006 ± 0.002
Kardinaal et al. (1995) [130] mg/d, mean(SD): for b-carotene
M ¼ 1.73 (0.0.66); F ¼ 1.75 (0.72)
mmol/L, mean (SD): for b-carotene
M ¼ 0.41 (0.26); F ¼ 0.63 (0.67)
No sig correlations for b-carotene diet vs
plasma (r ¼ 0.15; n ¼ 82) and vs adipose
tissue (r ¼ 0.16; n ¼ 74)
Katsouyanni et al. (1997) [131] Mean(SD) mg/d.
M: 24R ¼ 3.6(2.1); FFQ1 ¼ 6.6(4.7);
FFQ2 ¼ 7.6(6.9). F: 24R ¼ 2.8 (1.2);
FFQ1 ¼ 9.0 (5.4); FFQ2 ¼ 6.7 (4.4).
UC 24R ¼ R ¼ 0.22 (n ¼ 61);
FFQ1 ¼ 0.03 (n ¼ 59);
FFQ2 ¼ 0.11 (n ¼ 58)
Kiely et al. (1999) [132] Mean (SD); mg/d. Total ¼ 3213 (1703);
S ¼ 3464(1885); NS ¼ 2977(1503)
mmol/L, mean (SD):
Total ¼ 0.22(0.1); S ¼ 0.22(0.1); NS ¼ 0.22(0.1).
Plasma b-carotene levels of 40 neonates also
reported:
total 0.04(0.03); S ¼ 0.058 (0.04); NS ¼ 0.03 (0.02)
Smokers, r ¼ 0.41, p ¼ 0.015.
Non-smokers, r ¼ 0.28, p ¼ 0.12
Knutsen et al. (2001) [133] Mean (SD), mg. Reported including and
excluding supplements. Including
supps;
Black: total ¼ 6361.8(18317.3);
(n ¼ 61) ¼ 6991.1(22882.8);
(n ¼ 36) ¼ 5295.5 (4556.7). White:
Total ¼ 6161.9(6966.9);
F(n ¼ 56) ¼ 6267.7(6480.9);
M(n ¼ 40) ¼ 6013.9(7678.5).
Excluding supps; Black: total ¼ 5963.4
(18292.3); F(n ¼ 56) ¼ 6609.0
(22857.8); M(n¼ 40)¼ 4869.4 (4489.1).
White: total ¼ 5142.3(6239.1);
F(n ¼ 56) ¼ 4830.6(4968.2);
M(n ¼ 40) ¼ 5578.7(7725.1)
Mean (SD), mg/dl. Black: total ¼ 175.1 (74.3);
F ¼ 167.9(78.1);
M ¼ 187.7 (66.3).
White: total ¼ 164.2(63.5); F ¼ 165.6 (67.5);
M ¼ 162.3 (58.4)
Black: 24 h recall, without supp (n ¼ 83)
r ¼ 0.351; including supp users (n ¼ 97)
r ¼ 0.380; FFQ, without supp (n ¼ 60)
r ¼ 0.393, with supp (n ¼ 97) ¼ 0.340.
White: 24 h R, without supp (n ¼ 66)
r ¼ 0.351, with supp (n ¼ 96)r ¼ 0.380; FFQ,
without supp (n ¼ 60) r ¼ 0.291, with supp
(n ¼ 96) r ¼ 0.284.
Highly educated population
Kobayashi et al. (2011) [134] Mean ± SD (mg) Raw database e
a ecarotene M:997 ± 1994
F:826 ± 1324,
b e carotene M: 3413 ± 5041 F:
3309 ± 4114, lycopene
M:3408 ± 3756 F:3877 ± 4217, cooked
database - a -carotene
Serum (mg/ml):
a -carotene M:0,07 ± 0,04 F:0,10 ± 0,05,
b - carotene M: 0,32 ± 0,24 F: 0,57 ± 0,37,
lycopene M:0,11 ± 0,05 F:0,13 ± 0,06
P-values not provided. Values with 95%CI
not crossing zero presented: Raw database
-b - carotene M: 0.24(0.04e0.44) F:
0.21(0,01e0.41), lycopene M:0,30(0.09
e0.50) F:0.35(0.15e0.56). cooked database
-a -carotene M:0.22(0.02-0.43), b - carotene
Not adjusted for smoking or alcohol
intake
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M:1095 ± 1800 F:893 ± 1164,
b - carotene M: 3484 ± 7137 F:
3443 ± 6007, lycopene M:
2835 ± 3690 F:3126 ± 3661,
M: 0.24(0.02e0.41), lycopene M:0.37(0,18
e0.57) F:0.37(0,16e0.57)
Le Marchand et al. (1994) [135] Mean value (mg/D) e Baseline
(3months):
a -carotene 1398(1598);
b - carotene 4357(9943);
b - cryptoxanthin 318(370);
lutein 1637(5126);
lycopene 2407(13071);
total carotenoids 10117(30108)
Mean value (mg/L) - Baseline(3months):
a -carotene 62(92);
b - carotene 461(618);
b - cryptoxanthin 245(284);
lutein 291(352);
lycopene 199(242);
total carotenoids 1552(1964)
a -carotene 0.25; lutein 0.41;
b - carotene 0.50;
b - cryptoxanthin 0.04;
total carotenoids 0.41
Not 'healthy' population (former cancer
pts)
Lin et al. (2010) [136] Mean (SD), ug/d: a -carotene COPD
221(361) HC 333(422); b - carotene
COPD 3210(1904) HC 4291(2208);
lutein COPD 2278(1843) HC
3370(2370);
lycopene COPD 525(669) HC
1281(1144);
total carotenoids COPD 6234(3480) HC
9271(4838)
Mean (SD), mg/ml:
a -carotene COPD 0.07(0.83) HC 0.44(0.76);
b - carotene COPD 0.35(0.14) HC 0.62(0.58);
lutein COPD 0.05(0.58) HC 0.07(0.04);
lycopene COPD 0.02(0.01) HC 0.04(0.08);
total carotenoids COPD 0.49(0.20) HC 1.12(0.98)
a -carotene 0.382, p ¼ 0.008;
total carotenoids 0.242, p ¼ 0.006
Complete data not shown as not
primary outcome
Liu et al. (1992) [137] Mean (SD):
b -carotene mg FFQ 2470.11(2137.15)
NR UC - appears corrected associations for b
-carotene only. FFQ b-carotene 0.23.
Patient population and result reporting
unclear
Ma et al. (2009) [138] Baseline mean (SD), mg/d:
b -carotene 3.5(2.5)
lutein 2.4(2.0);
serum lutein mean (SD), mmol/L: 0.34(0.12) baseline lutein 0.56 (p < 0.01); plateau
lutein concentration in serum as a linear
function of dosage r ¼ 0.71 (p < 0.001);
baseline serum lutein as predictor of change
in serum lutein r ¼ 0.41
Small n
Machefer et al. (2007) [34] Reported as % of DRI. 57.9% had intake
>150%DRI
Mean(SD), mmol/L:
B-carotene 0.91(0.14)
b -carotene 0.52, p < 0.05; Small n; not general population
Maleksha et al. (2006) [139] 24 h recalls b -carotene, mg: M 90(107)
F 66(78); FFQ b -carotene: M 156(184) F
156(21)
First measurement: a-carotene 0.04(0.02),b
-carotene 0.164(0.12), cryptoxanthin 0.04(0.03);
lutein 0.31(0.16), zeaxanthin 0.053(0.02), lycopene
1.34(0.75), second measurement: a-carotene
0.05(0.03),b-carotene 0.198(0.15), cryptoxanthin
0.13(0.19)lutein 0.35(0.2), zeaxanthin 0.068(0.04),
lycopene 1.56(0.64),
b-carotene only reported with mean of 12
24 h recalls: 0.35; mean 4 FFQs: 0.37
Did not account for smoking or gender
differences
Mandel et al. (1997) [140] All subjects (mg/d) b carotene 400(78) UC b carotene 0.16
Non supplement users 0.20
Small n; uneven gender ratio
Margetts et al. (1993) [141] Carotene (mg):Males: non-smoker
2615(2456, 2773), light smoker
1936(1705, 2168), heavy smoker 2233
(1899, 2568); Females: non-smoker
2359(2192, 2526), light smoker
1766(1585, 1948), heavy smoker
1601(1321, 1881)
NR Dietary carotene with serum B-carotene
r ¼ 0.26, p < 0.01
Methods not adequately reported;
gender analysis not reported; non-
smokers not separated into never and
ex-smokers.
McNaughton et al. (2005) [142] mg, mean(SD):
WFR: a -carotene 1601(856),b -
carotene 4067(2271), b - cryptoxanthin
213(214),
lutein 523(264), lycopene 2336(1464),
total carotenoids 8741(2937);
FFQ: a -carotene 4234(2275), b -
carotene 10002(4954),b -
cryptoxanthin 626(528),
lutein 1631(1172), lycopene
Serum mmol/l, mean(SD):
a -carotene 0.11(0.08),
b - carotene 0.62(0.59),
b - cryptoxanthin 0.25(0.35), lutein 0.36(0.45),
lycopene 0.17(0.12), total carotenoids 1.51(1.23)
[1] Correlation, WFR and biomarker: b -
cyptoxanthin 0.42* [2]. validity coefﬁcients
(NB: UC if stat signif)FFQ: a -carotene 0.85,
b - carotene 0.55, lutein 0.19, lycopene 0.62,
total carotenoids 0.55; WFR: a -carotene
0.45, b - carotene 0.65, lutein 1.0, lycopene
0.23, total carotenoids 0.64; Biomarker: a
-carotene 0.42, b - carotene 0.40, lutein
0.16, lycopene 0.30, total carotenoids 0.51
Measures not collected at same time
point nor reﬂect same time frame; small
n for analysis by gender, age, etc.
3813(2299),
total carotenoids 20306(8514)
Meyerhardt et al. (2005) [143] NR Median (95% CI), mmol/L:
a -carotene 71(8e467),
b - carotene 277(28e1354)
Multi-variate adjusted:
a -carotene 0.36, b - carotene 0.33,
lutein þ zeaxanthin 0.39, b - cryptoxanthin
0.44
lycopene 0.34,
Fasting prior to blood collection not
consistent between patients; gender NR
Michaud et al. (1998) [144] Log-transformed values mean(SD),
unadjusted, mg/d [1] FFQ1-
M:a -carotene 1011(1019), b - carotene
5004(3313),lutein 3784(2382), b -
cryptoxanthin 94(82); lycopene
11119(6221), F:a -carotene 919(712),
b - carotene 5100(2997),b -
cryptoxanthin 75(72).lutein
4438(3674),
lycopene 11270(7212), (2) FFQ2-
M:a -carotene 910(771), b - carotene
4888(2873), b - cryptoxanthin 77(56);
lutein 2803(2038), lycopene
10497(6177), F:a -carotene 884(675),
b - carotene 4755(2574),b -
cryptoxanthin 67(68)lutein
3984(2690),
lycopene 10405(7278),
Mean(SD), mg/dl eMales:
a -carotene 612(5,54, b - carotene 24,67(15,58),
b - cryptoxanthin 13.29(6.54); lutein 15,68(5,62),
lycopene 43.9(20.17), Females: a -carotene,
6.71(5.24)
b - carotene 30.87(20.14),b - cryptoxanthin
12.26(6.27)
lutein 15.38(6.18), lycopene 40.77(17.11),
Correlations adjusted for TEI, using adjusted
plasma concentrations (1) FFQ1 - Males:
a -carotene 0.36, b - carotene 0.30, b -
cryptoxanthin 0.39;
lutein 0.30, lycopene 0.35, Females:
a -carotene 0.40, b - carotene 0.21, b -
cryptoxanthin 0.29.
lutein 0.27, lycopene 0.18, (2) FFQ2 -Males:
a -carotene 0.48, b - carotene 0.31, b -
cryptoxanthin 0.40;
lutein 0.38, lycopene 0.46, Females:
a -carotene 0.47, b - carotene 0.30, b -
cryptoxanthin 0.31
lutein 0.23, lycopene 0.18,
Correlations in FFQ2 may have been
raised due to improved diet reporting
following FFQ1 and 2 DR. Women
analysis may be affected bymenopausal
status
Mohammadifard et al. (2011) [39] Whole fruits and vegetables NR T1: Fruits 0.44, Citrus 0.33, Other fruits 0.44,
Dry fruits/nuts 0.27, Fruit juices 0.29;
Vegetables 0.41, Root vegetables 0.42,
Onions 0.41, Leafy veges 0.39, Non-leafy
veges 0.37, Pickles 0.27, Dry veges 0.24;
Total fruit & veges 0.47. T2: Fruits 0.42,
Melons 0.35, Other fruits 0.45, Dry fruits/
nuts 0.31, Fruit juices 0.3; Veges 0.43, Root
veges 0.38, Onion 0.35, Leafy veges 0.46,
Non-leafy veges 0.38, Pickles 0.28, Dry
veges 0.28; Total fruits & veges 0.45
Included smokers and supplement
takers and not adjusted or reported
Natarajan et al. (2006) [145,146] Total carotenoids, mean(SD), mg/d:
24-hr recalls
baseline 20.21(34.67),
12 months 18.78(27.35);
FQ
baseline 24.88(27.97),
12 months 25.31(32.50)
Total carotenoids, mean(SD), mmol/L: baseline
2.40(1.56), 12months 2.34(1.40)
Pearson correlations: with 24-hr recall
baseline r ¼ 0,45, 12months r ¼ 0,40; with
FFQ baseline r ¼ 0,35, 12months r ¼ 0,31.
Model-based estimate of correlation
between dietary measure and true intake:
24-hr recall a -carotene 0.45, b - carotene
0.52, b - cryptoxanthin 0.33; lutein 0.29,
lycopene 0.27, total carotenoids 0.44, FFQ a
-carotene 0.45, b - carotene 0.47, b -
cryptoxanthin 0.36; lutein 0.21, lycopene
0.24, total carotenoids 0.39, plasma
biomarker a -carotene 0.85, b - carotene
0.87, b - cryptoxanthin 0.83
lutein 0.86, lycopene 0.76, total carotenoids
0.86,
Only total carotenoids reported;
population not adequately described;
unadjusted for confounders
Neuhouser et al. (2007) [148] Proportion who reported having a food
in their house non Hispanic/Hispanic/
native American Orange Juice73.4/73.3/
61.5Tomato/tomato products 96.8/
98.1/96.2Deep yellow or orange fruits
77.1/86.0/79.8Bright orange/dark green
vegetables 95.4/92.4/74.0
NR Total sample. Household inventory: a
-carotene 0.12, b - carotene 0.14,b -
cryptoxanthin 0.23; total carotenoids 0.12,
5 A DAY fruit & veg servings: a -carotene
0.15, b - carotene 0.17, b - cryptoxanthin
0.17
NR of smoking or supplement use
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correlations
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Newby et al. (2003) [30] Mean DQI-R 67.2 ± 14.3 a carotene (mmol/l) 1.52 ± 0.75
b 2.98 ± 0.61
lutein 2.70 ± 0.38
lycopene 3.67 ± 0.41
DQI- R from FFQ with
a carotene 0.43 b carotene0.35 lycopene
0.17 lutein 0.31
Men only
Nolan et al. (2007) [147] MEAN(sd), mg/d:
LUTEIN 1.399(0.79),
Zeaxanthin 0.199(0.117)
Mean(SD), mg/ml:
Lutein 0.087(0.042),
Zeaxanthin 0.026(0.016)
Lutein (ug/ml): absolute dietary (mg/d)
0.286, energy-adjusted dietary (residuals
method) 0.301, nutrient density (mg/kcal)
0.300.
zeaxanthin (ug/ml): absolute dietary (mg/
d) 0.249, energy-adjusted dietary (residuals
method) 0.254, nutrient density (mg/kcal)
0.258.
Basic demographics not adequately
reported.
Ocke et al. (1997) [149] b - carotene mean(cv%), mg:
Recalls e
M 1.62(43.9), F 1.22(48.7);
FFQ e
M 1.88(48.0), F 1.51(40.3)
NR (serum) NB: does not indicate signiﬁcance level [1].
FFQ Unadjusted b - carotene: Males ¡0.17
(non-smokers ¡0.17), Females 0.14 (non-
smokers 0.12); Energy adjusted b - carotene
(residuals method): Males 0.15 (non-
smokers 0.08), Females 0.18 (non-
smokers 0.18) [2]. recall: males 0,14,
females 0,15.
Low initial response rate (25%);
demographics not provided; lab CV for
B-carotene 12,5%
Olafsdottir et al. (2006) [150] b - carotene (ug)
FFQ:
absolute intake 982(630),
nutrient density 1268(762);
24-hr recall:
absolute 1296(1112),
nutrient density 1450(1362). *Nutrient
density ¼ ug/10 MJ
b - carotene, mmol/L, mean(SD): 0.4(0.3) Plasma b - carotene with 24-hr recall
absolute b - carotene intake r ¼ 0.301,
p ¼ 0.029
Underpowered due to small sample
size; self-reported height and weight
(known to be underestimated in
females and obese)
Palli et al. (1999) [151] Carotene mg/d, mean(SE):
M 2690.8(47.9),
F 2786.6(53.6)
Carotene, mg/dl, mean(SE):
M 32.7(1.2),
F 45.7(1.3)
M: 0.27,
F: 0.23; p-value NR
Unadjusted for BMI; individual
carotenoids NR; supplement use data
not collected
Pierce et al. (2006) [152] Whole foods only, no values reported Log transformed(mmol/L) Mean (SD). Intervention
group: Baseline, [12mo]: a -carotene 0.204 (0.230),
[0.597 (0.686)];
b - carotene 0.865 (0.874), [1.466 (1.416)];
cryptoxanthin 0.171 (0.155), [0.179 (0.159)];
lutein þ zeaxanthin 0.380 (0.200), [0.459 (0.243)];
lycopene 0.653 (0.345), [0.739 (0.368)]; Total 2.272
(1.294), [3.440 (2.320)]. Comparison group:
Baseline, [12mo]: a -carotene 0.204 (0.213), [0.203
(0.219)]; b - carotene 0.914 (1.065), [0.868 (0.937)];
cryptoxanthin 0.178 (0.175), [0.177 (0.157)]
lutein þ zeaxanthin 0.376 (0.204), [0.381 (0.213)];
lycopene 0.655 (0.344), [0.650 (0.340)]; Total 2.327
(1.470), [2.279 (1.371)]
Full model b coefﬁcients: Juice a -carotene
0.083 (P < 0.001), b - carotene 0.011
(P < 0.001), lutein þ zeaxanthin 0.005
(P < 0.05), lycopene 0.018 (P < 0.001). Food:
a -carotene 0.074 (P < 0.001), b - carotene
0.135 (P < 0.001), lutein þ zeaxanthin 0.096
(P < 0.001), lycopene 0.034 (P < 0.001).
Supplement: b - carotene 0.040 (P < 0.001),
lutein þ zeaxanthin 0.017 (P < 0.001)
Actual dietary level of nutrients not
calculated, correlations between
plasma levels and food, juice and
supplement intake not assessed against
covariates individually, correlations
only performed for 2346 of 2922
participants
Pollard et al. (2003) [153] Excluding supplements. Geometric means
(mg/day) mean (range)
T1: b-carotene: 1635 (1338.0e1988.0),
carotene equiv: 2316.7 (1955.3
e2744.9).
T2:b-carotene: 460.8 (221.5e958.6),
carotene equiv: 1281.3 (944.6e1738.0).
Geometric means. Values log transformed (nmol/L)
mean (range)T1: b-carotene 495.3 (420.9e582.9),
cryptoxanthin 258.9 (219.1e305.9),
lutein 556.6 (501.2e618.2),
lycopene 469.2 (396.9e554.8).
T2: b-carotene 461.9 (385.3e553.6),
cryptoxanthin 295.6 (241.6e361.5),
lutein 525.6 (466.8e591.8),
lycopene 404.8 (330.4e496.1).
(After adjustment for age, BMI and total
caloriﬁc intake including alcohol) Four day
diary record:When total b-carotene intake
from all sources was doubled there was 31%
increase in plasma b-carotene (P < 0.01).
24 h recall: When carotene equiv from all
sources was doubled, plasma lutein rose by
13% (P < 0.01) and plasma lycopene rose by
15% (P ¼ 0.04)
Only dietary b-carotene and carotene
equivalents assessed. Unsure why
dietary carotenoids doubled to ﬁnd
effect??
Polsinelli et al., 1998 [154] Mean ± SD:
Vegetable (servings) 2.6 ± 1.3,
Fruit servings 2.5 ± 1.3
(mmol/L) Mean ± SD.
a -carotene 0.28 ± 0.40,
b - carotene 0.87 ± 1.03,
b-cryptoxanthin 0.16 ± 0.89,
lutein 0.51 ± 0.27,
lycopene 0.57 ± 0.22,
Total 2.40 ± 1.52
Vegetables a -carotene 0.62,
lutein 0.58 (both p < 0.01).
Fruit a -carotene 0.64 (p < 0.01)
lutein 0.44 (p < 0.05).
F þ V a -carotene 0.73 (p < 0.01),
b - carotene 0.48 (p < 0.05),
lutein 0.60 (p < 0.01),
total 0.48 (p < 0.05)
Very small n; actual dietary carotenoids
not calculated; correlations not
assessed for confounders
Porrini et al. (1995) [155] (mg/d) mean (SD) b-carotene:
FFQ: 3569.5 (1308.8).
7 day FR: 2653.2 (1245.2)
(mg/L) mean (SD). b-carotene 391 [192]. b-carotene r ¼ 0.439, P ¼ 0.008 (seven day
food record)
Results not assessed for confounding
variables. Small n. Unequal number of
M to F
Rao et al. (2007) [156] Total average
Lycopene 5.09 ± 0.95 mg/day.
Average Lycopene by quartiles (mg/
day)
Quartile 1: 1.76 ± 0.76,
quartile 2: 3.68 ± 0.94,
quartile 3: 3.03 ± 1.09,
quartile 4: 7.35 ± 0.80.
Total average
Lycopene 247.50 ± 32.56 (nM), 4.01 ± 0.51 [(nM)/
kg].
Average lycopene by quartiles (nM) & [(nM)/kg]
Quartile 1: 74.99 ± 15.09 & 1.13 ± 0.25, quartile 2:
165.60 ± 12.04 & 2.62 ± 0.11, quartile 3:
234.5 ± 24.15 & 4.04 ± 0.22, quartile 4:
502.8 ± 47.39 & 8.11 ± 0.63.
Serum lycopene (nM/kg) positively
associated with average lycopene intake in
quartiles 2, 3 and 4 with 2.62 ± 0.11,
4.04 ± 0.22 and 8.11 ± 0.63 respectively
(r2 ¼ 0.46, p < 0.005)
No mention of whether lycopene intake
was related to serum levels without
adjusting for body weight. Method of
dietary assessment not clear.
Re et al. (2003) [157] Weight of tomato product consumed
(g/d). Mean (SD).
Free-living 37.6 [43].
Institution 29.2 (33.0).
Type of tomato product consumed
(%):
Free living: None 29;
Raw 26;
processed only 7;
TCP 11;
raw & processed 8;
raw &TCP 11;
processed & TCP 3;
Raw, processed and TCP 5.
Institution: None 24;
Raw 16; processed only 11;
TCP 12; raw & processed 10; raw &TCP
8; processed & TCP 10; Raw, processed
and TCP 9.
(mmol/L) Mean (SD).
Free living 0.27 (0.20),
Institution 0.16 (0.13).
(P < 0.0001 between groups)
Log transformed value Relation between
weight of tomato products and plasma
lycopene. Beta coefﬁcient (s.e) Free living
0.07 (0.01), P < 0.001. Institution 0.10
(0.01), P < 0.001. Pearson's: free living:
r¼ 0.36, P < 0.0001 and institution r ¼ 0.39,
P < 0.0001. Relation between type of
tomato product consumed and plasma
lycopene. Beta coefﬁcient (s.e) Free living
Raw 0.41 (0.07); processed only 0.52 (0.10);
TCP 0.58 (0.09); raw & processed 0.70
(0.10); raw &TCP 0.61 (0.08); processed &
TCP 0.73 (0.14); Raw, processed and TCP
0.72 (0.11) ALL P < 0.0001. Institution:
Processed only 0.50 (0.16) P ¼ 0.002; TCP
0.58 (0.18) P ¼ 0.001; raw & processed 0.79
(0.18) P < 0.0001; raw &TCP 0.67 (0.20)
P ¼ 0.0010; processed & TCP 0.89 (0.19)
P < 0.0001; Raw, processed and TCP 1.20
(0.19) P < 0.0001.
Actual dietary intake of carotenoids not
measured; groups not comparable on a
number of sociodemographic
parameters; not all participants
provided a blood sample.
Resnicow et al. (2000) [158] (mg/day) 36-item FFQ [mean(SD)] a
-carotene 532 (661), b - carotene 3650
(3041), cryptoxanthin 100 [90], lutein
2628 (1975), lycopene 2065 (2913).
Single 24 h recall: a -carotene 401
(1595),b - carotene 2867 (5948),
cryptoxanthin 97 [136], lutein 3270
(6752), lycopene 2787 (6341). Three
24hr recall: a -carotene 303 (418), b -
carotene 2578 (3089), cryptoxanthin 93
[89], lutein 3033 (4077), lycopene 2200
(2612)
(mg/dL) (n ¼ 813)
a -carotene 4.1 (6.1),
b - carotene 23.6 (25.3),
cryptoxanthin 9.4 (6.2),
lutein 22.4 (10.2),
lycopene 18.0 (8.8)
36- item FFQ: a-carotene 0.40, b-carotene
0.39, Cryptoxanthin 0.35, Lutein 0.21, total
0.33, total without lycopene 0.37 (all
p < 0.01). Single 24 h recall: a-carotene
0.29, b-carotene 0.25, Cryptoxanthin 0.34,
Lutein 0.19, total 0.31, total without
lycopene 0.39 (all p < 0.01). Three 24 h
recall: a-carotene 0.31 (p < 0.01),
Cryptoxanthin 0.48 (p < 0.01), Lutein 0.27
(p < 0.05), total 0.24 (p < 0.05), total
without lycopene 0.40 (p < 0.01)
Different number of participants
completed the assessments: eg FFQ
n¼ 1002, Single recall n ¼ 414, 3 recalls
n ¼ 105, serum levels n ¼ 813. The
recall subset was signiﬁcantly different
to remaining subjects re college and
alcohol use.
Rifas-Shiman et al. (2001) [159] Actual intake of carotenoids not
reported
Actual plasma levels of carotenoids not reported Correlation between plasma conc and
PrimeScreen results:
b-carotene (r ¼ 0.43) and lutein/zeaxanthin
(r ¼ 0.43). No mention of signiﬁcance level.
These correlations similar to those between
the SFFQ and plasma levels.
Actual dietary and plasma levels of
nutrients not reported. Source of
plasma levels and biochemical method
not reported. PrimeScreen does not
assess total diet
(continued on next page)
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Ritenbaugh et al. (1996) [160] Total study population (mg/day)
Mangels'
a-carotene 0.55 ± 0.45, b-carotene
3.45 ± 2.07, lutein 1.89 ± 1.47. lycopene
0.43 ± 0.29, Block's a-carotene
0.60 ± 0.64,
b-carotene 2.87 ± 2.24, lutein
2.13 ± 1.97.
lycopene 0.40 ± 0.31,
(mmol/L)
a-carotene 0.12 ± 0.11 (n ¼ 144),
b-carotene 0.43 ± 0.36 (n ¼ 157),
lutein 0.18 ± 0.09 (n ¼ 92).
lycopene 0.63 ± 0.28 (n ¼ 144),
b-carotene: Mangels' data base more
strongly correlated to plasma values than
Block's 0.441 and 0.317 respectively
(P ¼ 0.015)
Details of studies included were not
described. Other demographic and
confounders information besides age,
BMI & smoking status not reported.
Rock et al. (1997) [161] b-carotene. (mg/d)
White: 2599 ± 184.
African American: 1749 ± 204
(mmol/L) White: a -carotene 0.004 ± 0.007,b -
carotene 0.218 ± 0.038,
b - cryptoxanthin 0.079 ± 0.010, lutein
0.158 ± 0.017,
lycopene 0.359 ± 0.031 Total 0.857 ± 0.068, Total
minus lycopene 0.498 ± 0.054 African-American:
a -carotene 0.040 ± 0.012, b - carotene
0.288 ± 0.054,
b - cryptoxanthin 0.097 ± 0.017, lutein
0.266 ± 0.032,
lycopene 0.396 ± 0.054 Total 1.086 ± 0.118, Total
minus lycopene 0.690 ± 0.088
B carotene 0.18 Haemodialysis patients so cannot
generalise. Unequal number of
participants in groups.
Rock et al. (1999) [162] NR Log transformed(mmol/L) mean (SD). Females:
-carotene 0.06 (0.06),b-carotene 0.23 (0.20),b-
cryptoxanthin 0.09 (0.06), lutein 0.22 (0.10),
zeaxanthin 0.07 (0.04).
lycopene 0.55 (0.34),Males: a-carotene 0.04 (0.05),
b-carotene 0.18 (0.15), b-cryptoxanthin 0.08 (0.06),
lutein 0.22 (0.10), zeaxanthin 0.07 (0.04)lycopene
0.58 (0.40)
Association between total dietary
carotenoids and individual serum
carotenoids: Reported as % Change (95%
CI) a-carotene 2.9 (2.4, 3.5),
b-carotene 2.9 (2.4,3.4),
b-cryptoxanthin 0.8 (0.5, 1.0)
Lutein 0.8 (0.4, 1.3)
Lycopene 1.8 (1.2, 2.5), and All P¼ 0.05
No direct association between
individual dietary carotenoids and
individual serum carotenoids assessed.
Rock et al. (2001) [163] (mg/day) Median (range).
Control: Baseline, [6 mo]
a-carotene 306 (7e1707), [310 (84
e1604)]; b-carotene 1890 (651e9987),
[2422 (454e7294)]; b-cryptoxanthin 10
[1e108], [20 (1e3838)]; lutein/
zeaxanthin 1028 (211e4653), [1166
(260e3594)];
lycopene 2057 (510e8473), [3831 (377
e8173)], total 6670 (1666e24679),
[7763 (1184e17936)]. Intervention:
Baseline, [6mo]: a-carotene 330 (24
e1312), [1423 (88e7744)]; b-carotene
2394 (444e5780), [9531 (876e30994)];
b-cryptoxanthin 12 [1e154], [28 (1
e201)]; lutein/zeaxanthin 788 (310
e6340), [2338 (271e6159)];
lycopene 2372 (675e12486), [3899
(1287e12303)]; total 6670 (1666
e24679), [18923 (2530e44390)].
Log transformed, not cholesterol adjusted(mmol/L)
Mean ± SE.
Control: Baseline, [6mo]
a-carotene 0.13 ± 0.02, [0.12 ± 0.02];
b-carotene 0.46 ± 0.09, [0.39 ± 0.07;
b-cryptoxanthin 0.19 ± 0.03, [0.16 ± 0.03];
lutein/zeaxanthin 0.41 ± 0.05, [0.39 ± 0.04];
lycopene 0.75 ± 0.09 [0.75 ± 0.08];
total 1.94 ± 0.20, [1.83 ± 0.16].
Intervention: Baseline, [6mo]
a-carotene 0.11 ± 0.01, [0.84 ± 0.02];
b-carotene 0.47 ± 0.09, [1.55 ± 0.30];
b-cryptoxanthin 0.20 ± 0.02, [0.31 ± 0.03];
lutein/zeaxanthin 0.46 ± 0.03, [0.55 ± 0.06];
lycopene 0.79 ± 0.07 [0.65 ± 0.07];
total 2.04 ± 0.13, [3.90 ± 0.56].
From Regression models
a-carotene 0.30
b-carotene 0.16
b-cryptoxanthin 0.09
lutein/zeaxanthin 0.06
lycopene 0.01
total carotenoids 0.14
Limited analysis of assoc between
dietary and plasma carotenoids. Small
n. Groups homegeneity.
Rock et al. (2002) [164] Log transformed (mg/day)
Cross-section Mean (SD):
Lutein þ Zeaxanthin 1347 (891).
Cohort Mean ± SD:
1367 ± 829 at baseline and
1345 ± 831 at 1 year
Log transformed (mmol/L)
Cross-section Mean (SD):
Lutein 0.226 (0.120),
Zeaxanthin 0.071 (0.039).
Cohort Mean ± SD:
Cross-section: For every 10% increase in
estimated dietary lutein þ zeaxanthin was
assoc with 2.4% increase in serum lutein,
P < 0.05 (partial correlation coefﬁcient 0.24)
and 1.2% in serum zeaxanthin, P < 0.05
(partial correlation coefﬁcient 0.11).
Difference in demographic
characteristics between cross-section
and cohort not reported. No correlation
(Pearson or Spearman) conducted.
Lutein 0.225 ± 0.111 at baseline and
0.259 ± 0.125 at 1 yr.
Cohort: Every 10% change in dietary
lutein þ zeaxanthin intake, 1.1% change in
serum lutein (no mention of signiﬁcance)
Roidt et al. (1988) [173] (IU) Mean (SD)
Total dietary carotenoids: 8784
(10740),
b-carotene: 7221 (8995),
other dietary carotenoids: 1563 (1763)
(ng/ml) Mean (SD)
a-carotene 42 [35],
b-carotene 219 (203)
Correlations for serum b-carotene: Total
dietary carotenoids 0.21, dietary b-carotene
0.21, other active dietary carotenoids 0.19
(all p < 0.001). Correlations serum a-
carotene: Total dietary carotenoids 0.26,
dietary b-carotene 0.25, other active dietary
carotenoids 0.25 (all p < 0.001).. Regression
coefﬁcient (SE). Serum b-carotene Dietary
b-caroten 0.13 (0.04) (Signiﬁcance 0.002).
Serum a-carotene Dietary b-carotene 0.24
(0.05) (signiﬁcance 0.000)
Small n; correlation with separate
confounders not performed; dietary
carotenoids other than b-carotene
grouped together; study over 20 years
old
Romieu et al. (1990) [165] (IU/day) Mean (SD)
b-carotene 9245 (7474)
(mg/dl) Mean (SD)
b-carotene 28.1 (26.5)
Halving (n¼189). All food 0.38, all foods
(calorie adjusted) 0.40, Cumulative %
method 0.42, Bivariate regression 0.42,
stepwise regression 0.42 ALL p < 0.0001.
Cross validation (n¼ 370). All food
(calculated intake) 0.35, all foods (calorie
adjusted) 0.37, Cumulative % method 0.43,
Bivariate regression 0.43, stepwise
regression 0.42 ALL p < 0.0001.
Small n; article over 20 years old; actual
dietary carotenoids not assessed
Romieu et al. (1999) [166] Log transformed Mean (SD) (mg/day)
24 h recalls: a-carotene 185 (291), b-
carotene 1079 (849),
utein þ zeaxanthin 496 (337), lycopene
1190 (573),
total carotene 3122 (2611).FFQ1: a-
carotene 144 [125],b-carotene 1257
(812), lutein þ zeaxanthin 998 (574),
lycopene 1212 (1108), total carotene
3626 (2320).
FFQ2: a-carotene 156 [152], b-carotene
1165 (724),lutein þ zeaxanthin 875
(594), lycopene 1020 (1097), total
carotene 3260 (1784)
Log transformed Mean (SD) (mg/L)
a-carotene 39.5 (27.6),
b-carotene 253.0 (166.0),
lutein 187.0 (70.0),
zeaxanthin 73.1 (30.1)
lycopene 283.0 (127.0),
Pearson correlations: FFQ1:
a- carotene 0.37 (p ¼ 0.001),
b-carotene 0.33 (p ¼ 0.015),
total carotene 0.38 (p ¼ 0.001).
FFQ2:
a-carotene 0.33 (p ¼ 0.001),
total carotene 0.27 (p ¼ 0.015).
Diet recalls:
a-carotene 0.21 (p ¼ 0.05).
Small n. 24 h recalls were collected
every three months whereas FFQ were
administered only at baseline and at
1 yr and blood sample only taken at
3months and 9 months.
Russel Breifel et al. (1985) [29] Total dietary carotene index (IU/day)
total sample of men 6359 ± 296
Plasma carotenoids (mg/dl) 178.8 ± 3.8 0.25 (0.11e0.38) all sample subsample
r ¼ 0.21
Men only
Ryden et al. (2012) [167] Actual amount of dietary carotenoids
not reported, high carotenoid Fþ V only
Median (interquartile range). (mmol/L) Men:
a-carotene 0.08 (0.05e0.12), b-carotene 0.26 (0.18
e0.39), b-cryptoxanthine 0.07 (0.04e0.12), lutein
(þzeaxanthin) 0.25 (0.18e0.31), lycopene 0.34
(0.19e0.47).
Total carotenoid 1.03 (0.77e1.33)Women: a-
carotene 0.13 (0.09e0.26), b-carotene 0.45 (0.30
e0.73), b-cryptoxanthine 0.12 (0.08e0.18), lutein
(þzeaxanthin) 0.28 (0.20e0.36), lycopene 0.37
(0.25e0.49)Total carotenoids 1.44 (1.11e1.94)
Total dietary carotenoid and plasma
carotenoid spearman rank correlation
coefﬁcients:
a-carotene 0.35, b-carotene 0.33 b-
cryptoxanthine 0.39,
Total 0.35, (all P < 0.001),
Lutein 0.13 (P < 0.05)
Small n; individual dietary carotenoid
levels not measured, nomention of how
FFQ was analysed. Signiﬁcant
differences in certain demographics
between genders.
Sauvageot et al. (2013) [174] Median (IQR) mg/day Women b-
carotene 3818.6 (2597.6,5464.4)Men
3655 (2334.6, 5392)
Median (IQR) (mg/L) b-carotene Women 0.23
(0.12,0.37) Men 0.15(0.08,0.24)
b-carotene men 0.18 Women 0.22
(P < 0.001)
Assessed b-carotene only
Stallone et al. (1997) [168] Exact values not reported, shown by
employment grade on bar chart and
separated into 3 categories: all data, low
energy reporters (LER) excluded and
energy adjusted
Actual plasma levels of carotenoids not reported (Adjusted for age and employment grade)
b-carotene þ dietary carotenoids.
All data:
Men 0.24 (P  0.01),
Women 0.17 (P  0.05).
LER excluded: Men 0.32 (P  0.001).
Results difﬁcult to interpret from bar
graph
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Sasaki et al. (2000) [169] Crude values: (mg) Mean ± SD
Men: a- carotene 181 ± 185,
b-carotene 2253 ± 1632, total carotene
2514 ± 1803 Females: a- carotene
185 ± 130, b-carotene 2073 ± 1451,
total carotene 2322 ± 1594. Energy
density: (mg/4.184 kJ) Mean ± SD
Men: a- carotene 77 ± 58, b-carotene
969 ± 517, total carotene 1082 ± 571.
Female: a- carotene 94 ± 59,
b-carotene 1036 ± 603, total carotene
1161 ± 660
VALUES FOR ONLY 42 OF 44 WOMEN (mmol/L)
Mean ± SD.
Men:
a- carotene 0.18 ± 0.11,
b-carotene 0.41 ± 0.20,
total carotene 0.59 ± 0.30.
Female:
a- carotene 0.16 ± 0.08,
b-carotene 0.45 ± 0.22,
total carotene 0.61 ± 0.29
Crude values Men:
a- carotene 0.43,
b-carotene 0.40,
total carotene 0.44 (all p < 0.01).
Women:
a- carotene 0.42
(p < 0.01),
b-carotene 0.60 (p < 0.001),
total carotene 0.56 (p < 0.001).
Small n; the nutrients derived from
supps not included; 2 women excluded
from carotenoid analysis due to
extremely high serum carotene
concentrations and these two women
were not assessed to determine if
signiﬁcantly different from the rest of
the women in terms of demographics.
Satia et al. (2009) [170] (mg) Median (25the75th percentile)
Whites FFQ, [diet recalls]:
a- carotene3625 (2168e6168), [2937
(1708e4488)]; b- carotene 617 (296
e976), [305 (122e718)]; b-
cryptoxanthin, 194 (85e327), [164 (76
e294)] lutein þ zeaxanthin 3034 (1607
e4843), [2411 (1201e3694)]; lycopene
4343 (2986e7654), [4890 (2868
e10446)].
AA FFQ, [diet recalls]:a- carotene 2865
(1267e5490), [2151 (988e4072); b-
carotene 242 (96e714), [175 (70
e419)], b-cryptoxanthin 125 (68e379),
[140 (39e297)]; lutein þ zeaxanthin
1936 (1057e3982), [1631 (934e2907)],
lycopene 3970 (2258e7916), [3241
(1219e6129)]
(mmol/L) Median (25the75th percentile). White:
a- carotene 0.190 (0.131e0.302),
b- carotene 0.051 (0.028e0.085),
b-cryptoxanthin 0.091 (0.062e0.119),
lutein þ zeaxanthin 0.128 (1057e3982),
lycopene 0.392 (0.295e0.476).
AA:
a- carotene 0.133 (0.094e0.233),
b- carotene 0.031 (0.019e0.046),
b-cryptoxanthin 0.094 (0.058e0.135),
lutein þ zeaxanthin 0.114 (0.089e0.141),
lycopene 0.402 (0.311e0.549)
All Pearson correlations adjusted for age, sex,
education and BMI Antioxidant Nutrient
Questionnaire & plasma carotenoids:
Whites, [AA]:
a- carotene 0.33 (P  0.01), [0.27
(P  0.05)];
b- carotene 0.31 (P  0.01), [0.31
(P  0.01)];
b-cryptoxanthin, 0.28 (P  0.01), [0.33
(P  0.01)]; lutein þ zeaxanthin 0.24
(P  0.05), [0.32 (P  0.01)]. Dietary recalls
& plasma carotenoids: Whites: a-carotene
0.24 (P  0.05), Lutein þ Zeaxanthin 0.31
(P  0.01). AA: a- carotene 0.24 (P  0.05),
b-cryptoxanthin 0.43 (P  0.0001),
Lutein þ Zeaxanthin 0.48 (P  0.0001),
lycopene 0.28 (P  0.01).
Small n; demographics and subject
characteristics not well presented;
results were not adjusted for total
energy intake; Not generalizable as
subjects were healthy volunteers.
Schroder et al. (2001) [40] (g) Mean ± SD. b-carotene
1.9 ± 2.2 (3-day estimated food record),
7.4 ± 9.1 (FFQ),1.2 ± 1.8 (72-hr recall).
The b-carotene for the FFQ was
signiﬁcantly different from the three
day record (P < 0.001)
Actual plasma levels of carotenoids not reported Correlation coefﬁcients. b-carotene 0.44
(3-day food record), 0.34 (72 h recall) and
0.17 (FFQ). No signiﬁcance level reported.
small n; not all participants provided
blood samples; no associations with
confounders conducted
Shai et al. (2005) [171] Adjusted for gender(mg) Mean ± SE. As
reported: b-carotene
827 ± 56 (24 h recalls),
1508 ± 68 (FFQ).
Energy adjusted:
825 ± 59 (24 h recalls),
1505 ± 76 (FFQ).
(mmol/L) Mean ± SE. b-carotene 2.30 ± 0.097 Log transformed and adjusted for energy and
serum cholesterol. Without supplements:
b-carotene 0.38, P < 0.001 (24 h recalls)
0.35, P < 0.001 (FFQ's).
With supplements:
b-carotene 0.36, P < 0.001 (24 h recalls)
0.38, P < 0.001 (FFQ's).
Small n; no associations with
confounders conducted
Shiriashi et al. (2013) [35] Mean ± SD mg/day
B carotene e 3.08 ± 2.05
Mean ± SD mg/dl
B carotene e 41.0 ± 22.2
B carotene 0.224 (P0.03) Assessed B carotene only
Signorello et al. (2010) [172] All log transformed (mg/day) Mean* (SD)
where* is P< 0.05 for 2-sample t-test
comparing mean values by race
within each sex. AA female:
a- carotene 666.0* (787.5),
b- carotene 5820.8* (5119.8),
b-cryptoxanthin 264.1* (213.5),
lutein þ zeaxanthin 5025.2* (4934.4),
lycopene 4892.1 (5301.7).
AA male: a- carotene 556.2 (533.1),
b- carotene 6212.2* (5750.7),
All log transformed, except lycopene which is square
root transformed (mg/dL) Mean* (SD) where* is
P< 0.05 for 2-sample t-test comparing mean
values by race within each sex. AA Female:
a- carotene 4.4* (4.8),
b- carotene 21.3* (20.6),
b-cryptoxanthin 10.7* (6.7), lutein þ zeaxanthin
21.8* (10.4),
lycopene 28.5 (12.7).
AA male:
a- carotene 2.7 (2.6),
a- carotene 0.32 (P < 0.001),
b- carotene 0.25 (P < 0.001),
b-cryptoxanthin 0.37 (P < 0.001),
lutein þ zeaxanthin 0.35 (P < 0.001),
lycopene 0.18 (P < 0.01)
Small n; Non-fasting blood samples;
b-cryptoxanthin 298.6* (263.4),
lutein þ zeaxanthin 5497.4* (5769.8),
lycopene 6994.7 (5098.4).
White female: a- carotene 419.0*
(364.3), b- carotene 3203.4* (1952.5),
b-cryptoxanthin 160.5* (164.0),
lutein þ zeaxanthin 2223.4* (1375.1),
lycopene 4050.9 (2979.3).
White male:a- carotene 572.2 (483.9),
b- carotene 3617.0* (2656.1),
b-cryptoxanthin 175.7* (150.6),
lutein þ zeaxanthin 2583.7* (2199.7),
lycopene 6949.9 (5299.3)
b- carotene 13.1 (11.1),
b-cryptoxanthin 8.2 (5.6),
lutein þ zeaxanthin 20.9* (10.0),
lycopene 33.4 (17.2).
White female:
a- carotene 2.7* (2.0),
b- carotene 13.8* (12.6),
b-cryptoxanthin 6.4* (4.3), lutein þ zeaxanthin
14.3* (6.3),
lycopene 31.1 (13.6).
White male:
a- carotene 3.7 (4.8),
b- carotene 11.2 (9.9),
b-cryptoxanthin 6.9 (4.1),
lutein þ zeaxanthin 15.3* (7.0),
lycopene 33.8 (14.8)
Stryker et al. (1990) [175] 9285 ± 7210 F;
7410 ± 5806 M
a-carotene (mg/dl)
F: 7.4 ± 6.4; M: 4.5 ± 6.1;
b-carotene (ug/dl)
F: 31.8 ± 27.7;
Males: 18.5 ± 19.1;
lycopene (ug/dl)
F: 35.7 ± 16.4; M: 33.9 ± 16.1
Plasma a-carotene & dietary carotene
Females: 1) 0.40; 2) 0.41; 3) 0.44; 4) 0.45;
Males: 1) 0.29; 2) 0.34; 3) 0.32; 4) 0.36;
Plasma b-carotene & dietary carotene
Females: 1) 0.37; 2) 0.39; 3) 0.41; 4) 0.42;
Males: 1) 0.27; 2) 0.33; 3) 0.31; 4) 0.36;
Plasma lycopene & dietary carotene
Females: 1) 0.03; 2) 0.04; 3) 0.01;
4) 0.02; Males: 1) 0.05; 2) 0.07; 3) 0.04; 4)
0.06; Plasma carotenoid index (b-
caroteneþ 0.5 a-carotene) Females: 1) 0.38;
2) 0.40; 3) 0.42 4) 0.43; Males: 1) 0.28; 2)
0.34; 3) 0.32; 4) 0.38. 1)not calorie adjusted/
not lipid adjusted; 2) not calorie adjusted/
lipid adjusted; 3) calorie adjusted/not lipid
adjusted; calorie adjusted/lipid adjusted
Few individual dietary carotenoids
reported. Signiﬁcance for correlations
not reported. Cross-sectional study.
Su et al. (2006) [176] Salad consumptionMean± SD g/d - 18
e45 yrs:
F 39.2 ± 82.3; M 40.0 ± 90.1;
55 þ yrs: F 36.1 ± 76.6;
M 37.7 ± 83.1; Vegetable consumption
Mean ± SD g/d e 18e45 yrs:
F 33.6 ± 75.2; M 36.0 ± 82.3;
55 þ yrs: F 31.3 ± 71.8; M 32.7 ± 77.6
Mean serum levels by level (L ¼ low, M ¼ medium,
H ¼ high) of salad/vegetable consumption (mg/dl) e
a-carotene salad: F (L) 4.84; (M) 4.84; (H) 5.91;
M (L) 3.76; (M) 4.30; (H) 4.84;
a-carotene vegetables: F (L) 4.84; (M) 4.84; (H)
5.81;
M (L) 3.76; (M) 4.30; (H) 4.84;
b-carotene salad: F (L) 20.97; (M) 20.97; (H) 24.73;
M (L) 16.13; (M) 18.28; (H) 19.35;b-carotene
vegetables:
F (L) 20.97; (M) 20.97; (H) 24.73; M (L) 16.13; (M)
18.28; (H) 19.35; lycopene salad: F (L) 20.43; (M)
21.51; (H) 23.12; M (L) 21.51; (M) 23.13; (H)
24.19;lycopene vegetables:F (L) 20.43; (M) 21.51;
(H) 23.12; M (L) 21.51; (M) 23.13; (H) 24.19
There was a positive relationship between
consumption (salad and vegetable) and
serum carotenoids for females and males:
Salad:
a-carotene F 1.24; M 1.35;
b-carotene F 1.06; M 1.27; lycopene
F 1.19; M 1.15; Vegetables:
a-carotene F 1.26; M 1.31;
bcarotene F 1.21; M 1.26; lycopene
F 1.18; M 1.12
Svendsen et al. (2007) [177] Intake at 3 months Control (C) and
Intervention (I):
b-carotene (mg/d)
C: 3600 ± 2729; I: 7086 ± 4528;
vegetables (g/d)C: 238 ± 144; I:
457 ± 240;
fruits C: 322 ± 258; I: 486 ± 285;
Change in intake from baseline to 3
months (mean, CI):b-carotene
C: 588(81, 1257); I: 4140(2948, 5334);
vegetables C: 12(33, 57); I: 245(194,
Change from baseline to 3 months:
a-carotene (uM):
C: 0.002(0.016, 0.020);
I: 0.046(0.026, 0.066);
b-carotene (uM):
C: 0.029 (0.077, 0.019);
I: 0.086(0.036, 0.150);
b-cryptoxanthin (uM)
C: 0.026(0.004, 0.056);
I: 0.055(0.021, 0.089);
Lutein (uM):
C: 0.017 (0.039, 0.005);
Correlations for changes in intake/plasma
conc intervention group only: Change is
vegetable intake and change in plasma a
carotene (r¼ 0.323; p¼ 0.0103); change in
b carotene intake and plasma b-carotene
(r ¼ 0.234; p ¼ 0.0135); Correlations for
intake and plasma conc. at 3 months
intervention group only: fruit intake and
plasma a-carotene (r ¼ 0.426; p ¼ 0.0006).
cryptoxanthin (r ¼ 0.270; p ¼ 0.0308);
When control subjects were added to the
analysis (no increase in fruit and veg
Those taking high does of multivitamins
were not excluded or reported
separately.
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296); Fruits C: 4(79, 71);
I: 248(176, 320)
I: 0.005 (0.013, 0.023);
Zeaxanthin (uM):
C: 0.010(0.020, 0.005);
I: 0.002(0.062, 0.058);
lycopene (uM):
C: 0.014(0.004, 0.068);
I: 0.073(0.009, 0.137)
intake) there were additional
signiﬁcances - change from baseline to 3
months: veg intake and plasma
a-carotene (r ¼ 0.422; p < 0.0001);
b-carotene (r ¼ 0.229; p ¼ 0.0159);
lutein (r ¼ 0.255; p ¼ 0.0073);
fruit intake and plasma a-carotene
(r ¼ 0.221; p ¼ 0.0198);
Intake at 3 months: vegetable intake and
plasma a-carotene (r ¼ 0.399;
p¼<0.0001);
b-carotene (r ¼ 0.315; p ¼ 0.0008);
cryptoxanthin (r ¼ 0.233; p ¼ 0.0133);
lutein (r ¼ 0.270; p ¼ 0.0041); lycopene
(r ¼ 0.207; p ¼ 0.0280);fruit intake and
plasma a-carotene (r ¼ 0.349; p ¼ 0.0002).
b-carotene (r ¼ 0.235; p ¼ 0.0126);
cryptoxanthin (r ¼ 0.319; p ¼ 0.0008);
Talegawkar et al. (2008) [178] Median (IQR), (mg/day):
Average of 24 h recalls:
a-carotene F: 144(37 487); M: 177(41,
548); total b-carotene F: 3044(2029,
6525); M: 3178(1696, 5360);
dietary b -carotene F: 2770(1409,
4933); M: 2928(1584,
6099);cryptoxanthin F: 98(43, 171);
M: 85(30, 183); lutein þ zeaxanthin F:
2607(1338, 5152); M: 2935(1345,
5261); lycopene F: 1467(502, 3827);
Males: 2222(592, 5075);
Short FFQ: a-carotene F: 349(221 517);
M: 385(247, 593);total b-carotene F:
3048(2419, 4100); M: 2886(2304,
3682);
dietary bcarotene F: 2561(1940, 3312);
M: 2802(2147, 3529);cryptoxanthin F:
111(61, 197); M: 108(62, 187);
lutein þ zeaxanthin F: 2149(1676,
2832); M: 2259(1735, 3065);lycopene
F: 2789(1622, 4248); M: 3537(2016,
5513);
Long FFQ a-carotene F: 251(143, 431);
M: 328(180, 509); total b-carotene F:
2707(1746, 4057); M: 2685(1776,
4574); dietary b-carotene F:
2211(1528, 2992); M: 2205(1534,
3424); b-cryptoxanthin F: 126(57,
199); M: 113(57, 193);
lutein þ zeaxanthin F: 1927(1428,
616); M: 1849(1311, 2594);lycopene F:
2600(1434, 4181); M: 3161(1923,
5537)
Mean ± SE (mmol/l):
acarotene
F: 0.07 ± 0.004; M: 0.07 ± 0.005; b-carotene non-
suppl users F: 0.64 ± 0.05; M: 0.51 ± 0.06; b-
carotene suppl users
F: 0.82 ± 0.07; M: 0.84 ± 0.09;cryptoxanthin
F: 0.18 ± 0.01; M: 0.17 ± 0.01;
Lutein þ zeaxanthin Females: 0.32 ± 0.01; Males:
0.32 ± 0.01;
lycopene F: 1.24 ± 0.05; M: 1.44 ± 0.06
Average 24 h recalls:
a -carotene 0.41; total b -carotene 0.35;
dietary b carotene 0.32;
b-cryptoxanthin 0.44;
lutein þ zeaxanthin 0.39;
lycopene 0.40; short FFQ:
a -carotene 0.32; total b-carotene 0.22;
dietary b -carotene 0.12;
b -cryptoxanthin 0.29;
lutein þ zeaxanthin 0.13;
lycopene 0.24; long FFQ:
a carotene 0.18; total b-carotene 0.28;
dietary b-carotene 0.21;
b-cryptoxanthin 0.25;
lutein þ zeaxanthin 0.20;
lycopene 0.14. Unclear which results are
signiﬁcant, possibly just short and long
FFQ?
Tangney et al. (2004) [179] FFQ Mean ± SD (mg/day):
a-carotene F: 640 ± 564; M: 629 ± 386;
total b-carotene F: 4012 ± 2276; M:
4724 ± 3395; dietary b-carotene F:
Crude concentrations:
a carotene F: 0.07 ± 0.05; M: 0.07 ± 0.06;
b carotene F 0.40 ± 0.21; M 0.52 ± 0.48;
b-cryptoxanthin F: 0.16 ± 0.11; M: 0.18 ± 0.10;
Energy adjusted correlations FFQ: a-
carotene F: 0.47; M: 0.54; Blacks 0.81;
total b-carotene Whites: 0.44;
Small number of subjects provided
blood sample, 24 h recalls were
required every 2 months (total of 6)
3760 ± 1913; M: 5429 ± 3648;
cryptoxanthin F: 83.3 ± 82.7; M:
60.8 ± 52.2; lutein þ zeaxanthin F:
3194 ± 3104; M: 4434 ± 5479;lycopene
F: 8158 ± 6997; M: 10696 ± 9863.Mean
of 24 h recalls Mean ± SD (ug/day):
total b-carotene F: 4650 ± 2585; M:
4738 ± 3318; dietary b-carotene F:
4452 ± 2638; M: 4662 ± 3340
lutein þ zeaxanthin F: 0.36 ± 0.16; M: 0.35 ± 0.14;
lycopene F: 0.35 ± 0.25; M: 0.51 ± 0.34. Lipid
adjusted
a-carotene F: 0.07 ± 0.05; M: 0.07 ± 0.05;
b-carotene F: 0.40 ± 0.21; M: 0.51 ± 0.38;
cryptoxanthin F: 0.16 ± 0.11; M: 0.18 ± 0.10;
lutein þ zeaxanthin F 0.36 ± 0.16; M: 0.35 ± 0.13;
lycopene F: 0.33 ± 0.23; M: 0.44 ± 0.28
b-cryptoxanthin F: 0.44; M: 0.46; Blacks
0.50; Whites 0.46; p < 0.05 for all.
however some subjects did not
complete this number.
Tan-Un et al. (2004) [180] Mean ± SD (IU/day - dietary carotene
asthmatic subjects: 7949 ± 5314;
control subjects: 7816 ± 3290
Mean ± SD (mmol/l) plasma b-carotene
asthmatics: 0.888 ± 0.575;
controls: 0.955 ± 0.576
Correlation between dietary carotene and
plasma carotene 0.653 (signiﬁcant but no p-
value reported).
No signiﬁcance levels reported. No
dosage recorded for supplement intake.
No adjustment for caloric intake, fat
intake or demographics.
Tarwadi et al. (2008) [181] Median b-carotene (mg/day): Cases (low
income-LI; high income (HI)) vs
controls (low income-LI; high income
(HI).
Cases (HI) F: 1307; M: 1313; (LI) F 618;
M: 690; Controls (HI) F 1437; M: 1577;
(LI) F: 675; males: 1064.
NR Log-transformed plasma b-carotene levels
were associated with dietary intakes of
beta-carotene, ascorbic acid and
polyphenols (R2Z 0.611, p < 0.01)
Less accurate method of measuring
plasma concentrations. No plasma
carotenoid data reported.
Thomson et al. (2007) [182] Mean ± SD (mg/d¡1):
a-carotene 1412 ± 3076; bcarotene
5781 ± 7882; cryptoxanthin 253 ± 201;
lycopene 5730 ± 4537;
lutein þ zeaxanthin 3536 ± 4080; total
carotenoid 16,712 ± 14,960; (IU/d)
supplemental b-carotene 1551 ± 6143
Mean ± SD (mmol/L1):
a-carotene 0.2 ± 0.3;
bcarotene 1.1 ± 1.7;
cryptoxanthin 0.2 ± 0.2;
lutein þ zeaxanthin 0.4 ± 0.3;
lycopene 0.7 ± 0.3;
total carotenoids 2.5 ± 2.0
a-carotene 0.46;
b-carotene 0.34;
b-cryptoxanthin 0.39;
lutein þ zeaxanthin 0.30;
lycopene 0.27;
total carotenoids 0.30. No p-values
reported.
Females cancer survivors only
Toft et al. (2008) [183] Median(5th&95th %tiles):
FFQ: b-carotene (mg/day) F: 2174 (818
e6015); M: 1553 (604e3881);
vegetables (g/day) F: 259 (110e549);
M: 263 (102e573);
Fruits (g/day) F: 318 (21e705); M: 133
(9e533);
Diet History b-carotene F: 3818 (944
e14 468); M: 3142 (783e15 156);
vegetables F: 299 (106e700); M: 321
(138e807);
fruits F: 243 (35e667); M: 190 (27
e582).
NR Correlations between plasma and FFQ:
a-carotene/fruits (0.30 M; 0.37 F); a
-carotene/veg (0.26; 0.23 F);
a carotene/fruit&veg (0.44 M; 0.41 F);
bcarotene/fruits (0.28 M; 0.24 F); b-
carotene/veg (0.28 M; 0.22 F); b-carotene/
fruit&veg (0.38 M; 0.29 F);
lutein/fruits (0.36 M; 0.20 F); lutein/veg
(0.23 F); lutein/fruit&veg (0.34 M; 0.25 F);
zeaxanthin/fruits (0.20 M; 0.19 F);
xeaxanthin/veg (0.19 F); eaxanthin/
fruit&veg (0.22 M; 0.23 F); b-
cryptoxanthin/fruits (0.37 M; 0.30 F): b-
cryptoxanthin/veg (0.27 M); b-
cryptoxanthin/fruit&veg (0.40 M; 0.29 F);
lycopene - nil signiﬁcant
Plasma concentrations NR, correlations
with diet history not undertaken, only
dietary carotenoid assessed was b-
carotene and this was not included in
the correlation analysis.
Torronen et al. (1996) [184] 3 low b-carotene groups: raw carrots
(Group 1), carrot juice (Group 2), b-
carotene capsules (Group 3).
Mean ± SD bcarotene (mg/day) during
10-day habitual intake
Group 1: 4838 ± 1893; Group 2:
4600 ± 2614; Group 3: 3909 ± 1793;
B-carotene (mg/day) during 6-week
supplemental period (low intake):
Group 1366 ± 231; Group 2360 ± 185;
Group 3456 ± 475.
Mean ± SD serum b-carotene (mg/l) during 10-day
habitual intake period:
Group 1: 570 ± 214;
Group 2: 512 ± 213;
Group 3: 524 ± 269;
serum b-carotene after 6-week supplementation
period (low intake):
Group 1: 452 ± 232;
Group 2: 570 ± 387;
Group 3: 937 ± 456.
No correlation. Only b-carotene measured, females
only, small sample size, likely
unvalidated dietary assessment tool.
Tucker et al. (1999) [185,186] [1]Mean (mmol/L) in 5th and 95th %ile
of intake: a-carotene: F 0.03/0.25; M
0.02/0.19; b-carotene: F 0.14/1.14; M
0.08/0.77; a-cryptoxanthin: F 0.03/
0.16; M 0.02/0.16; b-cryptoxanthin: F
[1] Mean ± SD in males and females under 79 yrs
and 80 yrs and over:
a-carotene: F < 80 0.12 ± 0.08; >80 0.11 ± 0.10;
M < 80 0.09 ± 0.09; >80 0.10 ± 0.05;
b-carotene: F < 80 0.51 ± 0.33; >80 0.46 ± 0.27;
Correlations between plasma
concentrations and dietary carotenoids:
a-carotene: F 0.33; M; 0.18;
total b-carotene: F0.36; M 0.25; dietary
bcarotene: F0.30; M0.16 (p < 0.05);
Non-fasting samples, dietary fat not
assessed.
(continued on next page)
Table 2 (continued )
Source Dietary carotenoid intake Plasma carotenoid concentrations Associations between diet and plasma
correlations
Limitations
0.07/0.54; M 0.05/0.44;
lutein þ zeaxanthin: F 0.19/0.99;
M0.20/0.89;lycopene: F 0.13/1.3; M
0.12/1.4; total carotenes (IU): F
9916 ± 6198; M 8319 ± 5879 [2];
Mean ± SD (ug/day) a-carotene: F
862 ± 781; M 656 ± 605; total b-
carotene: F 4508 ± 2925; M
3793 ± 2608; dietary b-carotene: F
4216 ± 2609; M 3520 ± 2474;b-
cryptoxanthin: F 75.1 ± 71.4; M
63.0 ± 65.1; lycopene: F 7002 ± 5558;
M 7636 ± 5984; lutein þ zeaxanthin: F
3087 ± 2380; M 2678 ± 1934; Fruit and
Veg intake (servings/day): F 5.1 ± 2.4;
M 4.4 ± 2.2
M < 80 0.33 ± 0.20; >80 0.40 ± 0.19; a
cryptoxanthin: F < 80 0.09 ± 0.04; >80 0.08 ± 0.04;
M < 80 0.08 ± 0.04; >80 0.03 ± 0.04; b-
cryptoxanthin: F < 80 0.27 ± 0.17; >80 0.25 ± 0.16;
M < 80 0.20 ± 0.12; >80 0.20 ± 0.10;
lutein þ zeaxanthin: F < 80 0.54 ± 0.26; >80
0.46 ± 0.22; Males <80 0.48 ± 0.24; >80 0.46 ± 0.21;
lycopene: F < 80 0.62 ± 0.34; >80 0.46 ± 0.35;
M < 80 0.65 ± 0.36; >80 0.47 ± 0.41 [2];Mean ± SD
(mmol/L)
a-carotene: F 0.117 ± 0.087; M 0.082 ± 0.053;
b-carotene: F 0.51 ± 0.34; M 0.33 ± 0.23;
b-cryptoxanthin: F 0.27 ± 0.17; M 0.20 ± 0.12;
lutein þ zeaxanthin: F 0.56 ± 0.27; M 0.52 ± 0.23
lycopene: F 0.61 ± 0.36; M 0.64 ± 0.38;
b-cryptoxanthin: F 0.44; M 0.32;
lutein þ zeaxanthin: F 0.27; M 0.10 (NS).
lycopene: F 0.35; M 0.21; All p values
<0.0001.
Correlations between plasma
concentrations and F&V intake: a-
carotene: F 0.25; M 0.17;
bcarotene: F 0.27; M 0.17;
b-cryptoxanthin: F 0.33; M (NS);
lutein þ zeaxanthin: F 0.17; M (NS).
lycopene: F 0.14; M (NS); p < 0.01 for all
female correlations with F&V intake and
<0.05 for the two signiﬁcant correlations for
males.
VandenLangenberg et al. (1996)
[50]
Mean ± SD (mg/day) carotenoid intakes
from HHHQ and USDA-NCI: HHHQ:
А carotene: 283 ± 240; b-carotene:
1553 ± 1005; cryptoxanthin: 80 ± 53;
lutein þ zeaxanthin: 816 ± 622;
lycopene: 715 ± 563; total carotenoids:
3446 ± 1890;
USDA-NCI: a-carotene: 267 ± 186;
b-carotene: 1490 ± 849; b-
cryptoxanthin: 29 ± 28;
lutein þ zeaxanthin: 962 ± 642;
lycopene: 1889 ± 1239; total
carotenoids: 4639 ± 2386
Mean ± SD (nmol/L):
a-carotene 87 ± 61;
b-carotene 334 ± 227;
cryptoxanthin 182 ± 129;
lutein þ zeaxanthin 287 ± 126;
lycopene 496 ± 245
Correlations between carotenoid
concentrations in serum and diet: HHHQ:
a-carotene 0.33; b-carotene 0.27; b-
cryptoxanthin 0.48; lutein þ zeaxanthin
0.28;
lycopene 0.29; USDA-NCI:
a-carotene 0.32; b-carotene 0.32; b-
cryptoxanthin 0.53; lutein þ zeaxanthin
0.24;
lycopene 0.25. All correlations signiﬁcantly
different from 0 (p < 0.05). No difference
between HHHQ and USDA-NCI.
FFQ assessed intake over preceding 12
months, serum carotenoids may reﬂect
intake over a shorter time period.
Vioque et al. (2007) [187] Mean ± SD (mg/day) of intake in males
and females.
acarotene: F 832.2 ± 504.2;
M 720.3 ± 558.7; b-carotene:
F 4358.2 ± 2134.3; M 4000$1 ± 2076$4;
cryptoxanthin: F 313$6 ± 231$8;
M 276$1 ± 184$9; lutein þ zeaxanthin
F 4600$1 ± 3063$3; M 4283$0 ± 2387$3
lycopene: F 4042$8 ± 2634$7;
M 4009$4 ± 2396$3;
Mean ± SD (mmol/L) plasma concentrations inmales
and females. a-carotene: F 0.096 ± 0.14;
M0.061 ± 0.07; b-carotene:
F 0.304 ± 0.34; M 0.196 ± 0.23; -cryptoxanthin;
F 0.135 ± 0.15; M 0.107 ± 0.13; luteinþ zeaxanthin
F 0.153 ± 0.16; M 0.139 ± 0.13lycopene;
F 0.703 ± 0.86; M 0.474 ± 0.56
Correlations between dietary intake and
plasma concentrations (dietary intake
adjusted for energy intake and plasma
concentrations adjusted for cholesterol).
a-carotene: Total 0.21; Females 0.17; Males
0.21; b-carotene: Total 0.19; Females 0.20;
Males 0.14; cryptoxanthin: Total 0.20;
Females 0.16; Males 0.23; lycopene: Total
0.18; Females 0.14; Males 0.21;
utein þ zeaxanthin: Total 0.19; Females
0.13; Males 0.07. All “total” correlations
signiﬁcant (no p-values reported). No other
signiﬁcances reported.
Non-fasting samples, signiﬁcance of
correlations unclear.
Vioque et al. (2013) [36] mean ± SD mg/day
a carotene 536 ± 468
b carotene 4499 ± 2438
lutein/zeaxanthin 3157 ± 2455
lycopene 4410 ± 2727
±360 ± 253
mean ± SD mmol/L
a carotene 0.15 ± 0.14
b carotene 0.40 ± 0.30
Lutein/zeaxanthin 0.32 ± 0.13
Lycopene 0.72 ± 0.62
Cryptoxanthin0.22 ± 0.15
a carotene 0.31 (P < 0.01)
b carotene 0.21 (P < 0.01)
Lutein/zeaxanthin 0.26 (P < 0.01)
Lycopene 0.05
Cryptoxanthin0.26 (P < 0.01)
Women only
Wahlqvist et al. (1994) [188] Mean ± SD (mg/day) in females and
males at baseline/12 months:
Supplement group: a-carotene: F
1.5 ± 1.2/1.5± 1.1; M 1.2± 1.2/1.5± 1.5;
b-carotene: F 3.5 ± 2.1/3.7 ± 2.2;
M 2.9 ± 2.1/3.2 ± 2.4; cryptoxanthin:
F 0.3 ± 0.6/0.2 ± 0.3; M 0.2 ± 0.3/
0.2 ± 0.6;
Mean ± SD (nmol/L) in females and males at
baseline/12 months: Supplement group:
a-carotene: F 47 ± 40/102 ± 85;
M36 ± 39/85 ± 72;b-carotene:
F 446 ± 1027/2367 ± 2448; M 280 ± 447/
2139 ± 2666;
b-cryptoxanthin: F 281 ± 328/297 ± 242;
M 193 ± 183/247 ± 239; lutein þ zeaxanthin:
Correlations between serum concentrations
and dietary intake in females and males:
Females:
b-cryptoxanthin 0.41(p < 0.0001);
Males:
a-carotene 0.27(p < 0.01);
b-carotene 0.25(p < 0.01);
lutein þ zeaxanthin: F 2.0 ± 1.5/
2.3 ± 1.8;
M 1.8 ± 1.2/1.9 ± 1.2; lycopene:
F 2.6 ± 3.1/2.7 ± 2.4; M 2.0 ± 1.8/
1.8 ± 1.7;
Placebo group: a-carotene: F 1.5 ± 1.4/
1.9 ± 1.3; M 1.1 ± 1.2/0.6 ± 0.4;
bcarotene: F 3.6 ± 3.4/4.8 ± 3.1;
M 4.7 ± 5.0/4.1 ± 2.8; -cryptoxanthin:
F 0.3 ± 0.4/0.3 ± 0.5; M 0.3 ± 0.3/
0.2 ± 0.3;
lutein þ zeaxanthin: F 2.1 ± 2.2/
3.0 ± 4.7;
M; 2.7 ± 2.6/2.7 ± 2.0lycopene:
F 1.7 ± 1.2/1.9 ± 1.2; M 2.5 ± 4.6/
1.9 ± 1.9;
F 569 ± 681/660 ± 712; M 521 ± 619/509 ± 476;
lycopene: F 285 ± 666/440 ± 619;
M 255 ± 296/530 ± 521;
Placebo group: a-carotene: F 37 ± 32/37 ± 32;
M 45 ± 41/55 ± 46;b-carotene:
F 236 ± 247/235 ± 219; M258 ± 275/270 ± 357;
b-cryptoxanthin: F 366 ± 654/291 ± 292;
M 213 ± 273/249 ± 299; lutein þ zeaxanthin:
F 512 ± 456/589 ± 523; M 547 ± 454/604 ± 494
lycopene:
F 179 ± 187/224 ± 201;
M 271 ± 286/327 ± 341;
b-cryptoxanthin 0.31(p < 0.001);
lutein þ zeaxanthin 0.26(p < 0.01).
Wallstrom et al. (2001) [189] Mean ± SD (mg/day)
Food derivedb-carotene:
F 3.86 ± 3.41; M 2.87 ± 2.81;
Total bcarotene (incl. suppl): F
3.95 ± 3.50; M 2.88 ± 2.82
Mean ± SD (mmol/L) serum b-carotene:
F 0.61 ± 0.49;
M 0.39 ± 0.32
Correlations between serum b-carotene and
total dietary b-carotene: Females
0.31(p > 0.001); Males 0.25 (p < 0.001).
Dietary fat not measured, few
carotenoids assessed, non-fasting
samples.
Wawrzyniak et al. (2013) [37] Mean ± SD (mg/day)
a carotene 1.03 ± 0.79 b carotene
3.47 ± 1.84 lutein/zeaxanthin
2.64 ± 1.29
cryptoxanthin 0.46 ± 0.41 Lycopene
2.15 ± 1.25
Mean ± SD (nmol/L)
a carotene 79.5 ± 60.2 b carotene 459.4 ± 421.1
lutein/zeaxanthin 293.4 ± 108 cryptoxanthin
504.8 ± 283.6
Lycopene 611.2 ± 292
a carotene 0.25 b carotene 0.37
lutein/zeaxanthin 0.29 cryptoxanthin 0.30
Lycopene 0.24
Women only
Willet et al. (1983) [190] Carotene 5650 IU ± 4020 Total carotenoids 179 ± 53 mg/dL Total carotenoids crude value r ¼ 0.29, P
0.02. Plasma Carotenoids inversely
associated with quetlets index (r ¼ 0.26,
P < 0.05)
Not clear how total carotene was
calculated
Wolters et al. (2006) [191] b - carotene (mg) 6.71 ± 4.37 b - carotene (mmol/L) 1.12 ± 0.88 b carotene r ¼ 0.173 P 0.025) Females only
Ylonen et al. (2003) [192] a carotene M 0.05 F 0.13
b - carotene (mg) M 1.74 F 2.13
lycopene M 0.82 F 0.61
a carotene M 0.12 ± 0.11 F 0.20 ± 0.16
b - carotene (mmol/L) M0.51 ± 0.30 F 0.73 ± 0.42
Lycopene M0.31 ± 0.24 F 0.30 ± 0.18
a carotene M r ¼ 0.31 P 0.005 F
r ¼ 0.45 P < 0.001 b carotene Males NS
F r ¼ 0.33 P 0.008 lycopene
M r ¼ 0.41 P 0.002, F r ¼ 0.33 P 0.008
Yong et al. (1994) [51] Diet records (ug/day) a carotene
573 ± 590, b carotene 2652 ± 2336,b
cryptoxanthin30 ± 40 Lutein
1860 ± 1543
Lycopene 3056 ± 2608 total
8171 ± 4998
FFQ a carotene 746 ± 685 b
carotene3335 ± 2154 b
cryptoxanthin38 ± 41 Lutein
2390 ± 1786 lycopene 3353 ± 1991
total 9862 ± 5177
a carotene (mmol/L) 0.11 ± 0.08
b carotene 0.34 ± 0.19,
b cryptoxanthin 0.17 ± 0.05
lutein 0.46 ± 0.15
lycopene 0.58 ± 0.24
total 1.66 ± 0.54
Diet records acarotene 0.59
b carotene0.52 bcryptoxanthin
0.49 lutein, 0.29 lycopene 0.41 total 0.51
FFQ a carotene 0.52 b carotene 0.44
b cryptoxanthin 0.30 Lutein 0.29
lycopene0.28 total 0.43
NR e not reported, DR e diet record, FR e food record, WR eweighed record, FFQe food frequency questionnaire, DHQ e diet history questionnaire, UC e unclear, F&Ve fruit and vegetable, DQI e diet quality index, F e females, M e
males.
Table 4
Mean correlation values derived by meta-analysis of similar studies for each
carotenoid, and by dietary assessment method.
T.L. Burrows et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 15e6456United States Department of Agriculture (USDA) database [42]
(n ¼ 35), followed by the National Cancer Institute (NCI) (n ¼ 10)
and the University of Minnesota (n ¼ 10) food and nutrient
databases.
The mean reported dietary intakes of carotenoids, by diet
assessment method are reported in Table 3. The dietary carotenoid
intakes (weighted mean from meta-analysis), in descending order,
were: lycopene (4555.4 mg/day), b-carotene (3679.8 mg/day) lutein/
zeaxanthin (2363.6 mg/day), a-carotene (814.4 mg/day) and cryp-
toxanthin (186.3 mg/day).When sub-analysis was completed by sex,
females had higher reported intakes than males for a- and b-
carotene but not for cryptoxanthin, lutein/zeaxanthin or lycopene.
3.2. Biochemistry
Blood samples were collected from participants in a fasting state
in 88 studies, with 26 in a non-fasted state. In studies where par-
ticipants were fasted, 49 did not specify the length of fasting time,
13 studies reported that it was overnight, 14 reported a 10e12 h
fast, nine studies reported four to 8 h, and two studies reported that
only a portion of the study sample fasted. High performance liquid
chromatography (HPLC), which is considered the gold standard
analytical technique for analysis of carotenoids, was used to assess
plasma carotenoids in all studies, except nine which used alterna-
tive methods such as spectrophotometry (Table 1), while in 11
studies the method was unclear.
The most commonly assessed plasma carotenoid was b-caro-
tene, assessed in 80% of studies (n ¼ 123), followed by a-carotene
(61%, n ¼ 87) and lycopene (59%, n ¼ 84). It was more common to
assess lutein and zeaxanthin as a combined variable (n ¼ 48
studies) than either of these carotenoids individually (n ¼ 37 and
n ¼ 20, respectively).
A total of 48 studies reported a combined variable of ‘totalTable 3
Mean reported dietary intakes of each carotenoid by dietary assessment type: re-
sults from meta analysis.
Mean intakes (ug/day) 95% Conﬁdence interval
a carotene
All (n ¼ 48) 814.4 584.5, 1044.3
24 h recall (n ¼ 5) 277.9 157.5, 398.4
Diet history (n ¼ 2) 84.5 47.3, 121.6
FFQ (n ¼ 41) 869.3 626.3, 1112.3
Food record (n ¼ 10) 892.3 726.6, 1057.9
b carotene
All (n ¼ 82) 3679.8 3265.8, 4093.8
24 h recall (n ¼ 18) 2341.4 2075.5, 2607.3
Diet history (n ¼ 8) 3296.9 2521.7, 4072.0
FFQ (n ¼ 67) 3924.7 3383.8, 4465.5
Food record (n ¼ 16) 3201.7 2223.0, 4180.3
Cryptoxanthin
All (n ¼ 37) 186.3 172.0, 200.6
24 h recall (n ¼ 2) 178.8 171.1, 340.5
Diet history (n ¼ 0) X X
FFQ (n ¼ 37) 189.9 175.4, 204.5
Food record (n ¼ 7) 106.4 68.1, 144.7
Lutein/Zeaxanthin
All (n ¼ 38) 2363.6 2221.0, 2506.3
24 h recall (n ¼ 2) 3293.9 2947.9, 3639.8
Diet history (n ¼ 0) X X
FFQ (n ¼ 11) 2423.1 2293.6, 2552.6
Food record (n ¼ 6) 1018.4 869.9, 1166.9
Lycopene
All (n ¼ 51) 4555.4 3586.1, 5324.7
24 h recall (n ¼ 5) 1476.3 1072.5, 1880.2
Diet history (n ¼ 2) 723.5 464.7, 982.3
FFQ (n ¼ 43) 4965.5 3966.6, 5964.3
Food record (n ¼ 11) 3116.2 2672.0, 3560.4
X Meta analysis not possible as not enough/no studies in this category.carotenoids’, however very few provided details as to how the
‘total’ was calculated. The most common report (n ¼ 10) was the
sum of a-carotene, b-carotene, cryptoxanthin, lycopene and lutein/
zeaxanthin [19,31,43e51].
Results from the meta-analysis indicate that the weighted mean
plasma carotenoid concentrations were, in descending order:
lycopene 0.62 mmol/L (95%CI: 0.61, 0.63, n¼ 56 studies), b-carotene
0.47 (0.46, 0.48, n¼ 78), lutein/zeaxanthin 0.31 (0.30, 0.32, n ¼ 31),
cryptoxanthin 0.17 (0.17, 0.18, n ¼ 44) and a-carotene 0.12 (0.11,
0.13, n ¼ 53). In the sub-analysis by sex, females had higher (not
statistically signiﬁcant) plasma concentrations of the carotenoids a
carotene, b carotene, cryptoxanthin, lutein/zeaxanthin compared
with males ranging from 1 to 7% higher but not lycopene where
males had values approximately 16% higher.
3.3. Correlations
Weighted mean correlations between diet and plasma carot-
enoids by dietary assessment method are reported in Table 4. The
strongest correlation between diet and plasma values was for
cryptoxanthin, with a mean correlation coefﬁcient of (r¼ 0.38; 95%
CI 0.34 to 0.42) Fig. 2. This was followed by a-carotene (r ¼ 0.34;
95% CI 0.31, 0.37) Fig. 3, lycopene (r ¼ 0.29; 95% CI 0.26, 0.32),
lutein/zeaxanthin (r ¼ 0.29; 95% CI 0.26, 0.33) and b-carotene
(r¼ 0.27; 95% CI 0.25, 0.29). Females had stronger correlations than
males for all carotenoids except, lycopene. It was found that fasting
was not a confounding factor for the observed association between
serum carotenoids levels and dietary intakes. Although not used in
many studies, food records tended to demonstrate the strongestMean correlation 95% Conﬁdence interval
a carotene
All studies (n ¼ 41) 0.34 0.31, 0.37
24 h recall (n ¼ 10) 0.32 0.28, 0.35
Diet history X X
FFQ (n ¼ 29) 0.34 0.30, 0.38
Food record (n ¼ 7) 0.45 0.32, 0.56
Questionnaire (n ¼ 5) 0.26 0.10, 0.40
b carotene
All studies (n ¼ 73) 0.27 0.25, 0.29
24 h recall (n ¼ 12) 0.29 0.25, 0.34
Diet history (n ¼ 3) 0.33 0.12, 0.51
FFQ (n ¼ 53) 0.27 0.24, 0.29
Food record (n ¼ 14) 0.27 0.24, 0.31
Questionnaire (n ¼ 4) 0.29 0.10, 0.46
Cryptoxanthin
All studies (n ¼ 35) 0.38 0.34, 0.42
24 h recall (n ¼ 6) 0.41 0.32, 0.49
Diet history (n ¼ 0) X X
FFQ (n ¼ 25) 0.39 0.35, 0.43
Food record (n ¼ 5) 0.47 0.310 0.61
Questionnaire (n ¼ 3) 0.25 0.17,0.33
Lutein/Zeaxanthin
All studies (n ¼ 28) 0.29 0.26, 0.33
24 h recall (n ¼ 4) 0.39 0.34, 0.45
Diet History (n ¼ 0) X X
FFQ (n ¼ 23) 0.26 0.22, 0.29
Food record (n ¼ 1) 0.44 0.28, 0.58
Questionnaire (n ¼ 4) 0.39 0.23, 0.54
Lycopene
All studies (n ¼ 42) 0.29 0.26,0.32
24 h recall (n ¼ 6) 0.3 0.20, 0.42
Diet history (n ¼ 0) X X
FFQ (n ¼ 27) 0.26 0.22,0.29
Food record (n ¼ 7) 0.41 0.35, 0.46
Questionnaire (n ¼ 3) X X
X ¼ metanalysis not possible as not enough studies.
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tionnaires’ demonstrated the weakest.
4. Discussion
The present review identiﬁed 142 studies that had reported on
the validation of a dietary intake assessment method against
plasma carotenoid concentrations as biomarkers of fruit and
vegetable intakes in adults. In general, the quality of studies
included in this reviewwas high with approximately 80% achieving
a positive rating. The majority of studies were of cross-sectional
design with healthy adults of Caucasian background, with few
evaluations conducted in other ethnicities, such as African Amer-
ican, Hispanics and Asian populations. A lack of diversity across
study populations means that current validated dietary assessment
tools do not necessarily apply across nationally representative
populations and future studies should include a wider ethnicity
base.
FFQs were the most common type of dietary assessment
method used in the included studies. This is not surprising given
that this method typically assesses dietary intake over longer
reporting periods compared with weighed records or 24 h recalls.Fig. 2. a: Forest Plot correlation a carotene and all dietary methods from random effects m
carotene and food frequency questionnaire (FFQ). d: Forest Plot correlation a carotene andThe reporting periods of the FFQs varied between the previous one
month and 12 months. However, despite the FFQs ability to capture
food intake over a longer time period, this review indicates that the
strength of relationships were typically less strong. This is to be
expected, and partly explained by the considerable range in the
number of food items included in the food lists used in FFQs in
particular the number of fruit and vegetable items, and the half-life
of plasma carotenoids of 26e76 days [17]. Approximately one third
of studies that used an FFQ included details on the reporting period,
while just over one half provided information regarding the food
items included. The limited detail for some FFQs and the hetero-
geneity in the food lists, speciﬁcally fruit and vegetable items, used
to measure dietary intake of carotenoids makes interpretation
difﬁcult.
Overall the correlations found in this review were weak to
moderate ranging from 0.26 to 0.47, however these results need to
be considered in context with the amount of confounding variables
of using carotenoids as a biomarker including adiposity, infection,
differences in absorption, digestion. Fruits and vegetables are quite
varied in their composition of carotenoids whichmakes selection of
a single carotenoid as a biomarker an arduous task. b carotene and
lycopene were reported as the most abundant carotenoidsodel. b: Forest Plot correlation a carotene and 24 h recall. c: Forest Plot correlation a
food records. e: Forest Plot correlation a carotene and dietary questionnaires.
Fig. 2. (continued).
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assessed biochemically. The strongest associations between diet
and plasma carotenoids were cryptoxanthin and a-carotene. From
this review, we conclude that in order to achieve the best estimate
of carotenoid intake, food records should be used.
Food records showed the strongest correlation with plasma
concentrations and this may be due to extra detail provided in this
dietary assessment method such as weight or measure of the actual
food item, brand of food and cooking method, which allows for
more accurate alignment of the consumed item with matching
foods in nutrient databases and hence carotenoid intake estima-
tion. However it is noted that food records carry a high researcher
and participant burden, and are expensive to collect and analyse.
Higher correlations may also be attributed to the shorter time
framewith food records typically kept for a period of three to sevendays and including both weekdays and weekends and hence more
proximal to plasma concentrations. It should also be noted that
FFQs and estimated food records both have limitations in terms of
accurate assessment of carotenoid intakes, compared to alternate
measures of dietary assessment such as weighed food records.
Studies using brief or generic questionnaires (n ¼ 11) produced the
poorest associations. This is not surprising given these non-
standard approaches may not validly represent usual dietary
intake, but rather provide a general overview of speciﬁc aspects of
dietary intake only such as serves of fruit and vegetables.
Many of the studies were cross-sectional in design, meaning
dietary intake and biomarkers were assessed at a single time point.
Whilst this was suited to the speciﬁc aim of studies examining
associations between intake and biomarkers, depending on the
dietary intake method it is likely that the biomarker measurement
T.L. Burrows et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 15e64 59and assessment of dietary intake did not cover the exact same time
period, hence reducing the potential to detect relationships as
statistically signiﬁcant. The issue as to whether a single biomarker
assessment reﬂects a person's usual or longer-term intake, or
simply recent intake has been raised previously [52]. However, it is
usually assessment of longer-term intake that is more appropriate
for evaluating chronic diseases risk rather than short-term intake.Fig. 3. a: Forest Plot correlation Cryptoxanthin and all dietary methods from the random
correlation Cryptoxanthin and Food Frequency Questionnaire. d: Forest Plot correlation C
Questionnaire.Further work is needed to determine whether measurement of
carotenoids in other samples types, e.g. erythrocytes, adipose tissue
provide a more suitable, long-term biomarker of carotenoid intake.’
‘It has been suggested that the less invasive measure of skin
carotenoid concentrations are potentially bettermeasures of longer
term marker of intake however skin has higher turnover [54,55]
but limited studies have been conducted to date.effects model. b: Forest Plot correlation Cryptoxanthin and 24 h recall. c: Forest Plot
ryptoxanthin and Food Records. e: Forest Plot correlation Cryptoxanthin and Dietary
de
Study name Subgroup within study Comparison Outcome Statistics for each study Correlation and 95% CI
Lower Upper 
Correlation limit limit
Neuhoser et al total-questionniare-cryptoxanthinquestionnaire cryptoxanthin
cryptoxanthin
cryptoxanthin
cryptoxanthin
cryptoxanthin
cryptoxanthin
0.23 0.14 0.32
Satia et al Combined questionnaire cryptoxanthin 0.31 0.16 0.44
0.25 0.17 0.33
-1.00 -0.50 0.00 0.50 1.00
Favours A Favours B
Fig. 3. (continued).
T.L. Burrows et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 15e6460Although dietary assessment methods have a number of limita-
tions, including over- or under-reporting, biomarkers are an objec-
tive marker of dietary intake that can be used to examine
relationshipswith disease risk [56,57]. It is acknowledged that using
carotenoids as biomarkers also has some limitations. For example,
plasma carotenoid concentrations can be inﬂuenced by a number of
factors including: an individual's baseline plasma carotenoid con-
centrations; the intra and inter variability in individuals digestion
and absorption; the amount of fat in the diet; cookingmethods used
when preparing carotenoid rich foods; and vitamin A status. a and b
-carotene and cryptoxanthin are readily converted to vitamin A in
thebody, such that an individualwith lowvitaminA statuswill likely
have higher conversion rates and this may reﬂect in having lower
carotenoid concentrations. The use of carotenoids also carry some
controversies such that male smokers supplemented with b-caro-
tene were found to have higher incidence of lung cancer than
compared with those who received no supplement. While plasma
concentrations of carotenoids have their limitations, they are still a
good measure of dietary intake, particularly when you compare to
the limitations of reported dietary intakes. Given that assessing
nutritional biomarkers is not feasible in many studies, particularly
large scale epidemiological studies, it is important that the dietary
assessment methods used have at least been validated against bio-
markers in a representative sample of the population in which they
are to be administered. This could lead to increased conﬁdence in the
ﬁndings from studies using these validated methods.
The USDA database was the most common nutrient database
used across the included studies, followed by NCI and University of
Minnesota. This is not surprising given themajority of studies (68%)
were undertaken within the USA. However, the popularity of these
databases in included studies conducted outside the USA is likely
due to the regular updates (all revised in 2013) and extensive range
of nutrients available (range 140e180 nutrients). All three data-
bases report on individual food carotenoid levels except for the
estimates of lutein and zeaxanthin which are combined, due to
difﬁculty in resolving the HPLC peaks for lutein and zeaxanthin, as a
result of their similar retention time. Limitations of these databases
for studies conducted outside the USA are that the estimates are
based on the US food supply and therefore will not reﬂect true
carotenoid compositions of foods sources from other countries.
This will explain some variation in the correlation values inincluded studies using these databases, but are not from the USA.
An additional consideration could also include how many items or
questions are included in the dietary assessment method, when
using questionnaires, compared to the carotenoid database. For
example if an FFQ contained 100 items but only a few of these foods
captured major sources of dietary carotenoids in this population,
this would limit the assessment by underestimating intake.
b-carotene and lycopene were the dietary carotenoids assessed
most frequently in the included studies, and not surprisingly also
the two carotenoids for which plasma concentrations were highest
and hence evidence exists examining the relationship between
intake and disease risk [58]. However the strongest correlations
were found for cryptoxanthin and a-carotene, and not b-carotene
and lycopene. This is likely to be due to the increased variety of food
items containing b-carotene and lycopene in FFQs and there are less
food sources of cryptoxanthin.
The strongest correlations between dietary intake and plasma
levels were found for cryptoxanthin and a-carotene. This is likely
due to the fact that these carotenoids are rarely included in dietary
supplements, which eliminates the potential confounding effect of
supplemental doses. The moderate correlations found may be
attributed to these carotenoids being highly prevalent in fruits and
not vegetables. It is well documented that individuals are more
likely to meet fruit targets than vegetable targets [59].
There was large variability in reporting of the fasting time of
when blood specimens were collected. This makes direct compari-
sons difﬁcult especially when in some studies, only a proportion of
participants were fasted. As carotenoids enter the blood stream
within 3e4 h after food consumption, which is also dependent on
the amount of fat in a meal, whether the food is cooked/uncooked
and the type of food (or supplement), for example the relative
bioavailability of b-carotene from vegetables compared with puri-
ﬁed b-carotene ranges between 3 and 6% for green leafy vegetables,
19 and 34% for carrots and 22 and 24% for broccoli [60], the fasting
timecould affect theoverall comparisonswithdiet and likely to have
contributed to the variability in ﬁndings across the included studies.
4.1. Limitations
This review was limited to studies published in the English
language and may be predisposed to a publication bias and an
T.L. Burrows et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 15e64 61overrepresentation of studies that found positive associations be-
tween diet and plasma biomarkers. There was a high level of sta-
tistical heterogeneity among the included studies which indicates
that the results should be interpreted with caution. We addressed
statistical heterogeneity by reporting random effects meta-analysis
and sub-group analyses. The potential sources of heterogeneity
include variations in dietary assessment methods, the participant
populations including sex, age and ethnicity, the range of plasma
carotenoids assessed and the differing study protocols. The review
was also limited by the less than optimal methodological quality of
some of the included studies. However strengths include the large
number of studies evaluated, the registered review methodology
that adheres to the PRISMA guidelines for reporting of systematic
reviews and the provision of meta-analyzed reference ranges for
both plasma carotenoid concentrations and dietary intakes and the
relationship between the two variables.
In conclusion this review summarizes typical intakes and
plasma concentrations and their expected associations between the
two. These will assist researchers conducting future validation
studies in assessing the performance of their dietary intake in-
strument. It will also provide conﬁdence in the use of dietary
assessment tools as meaningful measures of fruit and vegetable
intake.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jnim.2015.05.001.
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